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Abstract 
The analysis of the enantiomeric purity of chiral carboxylic acids requires a 
reagent to give acceptable NMR chemical shift non-equivalence with a wide 
range of substrate acids. Extensive studies of the behaviour of N-mono-
methyl, N,N-dimethyl and cyclic amines as chiral solvating agents led to the 
finding that 1,2 diphenyl-1,2-diaminoethane can induce substantial non-
equivalence in the diastereomeric salts of chiral a-phenyl and a-halo 
carboxylic acids. The diastereoisomeric complexes of the diamine with 
primary carboxylic acids (RCH2CO2H) presents an unusual case in which the 
internally enantiotopic methylene protons are rendered internally diasteretopic 
by an external non-covalently bonded reagent. Investigations of the physical 
parameters determining non-equivalence (stoichiometry, concentration, 
temperature and substrate enantiomeric purity), combined with NOE 
observations of the diastereomeric pairs and the crystal structure of the mono-
hydrobromide salt were used to suggest the structure for the conformation 
responsible for shift non-equivalence. 
The zero valent platinum complex, 3-0-isopropylidene-2,3-dihydroxy-1,4-
bis(diphenyl-phosphino)butane-platinum(0)-ethene (DIOP-Pt-ethene) was 
shown to be a versatile chiral derivatising agent for electron poor and strained 
ri^-donors. This was demonstrated by the enantiomeric purity determinations 
for alkynes, enones and norbornene derivatives. The crystal structure of 
DIOP-Pt-ethene was determined and found to be similar to the palladium 
analogue. 
If the achiral rhodium complex rhodium(I)-acetylacetone-diethene undergoes 
a reaction with 2 equivalents of a suitable chiral ri^-donor, it will result in the 
formation of 4 stereoisomers, two meso forms and a pair of enantiomers. The 
diasteroisomers should display chemical shift non-equivalence in the NMR 
spectrum of the product, reflecting the enantiomeric purity of the ri^-donor (self 
recognition). The derivatisation of rhodium(l)-acetylacetone-diethene with 
chiral ri^-donors was attempted. 
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CHAPTER 1 
Introduction 
1.1 Chiral i ty: A Briet Review ol Enant iomer ic Discrimination 
1.1 Chiralitv: A Brief Review of Enantiomeric Discrimination 
The increasing interest in asymmetric synthesis has sustained interest in 
techniques for the production of chiral reagents. Such reagents require 
accurate and reliable methods of enantiomeric analysis. The pharmaceutical 
industry under regulations imposed by the E.C. in Europe and by the F.D.A. in 
the USA will be required to market chiral drugs as a single enantiomer. This is 
reasonable when it is considered that potential drugs with chiral centres can 
give enantiomers with different pharmacological responses. One enantiomer 
may possess the desirable properties whilst the other may be at best ballast or 
at worst may exhibiting potentially harmful side effects. S-Warfarin 1 is an 
anticoagulant with six times the activity of its R-enantiomer, whilst 
S-propanolol 2 is used as an antihypertensive and antiarythmic but the 
R-enantiomer acts as a contraceptive! 
There is a clear requirement for enantiomeric discrimination and enantiomeric 
excess determination in clinical pharmacology and pharmacokinetics where 
assignment of activity due to particular enantiomeric composition is often 
absent ^ 
The methods of chiral analysis are varied but most require the intervention 
of a chiral auxiliary to convert the enantiomeric mixture into a mixture of 
diastereoisomers with different physical properties. The wide range of 
techniques available permit a degree of choice in the measurement of 
enantiomeric purity. It is desirable that at least two of these methods are used 
to avoid any discrepancy between actual and observed enantiomeric 
composition arising from the systematic error of the procedure. 
1.1 Chiral i ty: A tJriel Review ol Enant iomer ic Discriminat ion 
The rest of this section will summarise the chromatographic and spectroscopic 
techniques routinely used to determine enantiomeric excess. Further 
emphasis will be placed on NMR methods of analysis in the following 
sections. 
1.1.1 ChiroDtical Methods 
Poiarimetry, optical rotatory dispersion and circular dichroism methods are 
often used in the assignment of absolute configuration and the determination 
of enantiomeric purity. The measurement of enantiomeric purity involves 
recording the optical rotation (a) of a sample of known concentration, solvent 
temperature and wavelength of the incident plane-polarised light. The specific 
optical rotation defined in (1) is used to determine optical purity, (2). 
roc]t = — ^ -(1). Optical purity = — — x l O O -(2). 
a ] p - Specific rotation of Sodium D line at temperature t 
I - Path lengh (dm) 
p - Density of solution g.dm-3 
^ ^ ^ D M a x ' optical rotation for pure enantiomer. 
1.1 Chiral i ty: A Briel Review ot Enant iomer ic Discr iminat ion 
This is an essentially simple and straightforward technique, but it suffers from 
several problems. Enantiomeric purity and optical purity are not always 
consistent. For example optical purity may not vary linearly with enantiomeric 
purity with 2-methyl-2-ethyl-butanoic acid"* in non-polar solvents. Reports of 
inconsistencies of optical purity with enantiomeric purity in polar solvents have 
also been noted ^. 
To determine optical purities the maximum rotation of the pure enantiomer 
must be known. There are, however, numerous examples of incorrect optical 
rotations quoted in the literature. Consider {+)-3-methyl cyclopentene 2 before 
1974 [a]D = +78°. After having used a chiral gas chromatographic method^ 
the rotation was revised upwards [afo = +174.5°. The enone 4 has an 
optical rotation [a]o = +34° (C. 1.0, CHCIs) ^ but it has also been reported to 
have a negative rotation [a]o = -115.4° (C. 0.2, CHCI3) 
Large samples must often be used to give measurable optical rotations 
(particularly with compounds chiral by virtue of isotopic substitution) and it is 
not always possible to correlate absolute configuration with the sense of 
optical rotation. 
O . JD 
Me. H 
"••CHsCOMe 
Ph 
0 " X " ^NHiPr 
'OH 
H Me 
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1.1.2 Gas Chromato^raphv (GC) 
Gas chromatography offers a sensitive and accurate method of chiral 
analysis^. A chiral auxiliary is required to separate the enantiomers. The 
method may involve the formation of diastereomers " which are separated 
on a stationary phase. Alternatively a chiral auxiliary can be bound to the 
stationary phase and resolution is brought about by diastereomeric 
interactions between the chiral analyte and a chiral stationary phase (CSP). 
Gil-Av performed the first resolution with the CSP N-tri-fluoroacetyl-i-
isoleucine lauryl ester 5 (coated on a glass capillary column) on esters of N-
trifluroacetyl-amino acids Care must to taken to avoid racemisation or 
kinetic resolution during diastereomer formation. The resolving agent must be 
enantiomerically pure or an error between actual and calculated purities will 
arise. The detector must of course respond equally to both diastereoisomers. 
The diastereoisomers formed must be sufficiently volatile and possess 
sufficient thermal stability to allow GC analysis. 
GC utilising a CSP is preferred because it suffers from fewer sources of error. 
The detector responds equally to both enantiomers, and the entiomeric purity 
of the chiral stationery phase will only perturb the size of the separation 
factor a (defined by equation (3)). 
K = additional volume above the void volume of the column required to elute 
the sample divided by the void volume of the column. 
1.1 Cliirality: A Briel Review ot Enant iomeric Discrimination 
.OR' 
I I R = sec-Butyl 
F X ^ N H - ^ ' ' ' ^ R' = dodecyl 
H 
Absolute configuration can be correlated with enantiomer elution order for 
closely related series on specific CSP ^2-15 j h e major disadvantage with this 
method is that the substrate must have sufficient volatility and thermal stability. 
This requires pre-derivatisation in many cases which at worst leads to 
racemisation, and at best is tedious. 
1.1.3 High Pressure Liquid Chromatoaraohv (HPLC) 
Liquid chromatography is now a popular technique for chiral analysis i 6 , i7 , i8 
and is amenable to most chiral substrates. The separation of enantiomers 
requires the intervention of a chiral auxiliary and can be carried out in one of 
three ways. The first indirect method involves derivatisation with a chiral agent 
followed by chromatographic separation of the diastereoisomers. The second 
involves direct analysis with a chiral auxiliary bound to the stationary phase 
(CSP). Finally a chiral auxiliary may be added to the achiral solvent creating a 
chiral mobile phase additive (CMPA). Diastereomeric complexes are formed 
in situ which elute at different rates. 
Helmchen carried out the early work on indirect resolution ^^ '^ ^ with 
diastereomeric amide derivatives such as 6 on silica and alumina columns 
with separation factor a = 2.5. P/rWe ^2-25 analysed diastereomeric 
carbamates of general structure 7 derived from chiral alcohols and 
1.1 Chlral i ty: A Briel Review ol Enant iomeric Discriminat ion 
isocyanates or chloroformates and amines. The separation factor was on 
average a = 1.5. After resolution the chiral substrate may be recovered. 
Analogously to GC derivatisation, the chiral auxiliary must not undergo kinetic 
resolution or racemisation during the derivatisation reaction. A reduction in 
the enantiomeric purity of the chiral derivatising agent will reduce the 
observed enantiomeric purity. 
Direct resolution on a CSP is usually achieved by binding a chiral auxiliary on 
to an achiral polymeric support, but there are now a large number of reported 
cases of direct resolution with chiral polymeric supports or with polymeric 
supports which possess chiral cavities There is a wealth of data relating 
to synthetic chiral stationary phases Most of this data supports the "three 
point mechanism" wherein the CSP must possess a minimum of three binding 
interactions, one of which is stereochemical, to bring about chiral recognition. 
This model has been questioned by Topiol^^, who suggested that one or two 
point mechanisms may also be operating in competition. 
Gil-AV^° and Linder^^ had early success in resolving amino acids with chiral 
mobile phase additives comprising amino acids, amino acid derivatives or 
chiral amines. The separation mechanism is complex and the technique is 
rarely used since it required a constant supply of the CMPA to be in the mobile 
phase. 
H O H 
H 
7 
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1.1.4 Analysis bv NMR Spectroscopy 
Introduction and Historical Perspectiye 
The NMR analysis of chiral substrates can be accomplished by one of three 
techniques ^2 inyolying either chiral lanthanide shift reagents (CLSR), chiral 
solvating agents (CSA)^^, or chiral deriyatising agents (CDA). Each method 
requires a chiral auxiliary to induce magnetic non-equivalence in the 
enantiomeric substrate. 
Chiral derivatising agents react with substrate enantiomers to form discrete 
diastereoisomers. Mislowand Raban first reported chemical shift non-
equiyalence (A5) in esters of 1-(2-fluorophenyl)-ethanol with the CDA 
1-methylphenylethanoic acid^''. The proton NMR spectrum showed A5 = 0 .09 
ppm (CCI4) for the methyl group of the substrate in diastereoisomer B-
Chemical shift non-equivalence with CDA's can be large, usually 5 times 
greater than with the corresponding chiral solvating agent. Kinetic resolution 
and racemisation of the CDA must be avoided during derivatisation. The 
chance of kinetic resolution can be minimised by using an excess of the chiral 
derivatising agent. Racemisation during the use of a CDA is usually avoided 
by careful design of the CDA and of the methods used in derivatisation. The 
CDA must be enantiopure for accurate enantiomeric excess determinations. A 
reduction in the enantiomeric purity of the CDA will reduce the derived 
enantiomeric excess value. 
1.1 Chlral l ty: A Briet Review ot Knantiomeric Discrimination 
Chiral lanthanide shift reagents and chiral solvating agents form association 
complexes in solution with the chiral substrate. These chiral complexes are in 
rapid equilibrium with the uncomplexed reagents. M's/owand Raban first 
suggested that enantiomers could be distinguished if a chiral solvent was 
used ^ . The first examples were reported by Pirkle with the CSA 
a-methylbenzylamine acting as the solvent for 1-phenyl-2,2,2-trifluoroethanol, 
S, (A5 =0.04 ppm for the -CF3 group in ^^p NMR). 
Normally only 2-3 equivalents of CSA to substrate are used. The components 
are dissolved in a polar, non-protic NMR solvent (eg CCI4, CDCI3 or CQDQ). 
The method is quick, convenient and the enantiomeric purity of the CSA has 
no effect on the observed enantiomeric purity. Peak intensities remain the 
same but the effect of decreasing CSA enantiomeric purity is to decrease the 
size of the chemical shift non-equivalence, A5 . The size of this non-
equivalence is small compared to those obtained with a CLSR or a CDA. 
Whitesides and Lewis^'^ first applied chiral lanthanide shift reagents to 
enantiomeric purity determination using the CLSR Eu(pvc)3lQ. Large A5h 
was observed with a-phenylethylamine for the methyl, methine and ortho 
aromatic protons. Chiral lanthanide shift reagents may suffer from solubility 
problems and are prone to decomposition. Hydrolysis for example leads to 
formation of EU2O3 which causes excessive line-broadening. These reagents 
are best used at low or medium NMR field strengths. At higher fields 
exchange line-broadening (proportional to Bq^  ) may be excessive. 
Me O 
8 9 
•Bu 
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1.2 NMR Methods of Analysis 
The popularity of the NMR assay of Enantiomeric composition is reflected in 
the literature by the wide range and rich diversity of chiral reagents and 
substrates tested. 
There are several comprehensive reviews detailing the progress and the use 
of CDA, CLSR and CSA^2,33,4o J^Q following sections will discuss recent 
developments in each of these areas. 
1.2.1 Chiral Derivatising Agents 
Derivatisation of an enantiopure compound with a mixture of enantiomers 
yields distinct diastereoisomers. To maximise chemical shift non-equivalence, 
a minimum of two interactions, one of which is stereospecific must be present 
(Figure 1). 
a 
a) Ph - R Stereospecific interactions 
b) Ph - R^ 
Figure 1 Esters derived from mandelic acid^^. 
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As mentioned before, derivatisation must exclude the possibility of 
racemisation or kinetic resolution i.e. the rates of diastereomer formation must 
be similar. 
This effect may be minimised by the addition of an excess of the derivatising 
agent. Purification must proceed without the selective enrichment of one 
diastereomer. Purification by means of chromatography is generally used 
instead of crystallisation. 
1.2.1.1 CDA's for and ^^F NMR Analysis 
Acids 
Mosher's reagent, a-methoxy-a-trifluoromethyl-2-phenyl-ethanoic acid 
(MTPA) ! ! , first published in 1969^9 is the most utilised CDA in and ^^ F 
NMR. Unable to undergo racemisation due to the lack of a a-hydrogen, it is 
used principally in the analysis of chiral amines and 1°, 2° alcohols by 
derivatisation with the chiral acid or acid chloride Chemical shift non-
equivalence A5h is usually in the order of 0.1 - 0.2 ppm and A5p = 0.3 - 0.7 ppm 
(CDCI3, 298K). MTPA has undergone kinetic resolution in only isolated 
occasions (e.g. with timolol 12''^ or the enone 12'*'') and is usually reliable. It 
has recently been applied to the analysis of absolute configuration. Kakisawa 
has examined various synthetic and natural substrates''^"^^ by application 
of "Mosher's model" (Figure 2a). In this model the carbinyl hydrogen, C-0 
carbonyl bond and the trifluoro methyl group lie in the same plane. The R, 
group in the S-MTPA derivative will be subject to diamagnetic shielding of the 
benzene ring and hence will appear to lower frequency relative to the R-MTPA 
derivative. 
1 1 
1.2 NIMR IVlethods ot analysis 
The enantiopure substrate is reacted with both MTPA enantiomers then 
resonances from the R-MTPA derivative are subtracted from the S-MTPA 
derivative to give A5 (A5 = 5s - 5r). The AS values will be positive on the right 
hand side of the MTPA plane and negative on the left hand side (Figure 2b). 
This is due solely to the shielding effect of the phenyl moiety. 
OMe Ph - R 
O M e - S 
Aa < 0 
OMTPA 
— R 2 
A8 > 0 
Figure 2 
Substrates such as Sipholenol-A 14, Sinulariolide 15a and 11-
episinulariolide 13h which contain a sterically hindered secondary hydroxyl 
group are not amenable to MTPA analysis of configuration Steric 
crowding of the MTPA groups forces it into a non-ideal conformation, 
producing irregular results. A suggested solution to this problem is to invert 
the hydroxy group into a less hindered position, although this might not be 
possible in all cases. 
Ph 
A - •OMe 
'COgH 
1 1 
NH'Bu 
1 3 
Me OH 
14 1 5 a ) R i = H . R 2 = 0 H 
b) Ri = OH , Rg = H 
12 
1.2 NiVlK Methods ol analysis 
Many analogues of MTPA have been prepared l £ a j " ' ^ ^ . IZ^^ with the 
intention of improving A 5 and enhancing reactivity. This has only been 
partially successful. Most analogues studied undergo racemisation under the 
reaction conditions required for sterically hindered alcohols and many 
a-fluorometic acid derivatives, e.g. 16f-j. are highly toxic requiring special 
handling ^ .^ss. 
The continuing popularity of MTPA overshadows alternative carboxylic CDA, 
for instance 0-methyl mandelic acid ^ '^^ ^ 18 and 0-acetyl mandelic acid ^° 19. 
These CDA's often give bigger A6h than the equivalent MTPA derivatives. 
The chiral derivatising agent Camphanic acid^^-^^ 20 and more recently 
2'-methoxy-1,1*-binaphthyl-2-carboxylic ac id^ ' '21 (MBCA), also both give 
consistent results for a range of enantiomeric alchohols and amines. They 
sometimes require the addition 
R 
X . X ' ^COaH 
16 
a) R = Ph , X = OMe f) R = SPh , X = F 
b) R = P h , X = ' B u g )R = P h , X = F 
c) R = Ph , X = CF3 h) R = OPh , X = F 
d) R = Ph , X = OH i) R = CH2Ph , X = F 
e) R = Ph , X = CI j) R =Ph , X = ON 
Ph 
F3C ( 
17 
•NCO 
'OMe 
Ph 
M e O ^ ^ C O a H 
Ph 
1 8 JL 
— A c O ' ' ^ C 0 2 H 
19 
20 
COoH 
21 
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of an achiral lanthanide shift reagent to enhance A5 (Eu(fod)3, fod = 6,6, 7,7, 
8,8,8 -heptafluro-2,2-dimethyl-3,5-octanedione). The MBCA derivative of 
menthol 22 has a value of A6h = 0.05 ppm (CgDg) for MeO- proton. This 
increases when 1 equivalent of Eu(fod)3 is added, to A5h = 0.70 ppm. 
1.2.1.2 Amines and alcohols 
Chiral amines are mainly used in the analysis of enantiomeric carboxylic 
acids, via the formation of the corresponding diastereomeric amides. An early 
example is a-Phenylethylamine^^'^^ 22 which was used for ^H NMR 
enantiomeric analysis. Later the CDA 2-Fluoro-2-phenyl-ethylamine '^^  24 was 
examined and an MTPA analogue 2,2,2-Thfluoro-1-phenethylamine^^ 25 was 
studied by Mosher. Both used ^^F NMR and A5p values for 24 ranged from 0.1 
- 0.6 ppm (CDCI3, 298K) while 25 had smaller values 0.05 - 0.092 ppm 
(CDCI3, 298K), Table 1. Methyl mandelate 26 has been used as a CDA for 
carboxylic acids Typical values of A5h = 0.2 ppm for diastereomeric 
esters were observed. 
Chiral 1,2-diaryldiamines 2Z have been used in the analysis of carbonyl 
compounds by the formation of diastereoisomeric i m i d a z o l i d i n e s T h i s 
diamine fails to react with ketones restricting its use to chiral aldehydes. 
Chemical shift non-equivalence ranges from 0.04 - 0.17 ppm [CQDQ) for ^^F 
NMR, and ^H NMR analysis gave an average value in the range 0.08 - 0.16 
ppm (CeDe). Chiral diols e.g. butan-2,3-diol and pentan-2,4-diol ^^ -^ ^ have 
similarly been used in the analysis of carbonyl compounds operating via 
formation of diastereomeric 1,3-dioxolanes. 
14 
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Table 1 
^^F Chemical shift non-equivalence data for derivatives of 24 and 2^. 
o 
R' -C-NHCH(CF3)Ph^ 
o 
R^CHR^-C--NHCHjCHFPh' a3f^ 
Entry ppm r ' r ' ppm 
1. PhCH(0CH3)- 0.050 Ph F 0.62 
2. PhCH(OAc)- 0.070 Ph OCOCH3 0.56 
3. PhCH(CH3)- 0.089 Ph OH 0.48 
4. 0.088 iPr NHGOCF3 0.28 
C H 3 0 ^ ^ = ^ - ^ 
0CH(CH3)-
1 
5. 0.066 Ph NHCOGH3 0.23 
6. PhC(OCH3){CF3)- 0.087 CH3 NHCOCF3 0.30 
7. 0.092 Ph CH3 0.17 
8. 0.084 CH3 0.10 
a) Observed at 400 MHz in CDCI3. The diatereoisomers resonate in the range 4.015 to 3.538 ppm 
(relative to CF3CO2H external standared). 
b) A^ is defined as the differance between R-acid; S-amine and R-acid; R-amine diastereoisomers. 
c) Observed at 94.18 MHz in CDCI3. The diatereoisomers resonate in the range -22.45 to -21.48 ppm 
(relative to CfiFg ). 
d) A8p is defined as the differance between enantiopure amine and R/S acid. 
22 
Ph 
23 
Ph 
H C ^ ^ C O a M e 
26 
Ph 
F ' ^ C H g N H a 
24 
Ar,,. NHMe 
A r ^ NHMe 
27 
Ph 
F . C ^ N H p 
25 
a) Ar = CgHg 
b) Ar = 0-CF3C6H4 
0) Ar = m-CF3C6H4 
d) Ar = P-CF3C6H4 
15 
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1.2.1.3 CDA for 31P NMR Analysis 
There are several distinguishing features that make phosphorus-31 NMR 
desirable in the NMR determination of enantiomeric purity. The sensitivity of 
the nucleus is quite high with a large chemical shift dispersion. The 
availability of broad-band proton decoupling reduces the complexity of the 
spectrum. Usually only signals for the diastereoisomers are observed with no 
interference from other peaks. A number of reagents with similar structures 
have been examined. Chlorodioxaphospholane 2^' '^ for instance is a CDA for 
enantiomeric 1° and 2° alcohols and gives A5p 0 -0 .13 ppm (CDCI3 ) . The 
binaphthyl 22.'^^ forms diasteroisomeric phosphates with larger A5p in the 
presence of 1-methylimidazole. For both these reagents derivatisation with an 
enantiopure alcohol produces only one diastereoisomer due to the 
enantiotopic nature of the phosphorus atom which results from the C2 
symmetry of the molecule. 
The chiral derivatising agent 3Q^° derived from (1R,2S)-ephedrine reacts with 
chiral amines and alcohols usually with retention of configuration although 
some stereochemical scrambling is possible ^2. Values of A5h for the thio 
analogue are larger than for the equivalent phosphate and typically range 
from 0.11-0.84 ppm. 
Investigations by Alexakis^^'^'^ have led to the evaluation of several 
phosphorus(V) 31a-e and phosphorus(lll) 32a-c based CDA's. The reactivity 
of reagents 31a-e with many simple enantiomeric alcohols was very low. The 
lithium or sodium alkoxide was formed therefore (nBuLi or NaH) before adding 
the phosphorus(V) CDA, followed by reflux in THF for 2-6 hours. Although this 
solved the problem of reactivity, no reaction was seen with hindered 
secondary or tertiary alcohols. The strongly basic conditions made it 
impracticable to analyse C-silylated propargylic alcohols e.g. 22. due to partial 
16 
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Me 
M e - V P h ^ V 
28 ^ ^ - ^ 30 ^ = ° - 5 
29 
Me 
I 
f ^ V / \ ^0 c)R = Ph 
a)R = iPr T ^ p f d) R = Ph 
^^^ = ^ ^ r - ' ^ ^ N ^ CI e) R = p-CF3Cehi; 
I 
Me 
31 
desilylation. The reagent 31e gave the largest A5p with 2-Butanol A 5 = 0.54 
ppm (CeDe) although its applicability to other chiral alcohols was not stated. 
The reagent 21h gave consistent results with both 1° and 2° alcohols 
( A5p = 0.34-1.3 ppm). 
The high reactivity of chiral phosphorus(lll) CDAs 32a-c under mild reaction 
conditions (Toluene, RT., 2-15 hours) makes these reagents of more general 
use in analysis. The largest chemical shift non-equivalence was observed 
with 22£ (Table 2 gives selected data for 1°, 2° and 3° alcohols). Reactions 
of the air sensitive derivatives 32Q with sulphur yield diastereomehc 
thiophosphohmidates, which are air stable and suitable for GC analysis, but 
have reduced A5p values. Problems were encountered with diols and some 
alkyne and allene functionalised alcohols which underwent rearrangement or 
further reactions. 
Analysis of chiral ketones with a chiral hydrazine CDA M h a s met with 
limited success and only some chiral monosubstituted cyclohexanones have 
been studied. 
1 7 
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Table 2 
31P Chemical shift non-equivalence data for derivative of 22 with 1°, 2° and 3° 
alcohols. 
Me Me 
Entry R= ppm Ppm 
1. PhCH(CH3)CH20H 0.673 0.065 
2. nBuCH(CH3)CH20H 0.539 0.016 
3. (CH3)2CCHCH2CH2CH(CH3)OH 0.538 0.032 
o 
4. " ^ " ^ " " ^ O H 1-750 0.024 
5. PhCH(0H)CHCl2 12.182 1.010 
6. PhCH(OH)C(CH3)N(CH3)2 11-442 1.386 
7. 16.221 0 
OH SiMe3 
8. ^'^^^ 
9. CH3CH2CCH3(OH)Ph 1.728 0.118 
10. ) ^ ' ^ X " ° 
a) ^ NMR spectra were recorded at 36.22 MHz in C^De. The diastereomeric resonances were in the 
range of 147.061 to 130.840 ppm. 
b) ^ 1P NMR spectra of the Thio derivative were recorded at 36.22 MHz in C^D^. The diastereomeric 
resonances were in the range of 88.427 to 85.600 ppm. 
R 
Ph'" N 
R 
32 
Me 
OH I 
NHNHj 
I ^p(^ V ] ::pt-| 
3 3 3 4 1 5 
1 8 
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The achiral reagent PCI3 introduced by Feringa^^ will react with 2 equivalents 
of a chiral alcohol or thiol to produce two meso-forms and a pair of 
enantiomers, Figure 3. Recognition derives only from the combination of 
interactions of the enantiomeric substrates. For instance 1-phenyl-1-propanol 
will react with PCI3 in pyridine to yield four isomers (R*0)2PH0, which give 
three singlets in the ^^P NMR spectrum: Two for the meso form and one for the 
2 enantiomers. It has been suggested recently that formation of the equivalent 
tri ester will impart greater accuracy in enantiopurity measurements Feringa 
has continued this work with the introduction of several phosphorus 
analogues with increased A5p . The reagents MeP0Cl2 and MePSCl2 
give rise to typical values of A5p = 0.5 ppm (CDCI3) 
The organometallic CDA 25 has been devised for the ^^P NMR analysis of 
chiral 2-electron donors such as alkenes, alkynes and allenes. The zero 
valent DIOP-platinum and palladium ethene complexes were studied ^ "^^ 2. 
Displacement of ethene with electron-poor or strained alkenes, alkynes or 
allenes in situ (THF or CQDQ) followed by subsequent ^^P NMR analysis gives 
good AS for the diastereomeric complexes. 
The enantiomeric purity of a-amino-phosphonic acids has been analysed by 
the formation of their palladium(ll) complexes with PdC^^- in D2O'*'*. This 
yielded a single meso diastereoisomer and an enantiomeric pair 36 for which 
A5p = 0.1 ppm (pD 8.5, 298K). 
R-OH + PCIa 
(R,R) - (R 0)2PH0 
(S,S) - (R 0)2PH0 J 
(R,S) - (R 0)2PH0 
(S,R) - (R 0)2PH0 
Figure 3 
1 9 
Enantiomeric 
pair 
Non-equlvalant 
Meso pair 
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1.2.1.4 CDA's for NMR Analysis of Other Nuclei. 
Diphenyldichlorosilane has been used as a CDA in the determination of the 
enantiomeric purity of chiral alcohols using both ^^Si NMR^^ and ^^C NMR^^. 
Initially, derivatisation was carried out in two stages, first with an 
enantiomerically pure alcohol, menthol, quinine or methyl mandelate, followed 
by reaction with the enantiomeric alcohol to be analysed, e.g. the silyl metal 
diastereoisomers 21 had A5si = 0.053 ppm (CDCI3, 298K). NMR 
investigations involved derivatisation using two equivalents of the chiral 
alcohol with the achiral coupling reagent Ph2SiCl2, to produce two equivalent 
meso forms and a pair of enantiomers in an analogous manner to the ^'P NMR 
achiral reagents discussed earlier. Non-equivalence was typically 
A5c = 0.07 ppm (CDCI3, 298K) with a value of A5c = 0.10 ppm reported for 
the menthol derivation 22.- No data for ^^Si non-equivalence was given 
The chiral Pt amine complex 22. has been used in the determination of the 
enantiomeric purity of chiral allylic ethers, alcohols^'' and chiral trisubstituted 
allenes^^. The chiral substrate displaces the bound ethene in the complex to 
form four diastereomeric complexes (Figure 4). Non-equivalence is of the 
order of A5pt = 22 ppm (d6-Me2CO, 298K). 
NH2 o 
0 NH2 , \/ 7 
Pd 
NH2 
R 
.0 
0 
(R,R) (R,S) meso 
36 
2 0 
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The insensitivity of ^^^Pt and the line broadening associated with chemical shift 
anisotropy at high field of ^^^Pt NMR means that a considerable amount of 
complex is required (>100 mg) for adequate signal/noise to be attained. This 
problem renders this technique unsuitable for routine analysis. 
The selenium based reagent (45,5R)-(-)-4-methyl-5-phenyl-oxazolidine-2-
selone 4Q was recently reported as a CDA for chiral acids The relative 
sensitivity of ''''Se nucleus (2.98 compared to carbon, 6.93 x 10"^ with respect 
to hydrogen) coupled with a large chemical shift range (-3400 ppm) and a 
particular sensitivity to electronic environment makes such a reagent worth 
considering as a CDA; The selenocarbonyl group itself has a relatively short 
relaxation times (1-8 seconds) with a large chemical shift range (2,600 ppm). 
The CDA 4Q has subsequently been used to assay acids with remote chiral 
centres. The reaction of RS-5-methyl-heptanoic acid and lipoic acid with the 
enantiopure selone yielded the N-acylated selones 41 with ASge = 0.09 ppm 
and A5se = 0.119 ppm respectively. 
Ph 
^Si ^COgMe 
P h ^ - O - . 
Me 
3 7 
3 8 
2 1 
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CI 
Pt' Ph 
' • N H 2 ^ 
Me 
39 
Se 
Ph 
R 
O Se 
II a) R = CH3CH2CH(CH3) 
N O s ^ 
•ph 
41 
40 
C o n s t i t u t i o n a l isojTiers 
P t — A m P t — A m 
S** 
R2^ 
,R1 Ri-
Cl 
•P t—Am CI 
'R3 R3t 
D i a s t e r e o i s o m e r s 
,3* 
CI 
-P t—Am 
CI 
•R2 
Figure 4 
1.2.2 Chiral Lanthanide Shift Reagents 
The hexacoordihate lanthanide shift reagents form weak addition complexes 
with enantiomeric substrates, which are in rapid equilibrium with their 
unbound entities. Chemical shift non-equivalence results from the proximity of 
a given nucleus from the chiral lanthanide donor in the diastereomeric 
2 2 
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complex. The induced shift arising from the through space magnetic effects of 
unpaired electron magnetic moments (pseudo contact shift) in the seven co-
ordinate complex is described by the McConnell equation (4). 
A 5 = k ( 1 - 3 cos20)r -3 (4) 
r - distance from metal centre. 
0 - number of degrees the nucleus deviates from the principle axis of 
symmetry. 
As can be seen in (4), small changes in distance may lead to large non-
equivalence. Line broadening for LSR is proportional to BQ^ (The applied 
field). This increases their usefulness at low field (< 100 MHz) where overlap 
of broad resonances is greatly reduced or eliminated. 
Many commonly used CLSR are camphor based ligands and are structurally 
similar to the CLSR first introduced by Whitesides'^'^ IQ. {f\Qure 5) 
10 
4 2 
R = Bu , M = Eu - Eu[pvc]3 4 3 M = Eu - Eu[dcm]3 
a ) R = C F 3 , M = Eu - Eu[tfc]3 
b)R = CF3 , M = Pr - Pr[tfc]3 
c) R = CF3 , M = Yb - Yb[tfc]3 
d) R = C3F7 , M = = Eu - Eu[hfc]3 
e) R = C3F7 , M = Pr - Pr[hfc]3 
f ) R = C3F7 M --= Yb - Yb[hfc]3 
tfc — trifluorohydroxymethylene-d-camphorato 
hfc = heptafuorohydroxymethylene-d-camphorato 
dcm = dicamphoyl-d-methanato 
Figure 5 
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The reagent Eu(dcm)3 42 displays considerable differential shift dispersion, 
Eu(hfc)3 426 gives large A5 for diastereomeric complex in ^^C NMR but is out 
performed by Pr(Hfc)3 42e in NMR displaying large A5 for low 
concentrations of shift reagent, while Yb(hfc)3 42f is better for analysing chiral 
s u l p h o x i d e s ^ ° 4 ' i ° 5 ' i ° 6 
The achiral shift reagent Pr(tpip)3 44 [tpip = tris (tetraphenyl-
limidodiphosphinateo)] has been used as a CLSR for the determination of 
enantiomeric purity of carboxylic acids The chiral potassium 
carboxylate salts form dinuclear complexes with the reagent which are in slow 
exchange on the NMR time scale. The diasteromeric complexes (SS/RR, RS) 
are observed in the NMR spectrum. 
Eu(tfc)3 and Eu(hfc)3 are routinely used in the analysis of enantiomeric 
donors and have become an unofficial defacto standard for such 
analysis, regardless of the performance or better alternatives. These reagents 
need to be dried before use or the hydrolysis product E U 2 O 3 may cause 
severe line-broadening. 
Chiral carboxylic acids are analysed as 3° amides or directly in aqueous 
solution There are also reported cases of the analysis of chiral a-
amino acids in aqueous solution with Eu(EDDS) 45 [EDDS = (S.S)-
ethylene diamine-N, N'-disuccinic acid] and Eu(pdta) 46 [pdta = 1,2-
propane diaminetetra-acetate]. Chiral alkenes, arenes and allenes have been 
analysed with a mixture of Yb(hfc)3 42f and achiral shift reagent Ag(fod) 
47120-127 Chemical shift non-equivalence is typically 1 ppm for chiral alkenes 
and 0.3 ppm for arenes and allenes. 
2 4 
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By optimising data acquisition parameters and manipulation of the free-
induction decay, accurate values for enantiomeric excess can be obtained 
At low e.e. values (40-60%) accuracy is of the order ±2% ^^s, but this increases 
to ±10% with e.e. > 90% High enantiomeric purities are prone to error 
because it is difficult to identify the exact position of the minor diastereomeric 
resonance. It is possible to determine the S-minor diastereomeric position 
with calibration plots of the induced shift of the S-enantiomer against 
Induced shift for the R-enantiomer, following successive addition of the shift 
reagent to the racemic substrate. 
Ph^P^ 
Na^ 
4 4 4 5 
4 6 
Na^ 
*Bu 
C3F7 
A o ^ ^ g 
4 7 
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1.2.3 Chiral Solvating Agents 
Unlike CDA's and CLSR's chiral solvating agents form diastereoisomeric 
solvation complexes with solute enantiomers which are in rapid equilibrium 
with the solvent. 
-'ach KR . ^ 
RcSA + R* ^ — ^ RcSA-R* ' ( 5 ) 
Jach 
RcsA + S* •• — 1 - RcsA-S* - (6) 
Chemical shift non-equivalence may be induced by several factors, including 
solute-solute interactions but such interactions are negligible in the 
presence of a strongly solvating CSA and only become apparent at high 
concentrations. 
The two major factors determining chemical shift anisochrony are described 
by equations (5) and (6). Firstly, the two diastereomeric solvates may have 
slightly different spectra, possibly due to the position of a magnetically 
anisotropic group in the solvation complex. Secondly, if solvation causes 
changes in chemical shift, then the extent to which the enantiomers are 
solvated (KR and Ks) will result in non-equivalence. 
Exchange between 'solvent solvated' solute (R* and S*) and the 'chiral 
solvated' solute (RcsA^^* ^^^1 R C S A ^ * ) is rapid on the NMR time scale. The 
observed chemical shift for each enantiomer Sobs and b^^s is a function of the 
2 6 
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weighted averages for the populations of the achiral, 5ach and chiral 6R, 5S 
solvate resonances. If 0R and 0s are the fractional populations of achiral 
solute, then equations (7), (8) and (9) are derived. 
KR = (1-0R)/0R ; Ks = (1-0s)/0s -(7) 
5obs = 0R-Sach + (1 -0R)-5R ; ^tbs = 0S-5ach + (1 -^s)-h ' (8) 
A5 = 0R(6ach + KR.6R) - 0s{5ach + Ks.5s) - (9) 
It can be seen that A5 depends on the equilibrium constant for solvation and 
hence the relative amounts of CSA and solute. 
The most common model used to account for CSA chiral molecular 
recognition is the "Three Point Rule". This states that chiral recognition 
requires a minimum of three interactions between CSA and solvate to bring 
about non-equivalence, one of which must be stereochemically dependent. 
The types of interactions include single point i.e. hydrogen bonding, end to 
end dipole-dipole interactions, proton transfer or multi-point interactions 
including dipole stacking and charge transfer complexation (71-acid to jr-base). 
The stereochemical interaction must distinguish between solute enantiomers 
and not be collinear with the others. 
There is a considerable range of compounds which could be considered as 
CSA, for instance molecules involved in host-guest complexation e.g. 
cyclodextrins, chiral crown ethers, chiral synthetic receptors or any other 
substrate that will bring about NMR non-equivalence by chiral molecular 
recognition. 
27 
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The essential requirements of a CSA are that it must have complementary 
functionality to the solute, a simple NMR spectrum which will not interfere with 
observed solute resonances, it should incorporate anisochronous groups 
such as aryl, carbonyl or lone-pairs and it must be soluble in the solvent used. 
The enantiomeric purity of the CSA will not affect the diastereomeric 
composition obsen/ed in the NMR spectrum. Decreasing the enantiomeric 
purity of the CSA merely decreases the obsen/ed AS by the introduction of Ss. 
and SR. terms into equations (5) and (6) respectively. This is due to the 
formation of their enantiomers by the complementary CSA. 
Usually the chemical shift non-equivalence induced by a CSA is relatively 
small. The technique is rather limited to relatively non-polar solvents e.g. 
C D C I 3 , CqDq, C C I 4 , C D 2 C I 2 . These solvents maximise anisochrony by ion-
pair formation. More polar solvents lead to the break-up (solvation) of ion-
pairs and give reduced or zero values of AS. 
Although CSA's offer distinct advantages in ease of utilisation and analysis 
they remain perhaps the least popular technique. This is reflected in the 
published literature. Chiral solvating agents can be divided into two types: 
Those in which primary association between CSA and solute is electrostatic 
(mainly hydrogen bonds) and secondly those where complexation is achieved 
by complete proton transfer (salt formation). 
1.2.3.1 Electrostatic CSA 
The most commonly used CSA of this type is 1-(9-anthryl)-2,2,2-trifluoro-
ethanol 48 ^^S-HS introduced by Pirkle^^^ from earlier observations of 
2,2-thfluoro-1-phenylethanol with CSA R-a-phenylethylamine and R-2-
naphthylethylamine The alcohol 48 has been used for lactones 
2 8 
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HO^ X F ; 
4 8 
CH: 
CH3 Q 
• c 
P h 2 
^OH 
, 0 H 
4 9 
.OCH. 
ethers oxaziridenes ^^ ''^  and sulphinate esters A more recent 
example of a CSA the primary interaction of which is hydrogen bonding is that 
of 49 with selected primary and secondary alcohols Typical non-
equivalence was of the order of 0.05 ppm (1:2 ratio alcohol: 49, CDCI3, RT). 
1,5-Benzothia2epine 50 reportedly acts as a CSA for chiral alcohols, acids 
and other 1,5-Benzothiazepines but non-equivalence is very low, typically 
0.003 ppm (CDCI3, RT.). 
An unusual CSA is Troger's base 51, a chiral tertiary amine with nitrogen 
stereogenic centres, used in the analysis of secondary and tertiary alcohols 
it is ineffective in the analysis of chiral acids which bring about racemisation of 
the base, although the strongly acidic (-)-1,1-binaphthalene-2,2'-diylhydrogen 
phosphate 52 was used to resolve the base by crystallisation-induced 
asymmetric transformations of the salt. Non-equivalence is typically of the 
order of A5 = 0.02 ppm (CDCI3, 298K). 
5 1 5 2 
0 . / 
2 9 
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The CSA 2,2'-dihydroxy-1,1'-binaphthyl 52 introduced by Toda^'^^'^^^ has 
been used in the analysis of a wide variety of chiral compounds, recently 
Michalik'^^^ has suggested (based on experimental observations) that optimal 
non-equivalence may be observed with the cyclic amimo alcohol M and the 
CSA 52 in which both hydroxyl groups are involved in complexation. The diol 
55 has been used by Toda in the enantiomeric purity determination of chiral 
amine oxides ' ' ^ 2 . Chemical shift non-equivalence in the N-methyl groups 
of 52 was approximately 0.05 ppm (CDCI3, 295K). The general purpose CSA 
4,4',6,6'-Tetra chloro-2,2'-bis-(hydroxydiphenylmethyl)-biphenyl 5 Z ' " has 
been reported for the determination of non-equivalence in a range of N, P, S 
containing compounds. It was found to be effective in the determination of the 
absolute configuration of sulphoxides (Table 3). R-sulphoxides appear to 
lower frequency and non-equivalence was > 0.05 ppm. 
5 3 
OH 
NHCH3 
5 4 5 5 
5 6 
R = H , Me 
C(0H)Ph2 
C(0H)Ph2 
3 0 
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Table 3 
The chemical shift non-equivalence and the assignment of absolute 
configuration of selected sulphoxides with CSA 57. 
Entry Subs t ra te^ 
Observed 
resonance 
under l ined 
D ias te reomer i c 
resonance^ 
ppm 
A5, 
ppm 
1. Ph-SO-CH„ 2.446 R-(+) 0 .052 
2.498 s-(+) 
2. m-Toi -SO-CHg 2.375 R-(+) 0.105 
2.480 S-{+) 
3. P-T0I-SO-CH3 2.513 R-(+) 0.048 
2.561 S-{+) 
4. n-Bu-SO-CH„ 2.217 R-(+) 0.080 
0 2.297 s-(+) 
5. n -Am-SO-CH„ 2.300 R-(+) 0.088 
2.388 S-(-H) 
6. n -Hex-SO-CH. 2.286 R-(+) 0.048 
2.334 S-(+) 
7. n-Hep-SO-CHg 2.318 R-{+) 0.040 
2.358 S-(-H) 
8. n -oc t -SO-CH„ 2.227 R-(+) 0.053 
2.280 
a) The Spectra were recorded in CDCI3 
b) Absolute configuration of the solute is assigned to the observed resonances. 
1.2.3.2 Diasteromeric salt formation 
Salt formation usually leads to quite large chemical shift non-equivalence. 
Close ion-pair formation, due to rapid exchange between the CSA and the 
solute in the achiral solvent, is responsible for this non-equivalence. 
3 1 
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K 
(+)HA + (±)B 
CSA Solute 
(+)BH : (-H)A 
(±)BH + {+)A 
Solvent seperated 
ion-pair 
(-)BH : (-.)A 
Close ion pair 
The CSA's (R)-a-phenylethylamine and (R)-2-naphthylethylamine have been 
used for the analysis of chiral carboxylic acids via diastereomeric salt 
formation 154-162 J ^ Q observed chemical shift non-equivalence was small, 
A5H 0.05 ppm ( C D C I 3 , 298K). There are very few other amine CSA's which 
have been studied in this context although in this work 1,2-diphenyl-
1,2-diamino-ethane 53 will be shown to be an excellent CSA with typical 
values of AS of 0.15 ppm ( C D C I 3 , 293K) for a range of chiral acids. 
A more thorough investigation has been made using carboxylic acid CSA's in 
the analysis of chiral amines and amino-alcohols •'^ s-^ ey J^^Q Q Q ^ 
MTPA has been examined as a potential solvating agent, but its use is limited 
due to the low solubility of its salts 
F3C 
Ph 
/ \ - O M e 
CO2H 
1 1 
Ph^^^^NH2 
Ph^^  ^NH2 
5 8 5 9 
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1.2 NMR Methods oi analysis 
The effect of temperature, concentration, CSA:solute ratio on A5H has been 
studied for the amine 52. Decreasing the temperature increased A5H while at 
high salt concentrations A5H is reduced due to ion-pair aggregation. Non-
equivalence reaches a maximum at 1:1 stoichiometry corresponding to 
complete salt formation. The enantiopure 0-Acetyl mandelic acid I S and 
1,1'-binaphthyl-2,2'-diylphosphoric acid 52 gave large A5H , typically 0.08 
ppm {CQDQ, 293K) and 0.15 ppm {CQDQ, 298K) respectively for a range of 
chiral substrates. These salts tend to be reasonably soluble in non polar 
solvents. In the case of 0 A M the disassociated equilibrium constants are not 
always equivalent for the diastereoisomers, so that the enantiomeric 
composition, has been observed to affect A5H 
3 3 
CHAPTER 2 
Chiral Amines as Chiral Solvating Agents 
3 4 
2.1 Introduction 
2.1 Introduction 
There are many examples of carboxylic acid CSA's for amines (see Section 
1.2.3). The complementary experiment, where a chiral amine is used as a 
solvating agent for chiral carboxylic acids has received very little attention. 
The preferred method of chiral acid analysis requires the formation of an ester 
or amide derivative. With this in mind, a series of N-Mono-methyl,.N,N-
dimethyl and cyclic amines were initially examined (60-67) as potential CSA's 
for a limited range of chiral acids. The chiral amines possessed a minimum of 
one anisotropic group, (aryl group, carbonyl group, or additional Nitrogen lone 
pair) which is required to induce magnetic non-equivalence in the 
diastereomeric salt complexes by stereospecific interactions between the 
observed functionality and the anisotropic group. The interaction usually 
leads to a differential anisotropic shift between the two diastereomeric salt 
complexes. These initial investigations and subsequent observations led on 
to the consideration of 1,2-diphenyl-1,2-diaminoethane as a CSA for 
carboxylic acids. 
This chapter will discuss these chiral amines in the context of their ability as a 
CSA. 
2 . 2 q-Aryl-dimethylethylamines as Chiral Solvatina Agents 
The chiral amines a-phenylethylamine and a-naphthylethylamine have been 
examined previously as CDA's for carboxylic acids. a-Phenylethylamine and 
the 2-naphthyl-ethylamine analogue have been examined previously as 
CSA's (see section 1.2.3.2), although the observed chemical shift non-
equivalence was found to be small. 
3 5 
2.2 a-Aiyl -dimethylethylamlnes as chirai solvating Agents 
The tertiary amine analogues, with greater gas phase basicities then their 
primary and secondary amines could be considered to have increased 
solvating ability. The reagents £Q to 52 were examined as CSA's for the 
racemic acids 2Q, 55-7Q. The amine was added to the acid (1:1) in both 
CDCI3 and CQDQ. 
Ph 
H 3 C ' X N ( C H 3 ) 2 
6 0 
Ph 
( C H 3 ) 2 N ^ ^ C 0 2 M e 
6 1 
6 2 
N(CH3), 
Ph 
NHR 
6 3 
a) R = PhCHa-
b) R = CH3-
H 3 C ^ ^ N R C H 3 
P h - ' ^ G H 
6 4 
a) R = H 
b) R = CH3 
HgCRN^^CHg 
P h ^ ^ O H 
6 5 
a) R = H 
b) R = CH3 
a) R = -O^Bu 
b) R = -NH2 
c) R = -NH-P-NO2C6H4 
d) R = -NHMe 
6 6 6 7 
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2.2 a-Aryl-dimethylethylamines as chi ra l solvating Agents 
2.2.1 N.N-Dimethvl-1-Phenvlethvlamine (60) 
This commercially available reagent showed no chemical shift non-
equivalence with the racemic acids studied. 
2.2.2 N.N-Dimethvl-2-Phenvlalvcine Methyl Ester (61) 
The CSA was easily derived from 2-phenylglycine but showed chemical shift 
non-equivalence with only camphanic acid which is itself a CSA for chiral 
amines. The observed chemical shift non-equivalence AS for the 
diastereotopic Me groups was sufficient to provide enantiomeric purity 
determination. Spectrum 1. 
2.2.3 N.N-Dimethvl-1-n-naphthvn-ethvlamine (62) 
Derived from 1-(1-naphthyl)-ethylamine, this CSA also showed non-
equivalence with camphanic acid only, Spectrum 2. The methyl doublets 
were only partially resolved hindering the ease of enantiomeric purity 
determination. 
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2.2 a-Aryl-dimethylethylamines as chl ra l solvating Agents 
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2.2 a-Aiyl-dimethylethylamines as chira l solvating Agents 
Ph 
H C ^ C O g H 
Mandelic acid 
6 8 
Camphanic acid 
2 0 
Ph 
H g C ^ ^ C H s C O s H 
3-Phenylbutyric acid 
6 9 
Ph 
H g C ^ C O s H 
2-Phenylpropionic acid 
7 0 Ibuprofen 
7 1 
CH2CH(CH3)2 
Ketoprofen 
7 2 
Ph 
A c O ' ^ ^ C O a H 
0-Acetylmandelic acid 
1 9 
Ph 
OMe 
COgH 
MTPA 
1 1 
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2.3 a-Aiyl -N-methyl Amines as Ch i ra l Solvating Agents 
2 . 3 g-Aryl-N-methyl Amines as Chiral Solvating Agents 
The observation that In the enantiomeric analysis of equivalent 1°, 2°, 3° 
amines with a carboxyllc acid CSA such as mandellc acid secondary 
amines usually gave the larger chemical shift non-equivalence compared to 
the 1° and 3° amine diastereoisomeric complexes led to the study of the 
reciprocal experiment. Two secondary chiral amines were tested against a 
range of racemic carboxylic acids to assess their effectiveness as CSA. The 
results are summarised in Table 4. 
2.3.1 N-Benzvl-Phenvlethvlamine (63a) 
The benzyl substituted amine was prepared from enantiopure 
phenylethylamine and displayed non-equivalence with only mandelic acid 
and to a lesser extent, with 0-Acetyl mandellc acid (Table 4). The results 
suggest that non-equivalence was facilitated by the presence of an a-ether 
oxygen. The very limited use of this compound makes it unsuitable as a CSA. 
2.3.2 N-Methvl-1-Phenethvlamine (63b) 
The N-methyl amine £3b gave consistent results with the chiral acids tested 
(Table 4), except in the case of 2-phenyl-propanoic acid where non-
equivalence was not observed. 
The poor solubility of the mandelic acid salt necessitated the addition of a 
small amount of de-pyridlne. Values of A5 were small, but offered some 
improvement over the corresponding tertiary amine analogues. The observed 
non-equivalence between 63b and racemic mandelic acid (1:1 in CDCI3) is 
displayed in Spectrum 3 for the methine portion of mandelic acid (5.0 ppm). 
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2.3 a-Aiyl -N-methyl Amines as Chi ra l Solvating Agents 
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2.4 Ephedr ine and N-methyl Ephedrine as CSA 's 
2 . 4 Ephedrine and N-methvl Ephedrine as CSA's 
Extensively studied as reagents In chiral HPLC methods of analysis, 
ephedrine and its derivatives have features which were considered as 
desirable in a CSA. 
Ephedrine (64a) is an N-substituted amine, which has been shown previously 
with a-Aryl-N-methylamine CSA to bring about larger chemical shift non-
equivalence than their equivalent 1°, or 3° analogues (see section 2.3). The 
anisotropic phenyl group is two bonds away from the site of hydrogen bonding 
interaction. The proximate hydroxyl group was also considered to be a 
potential second point of interaction. These features may have allowed a 
degree of flexibility in the formation of the solvated complex which could lead 
to increased A6 and greater applicability to chiral carboxylic acids. Ephedrine, 
its N-methyl analogue and the related diastereomer pseudo-ephedrine were 
tested against a limited range of chiral carboxylic acids at 1:1 stoicheiometry in 
either CDCI3 or CQDQ. The results are summarised in Table 5. 
2.4.1 (IS.2R)-(-H)-Ephedrine (64a) 
The complexes displayed rather poor solubility in CDCI3 and CQDQ. Indeed in 
the case of CDCI3, complexes dissolved only in the presence of a small 
amount of deutero methanol. Chemical shift non-equivalence was small and 
could be observed with complexes dissolved in CQDQ. Only one case of shift 
non-equivalence was noted in CDCI3 solution. An example of NMR shift 
non-equivalence with the methyl protons of 3-phenylbutyric acid is shown in 
Spectrum 4. 
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2.4 Ephedrine and N-methyl Ephedrine as CSA 's 
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2.4 Ephedrine and N-methyl Ephedrine as C S A s 
2.4.2 (1S.2R)-N-Methvlephfidrine (64b) 
This reagent gave non-equivalence with almost all of the chiral acids studied 
unlike reagent 64a. However, the magnitude of A5 tended to be very small. 
The largest chemical shift non-equivalence was given with the 2-
phenylpropanoic acid methyl doublet in CQDQ. Spectrum 5 shows this 
doublet split into a pair of doublets at around 1.6 ppm. There is also a small 
amount of splitting in the acid methine proton at 3.8 ppm. 
2.4.3 (IS.2S)-(+)-Pseudoephedrine (65a) 
Unlike the situation with its diastereoisomer 64a. the mandelic acid salt of £5a 
was soluble in both CDCI3 and CQDQ. In most cases the observed shift non-
equivalence was very small. An example of chemical shift non-equivalence 
was given by 3-phenylbutyric acid in CDCI3, Spectrum 6 for the methyl 
doublet at 1.2 ppm. The non-equivalence of the acid 2-methylene group is 
small at 0.019 ppm (5 = 2.50 ppm) but easily distinguished in both methylene 
protons. 
2.4.4 (1S.2S)-(+)-N-Methvl Pseudn Eohedrine (65b) 
Observation of chemical shift non-equivalence was limited to salts which were 
dissolved in CQDQ and the non-equivalence tended to be very small. 
Spectrum 7 provides an example of this, the non-equivalence of the methyl 
doublet at 1.3 ppm is only just observed. The diastereotopic methylene group 
at 2.7 ppm also shows non-equivalence but with only one of the methylene 
protons. 
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2.4 Ephedrine and N-methyl Ephedrine as CSA 's 
It Is interesting to note that the introduction of an N-methyl group enhances 
CSA ability with ephedrine but diminishes this ability with pseudo ephedrine. . 
This is possibly due to the differential population of conformations giving rise 
to non-equivalence in the diastereoisomeric sets of solvation complexes. 
In all cases A5H was insufficient for base line resolutions hence enantiomeric 
purity determinations are prone to error. 
2 . 5 L-Proline derivatives as CSA 
L-Proline derivatives are known to be good chiral additives in HPLC 
analysis 168-171 jhe i r relatively simple ^H NMR spectra and good solubility in 
non-polar solvents makes them worth considering as a CSA. The L-proline 
derivatives 66a-d and Q7 were tested against a range of chiral acids, and the 
results are summarised in Table 6. The primary site of hydrogen bonding 
interaction with the proline derivatives tested was considered to be to the more 
basic proline nitrogen. The side group nitrogens 66a-d. 67, are less basic due 
to distribution of electron density between their carbonyl and phenyl groups 
respectively. Secondary and additional interactions may to be induced by 
those side groups containing a polar or anisotopic group. 
2.5.1 L-Proline t-Butvl Ester (66a) 
L-Proline Amide (66b) 
The readily available L-proline derivatives 66a and 66b showed no chemical 
shift non-equivalence with the chiral acids studied except with 66a and 
camphanic acid (A5 = 0 . 0 1 5 ppm, CDCI3). In the majority of X-ray structures 
of L-proline and its derivatives, the carbonyl bond is essentially co-planar with 
the proline nitrogen i''2-i77_ fjgure 6a, the carbonyl adopts a conformation in 
which it points towards the nitrogen. There are instances where the 
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2.5 L-Frol lne derivatives a s C S A 
Introduction of a bulky group on the proline nitrogen or an extra polar group a 
to the proline nitrogen will result in an 'out of plane' carbonyl group 178,179 
It could be considered that a combination of hydrogen bonding between the L-
proline nitrogen and the polar nitrogen, or oxygen moieties of the side groups 
in 66a.b orientate the anisotropic carbonyl groups away from the substrate 
acid, hence rendering it useless in inducing non-equivalence by 
stereospecific interaction within one of the diastereoisomeric complexes. 
Alternatively, the L-proline derivative could form 4 possible complexes with the 
acid Figure 6b, 3 of which have no ability to induce non-equivalence. If all 
these complexes were equally populated only minimal non-equivalence 
would be observed. The complexes of L-prolinamide also showed poor 
solubility in the solvents used {CQDQ, CDCI3). 
a 
Figure 6 
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2.5 L-ProUne derivatives as C S A 
2.5.2 L-proline N-methvlamide (66d) 
The N-methylamide (prepared from L-proline methyl ester) also showed only 
very limited CSA ability. The introduction of the N-methyl group on the amide 
will not significantly alter the preferred conformation of the diastereoisomeric 
complexes but offers some improvement in solubility. 
2.5.3 (S)-2-(Anilino Methvn-Pvrrolidine (67) 
L-Proline p-Nltroanilide (66c) 
Both reagents gave measurable values of A5H with a wide range of 
compounds. In the case of non-equivalence was modest across the whole 
range of chiral acids and was usually bigger than with Q6£. An example of the 
non-equivalence is given by Spectrum 8 in which non-equivalence is 
observed at 1.5 ppm in the Me doublets of ketoprofen. An unusual case arose 
with 66c. The measured shift non-equivalence A5H with MTPA as a substrate 
was large (A6H = 0.102 ppm for OMe group at 3.7 ppm in CQDQ, Spectrum 9). 
This could possibly be due to the preferential orientation of the nitroanilide 
group placing it proximate to the methoxy group of the MTPA in one of the 
diastereoisomeric complexes leading to an increase in ASH- A slight increase 
for £££ salt complexes in benzene-de was also observed, this could also be 
due to the preferential orientation of the nitroanilide group in benzene. 
Finally the 1,2-diamine Q7 with a N-substituted phenyl group gave the best 
results of all of the amines tested so far. The observation that a potentially 
chelating chiral diamine gave the highest observed shift non-equivalence was 
very significant. It suggested that the primary hydrogen bonding interaction 
involved both N-H groups (figure 7) restricting the number of possible 
conformers available to each of the diastereoisomeric complexes, so 
enhancing the differentiating influence of the proximate phenyl ring. 
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2.5 L-Proline derivatives as C S A 
It was considered desirable to investigate other chiral 1,2-diamines as 
potential CSA. After careful deliberation 1,2-diphenyl-1,2-diamimoethane 5S 
was chosen. Chapter 3 details the effectiveness of this reagent. 
T 
H"" " ' 0 
Figure 7 
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CHAPTER 3 
1,2-Diphenyl-1,2-diaminoethane, a 
Chiral Solvating Agent for Carboxylic 
Acids 
5 6 
3.1 Jntroduction 
3.1 Introduction 
1,2-Diphenyl-1,2-ciiaminoethane 5S is an easily synthesized chiral reagent, 
which has been used previously as the precursor for several chiral 
derivatising agents, such as Tf'^''^^ and 31c-e. 32a^^ (see sections 1.2.1.2-3). 
It was considered as a CSA following the observations discussed in Chapter 2 
that the potentially chelating chiral diamine 2-(Anilino methyl)-pyrrolidine £7 
gave the highest observed shift non-equivalence for a range of acids. It has a 
very simple NMR spectrum.(Spectrum 10), and its high solubility in non-
polar solvents (CDCI3 and CsDs) and C2 related anisotropic phenyl groups 
(capable of inducing non-equivalence in one diasterisomeric pair) render it 
highly suitable as a potential CSA. 
The synthesis of the racemic diamine involved the reaction of benzil with 
cyclohexanone, ammonium acetate and acetic acid to form the isoimidazole 
(Scheme 1). The isoimidazole was then reduced with lithium and ammonia 
and the free amine obtained in excellent yield by acid catalysed hydrolysis. 
Resolution of the racemic mixture was achieved in high yield by differential 
crystallisation of the diastereoisomeric salts formed with enantiopure mandelic 
acid. 
P h ^ N H 2 I \ H 
P h - ' ' ^ N H , H 
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3.1 Introduction 
Initially the chiral diphenyldiamine was tested against a selected range of 
racemic acids at both 1:1 and 2:1 stoichiometry. High shift non-
equivalence was observed in almost all cases in both CDCI3 and CQDQ 
solvents. The unexpected result that 2:1 stoichiometry produced larger A5H 
than the equivalent 1:1 stoichiometric salt complexes stimulated further 
investigation. The range of racemic acid substrates was increased to 
substantiate this observation and also to see if maximum non-equivalence 
was indeed observed at 2:1 stoichiometry, using both bulky mono-carboxylic 
or di-carboxylic acids. A thorough investigation of the parameters determining 
non-equivalence was carried out with selected racemic carboxylic acids 
including acid: amine stoichiometry, concentration, temperature and substrate 
enantiomeric purity. 
The origins of non-equivalence were also sought, NOE difference NMR 
spectroscopy was used to in an attempt to determine the relative positions of 
neighbouring protons in both intermolecular associations within the diamine 
and intramolecular association in the diastereoisomer salts. The X-ray 
structure of the protonated salt as its mono-hydrobromide was determined and 
may be used as a basis for a discussion of the favoured conformation of the 
diamine in its solution complexes. 
P h ^ O M / ^ ^ - M u . — - N / — s . l i NH, — N 
T + 
H 
P h - ^ O 6 CH3CD2NH4 T ^ ) F ~ \ Li, NH3 ^ T 
CH3OO2H P ^ X ^ N \ _ / -78 "C, THF p^J-N 'Vy 
R-DPDAE or ^ Resolve Ph, NH2 ^ HCI/Ether 
S-DPDAE R- or S-Mandelic acid ph^^NHg 
in EtOH 
Scheme 1 
5 9 
3.1 Introduction 
Related 1.2-dlamines 
Non-equivalence could in theory be attributed in part or totally to a self 
recognition process involving the chiral carboxylic acids in the 2:1 solvation 
complex. Meso-1,2-Diphenyl-1,2-diaminoethane, the achiral diastereoisomer 
of DPDAE was synthesized therefore in an attempt to define the extent to 
which non-equivalence may be due to a self recognition process. 
The synthesis of the meso-diamine involved the reaction of benzaldehyde with 
ammonium acetate to form the N-benzoyl-N^-benzylidene-meso-1,2-diphenyl-
1,2-diaminoethane followed by acid hydrolysis (Scheme 2). The meso-
diamine was mixed with selected racemic carboxylic acids, and the results are 
listed in Section 3.3.5. Enantiopure 1,2-diaminocyclohexane, a diamine 
which is structurally similar to DPDAE, was studied in parallel as a CSA in 
order to assess the extent of the anisotropic effect of the phenyl groups on shift 
non-equivalence. 
N-substituted derivatives of the chiral diamine were synthesised in order to 
determine the effect of N-substitution on shift non-equivalence. This idea 
arose from the observation that secondary amines generally gave a larger a5H 
than their 1° or 3° counterparts in such CSA experiments (Section 2.3). 
Q Q Ph^NCHPh 1) 6M H23D4 Ph^NHj 
4 X P h ^ + 2 x cH3-f _ R B U U ^ "T — m n u x _ ^ - r 
H ONH4 Ph^NHCOPh 2) NH3 sol. Ph^NHj 
Scheme 2 
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3.1 Introduction 
The chiral diamine was found to render the methylene protons of primary 
carboxylic acids diastereotopic and induced considerable chemical shift non-
equivalence. A range of such compounds were tested to discover the extent 
of this effect. Finally DPDAE 5S was used to accurately determine the 
enantiomeric purity of several commercially available chiral acids and to 
determine the absolute configuration of a sample of 2-methylbutyric acid. 
3.2 The Measurement of Chemical Shift Non-equivalence with 
Chiral Carboxylic Acids. 
The sample preparation required for the NMR experiment is relatively 
straightfon/vard. Typically 0.05 mmol of the diamine was mixed with 0.1 mmol 
of the chiral acid substrate (for 2:1 stoichiometry) and 0.1 mmol of both acid 
and diamine were used for 1:1 stoichiometry. The mixture was dissolved in 
the readily available halogenated solvent CDCI3 or aromatic solvent CQDQ 
and the proton NMR spectrum was recorded immediately. A range of aromatic 
mono- and di-carboxylic acids with cyclic alkane and branched alkyi 
substituents were used as substrates in the analysis of A5H in the salt 
complexes formed with the (IR,2R)-(-)-diamine (see Figure 8). The results 
are summarised In Table 7. Values for A5H at both 1:1 and 2:1 stoichiometry 
are given. 
Camphanic acid 2Q_ and 2-methylbutyric acid 74 display the lowest chemical 
shift non-equivalence of the carboxylic acids tested. This could be attributed 
to the lack of a sufficiently strong secondary interaction to maintain the 
diastereomeric salt in a conformation where A5H is observed. For 2-methyl 
butyric acid, the small difference in steric demand between a Me and Et group 
probably leads to little preference for a given conformer in the two 
diastereoisomeric salt complexes. 
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Ph 
H O ^ ^ C O g H 
Mandelic acid 
68 
.CO2H 
Camphanlc acid 
20 
Ph 
H g C ^ C H a C O a H 
3-Phenylbutyric acid 
69 
Ph 
Ph 
OMe 
•CO2H 
Ph 
A c O ^ ^ C O g H 
2-Phenylpropionic acid 
70 
MTPA 
1 1 
0-Acety lmandel ic acid 
19 
H O " ^COgH 
CH3 
HgCHgC^^COsH 
P h O C O ^ ^ C O g H 
PhOCO-'^'^COaH 
Hexahydromandelic acid 
73 
2-methylbulyric acid 
74 
O.O-Dibenzyl-L-tarlaric acid 
75 
.CO2H 
CO2H 
Trans-cyclohexane-
1,2-Dicarboxylic acid 
76 
c is -endo-b icyc lO[2 .2 .1 ] -6-methoxy-
carbony l -hepta-2-ene-5-o ic acid 
77 
Figure 8 
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Ibuprofen 
71 
CH2CH(CH3)2 
HOgC 
ketoprofen 
72 
HO2C HO2C 
OMe 
Flurbiprofen 
78 
Naproxen 
79 
Br 
P h ' ^ C 0 2 H 
Br 
M e - ' ^ C O a H 
2-Bromophenylacetic acid 
81 
CI 
M e ' ^ C O g H 
2-Bromopropionic acid 
80 
CH3CH2' 
r 
, ^ ^ C O o H 
2-Chloropropionic acid 
82 
2-Fluorobutyric acid 
83 
Figure 9 
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T A B L E 7 
The measurement of A 5 for a range of mono- and di-carboxylic acids 
Ent ry s u b s t r a t e observed 
resonance 
so l ven t 
S to i ch i ome t r y 
1:1 2:1 
8 
1 0 
1 1 
6 8 
2 0 
a 9 
70 
1 1 
1 9 
7 3 
7 4 
I S 
7 6 
7 7 
2 -H 
CH. 
2 -CH2 
2-H 
2-CH, 
2 -H 
2 -CH, 
2-OCH, 
2 -H 
2 -OAc 
2 -H 
2 -CH, 
2 -H 
2 -H 
OCH. 
CDCI3 
CDCI3 
0.049 
CDCI3 
CDCI3 
0 .007 
0 .009 
' 0 ^ 0 9 
CDCI, 
3 
CDCI„ 
0.011 
CDCL 
0.064 
CDCI3 
CDCI, 
3 
^6^3 
0.152 
0.163 
0.054 
0.050 
CDCI„ 0.076 
CDCI„ 
^6^3 
CDC!/C.D N 
O 3 3 
0.039 
0.027 
0.053 
CDCI3 
^ ^ 3 
0.027 
0.015 
0.193 
0.059 
0.013 
0.028 
0.019 
0.076 
0.089 
0.027 
0.012 
0.057 
0.065 
0.171 
0.178 
0.076 
0.016 
0.098 
0.006 
0.006 
0.017 
The sense of the chemical shift non-equivalence is consistent and the value is 
large (A5H > 0.05 ppm) for the majority of acids tested. The largest shift 
difference observed between the chiral diamine and a racemic acid involved 
1R,2R-(-)-1,2-diphenyl-1,2-diaminoethane and 0-acetyl-mandelic acid at 2:1 
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Stoichiometry (Spectra 11a,b). The marked non-equivalence between the 
diastereomeric resonance of the acetyl group at 2.0 ppm and the methine 
resonance at 5.6 ppm is evident in spectra 11a and l i b . Mono-a-phenyl 
carboxylic acids gave the bigger A5H compared to their di-acid or alkyI 
counterparts. 
3-Phenylbutyric acid displays a small degree of non-equivalence in the 2-
methylene protons at 1:1 stoichiometry which is not present at 2:1 
stoichiometry. This could be due to the different conformations adopted by 
each complex which in the case of 1:1 stoichiometry places the methylene 
protons near a stereochemically dependent group such as the phenyl ring. 
Salts of both hexahydromandelic acid Z2 and 0,0-dibenzyl-L-tartaric acid Z5 
suffered from poor solubility in the solvents examined. Compound Z2 
displayed good chemical shift non-equivalence (A5H = 0.098 ppm, CDCI3, 2:1 
ratio). This could be related to the strong secondary hydrogen bonding 
interaction caused by the hydroxyl group. The chemical shift non-equivalence 
is observed in the methine group at 3.7 ppm. Spectrum 12 shows the non-
equivalence observed for the 2:1 complex. 
The chiral di-acids 0,0-dibenzoyl-L-tartaric acid 75. and Trans-cyclohexan-
1,2-dicarboxylic acid 7£ (Spectrum 13) display shift non-equivalence at 1:1 
stoichiometry only. The loss of observed chemical shift non-equivalence at 
2:1 stoichiometry is possible due to a combination of factors in the rapidly 
reversible equilibrium, one of which could be the formation of a low energy 
complex with low A5H. 
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3.2 T h e measurement ot chemical shitt non-equivaience with chiral carboxylic acids 
The relatively bulky acid 77 shows a higher non-equivalence at 1:1 compared 
to 2:1 stoichiometry. This could be due to the increased steric crowding in the 
2:1 complex which may force the solvate into a very different conformations 
with a minimal resultant A5H. 
A series of antiinflammatory agents and a-halo acids (Figure 9) were 
assayed with the CSA, (Tables 8, 9). The summarised data shows the 
observed resonance in either CDCI3 or CQDQ at 2:1 and 1:1 stoichiometry for 
these substrates. The antiinflammatory a-aryl propionic acid derivatives 
(Table 8) typically display large chemical shift non-equivalence for both the 
methyl and methine protons under the conditions used. Ibuprofen gave the 
largest chemical shift non-equivalence for the methine proton (A5H = 0.168 in 
CQDQ, 2:1 stoichiometry). Spectrum 14 shows the non-equivalence of the 
fully resolved methine proton quartets. 
Large non-equivalence was associated with a-phenyl groups in the previous 
chiral mono carboxylic acids (Figure 8). The introduction of ortho and meta 
substituents on the phenyl ring affects the observed non-equivalence. If these 
reagents are compared to 2-phenyl propionic acid ZO which has essentially 
the same structure, but with no phenyl substituents, both 78 and 79 show no 
significant change while A5 values for 72 are reduced and Z l show significant 
increase in non-equivalence. The conformation which bhngs about non-
equivalence in the diastereomeric salts is not solely influenced by steric 
effects; the expected values for flurbiprofen 78 and Naproxen 72 would differ 
more if this was so. Electronic effects could also influence A5H. The iso-butyl 
group of Ibuprofen will weakly enhance the % basicity of the aryl group. This 
may increase the solubility of the diastereoisomeric salt complex responsible 
for A5H. The reverse is true for Ketoprofen where the carboxyl group may be 
increasing the K acidity of the aryl group. 
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3.2 T h e measurement ol chemical shil t non-equivalence with chiral carboxylic acids 
TABLE 8 
The measurement of A6 for selected anti-inflaminatroy agents. 
E n t r y s u b s t r a t e o b s e r v e d s o l v e n t 
r e s o n a n c e S t o i c h i o m e t r y 
1:1 2:1 
1 7 1 2 - H CDCI3 0 . 0 4 9 0 . 0 9 9 
0 . 0 1 4 0 . 1 6 8 
2 - C H 3 CDCI 
3 
0 . 0 1 6 0 . 0 3 1 
6 6 0 . 0 2 7 
2 12. 2 - H CDCI 3 0 . 0 1 4 0 . 0 3 2 
C D 
6 6 
0 . 0 1 9 0 . 0 5 6 
2 - C H 3 CDCI 
3 
0 . 0 1 2 0 . 0 2 5 
^6^6 0 . 0 1 4 0 . 0 2 5 
3 13. 2 - H CDCI3 0 . 0 3 6 0 . 0 7 5 
6 6 0 . 0 1 7 0 . 0 9 0 
2 - C H 3 CDCI 
3 
0 . 0 2 0 0 . 0 3 9 
^6^6 0 . 0 2 1 
4 12. 2 - H CDCI3 0 . 0 3 4 0 . 0 6 8 
^6^6 0 . 0 1 2 0 . 0 9 1 
2 - C H 3 CDCI3 0 . 0 1 8 0 . 0 3 4 
^6^6 0 . 0 2 5 
The nature of the solvent also affects the chemical shift non-equivalence in 1:1 
and 2 : 1 complexes. This is particularly notable in the case of the methine non-
equivalence of the anti- inf lammatory agents. At 2 : 1 stoichiometry maximum 
A5H occurs in dg-benzene, but at 1:1 stoichiometry maximum a6H is usually 
observed in deutero-chloroform, F igure 10 shows how the methine 
resonances of flurbiprofen vary with solvent. The apparent change in order 
could be due to the preferential solvation of a given conformation in the salt 
complexes which leads to A5H in the 1:1 (stoichiometry) diastereoisomeric salt 
complexes. This could be a result of Tc-stacking interactions between the aryl 
solvent and substrate 
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3.2 The measurement ot chemical shil t non-equivalence with chiral carboxyllc acids 
TABLE 9 
The mesurement of A5 for a-halopropionic acids. 
E n t r y s u b s t r a t e o b s e r v e d s o l v e n t A5 
H 
r e s o n a n c e S t o i c h i o m e t r y 
1:1 2:1 
1 2 - C H 3 CDCI 
3 
0 . 0 8 0 0 . 0 2 3 0 
0 . 1 1 8 
2 - H CDCI3 0 . 0 8 6 0 . 0 3 7 
0 . 0 4 6 
2 M 2 - H CDCI3 0 . 1 7 6 0 . 2 8 7 
0 . 2 0 6 0 . 3 3 9 
3 8 2 2 - C H 3 CDCI3 0 . 1 0 5 0 . 2 6 9 
0 . 0 6 2 0 . 1 5 1 
2 - H CDCI3 0 . 1 2 9 0 . 2 4 0 
6 6 0 . 1 5 0 
4 8 3 2 - C H 3 CDCI 3 0 . 0 5 4 0 . 0 8 6 
6 6 0 . 0 8 1 0 . 0 8 9 
2 - F CDCI 
3 
0 . 1 2 5 
6 6 0 . 1 7 2 
The a-halo acids displayed the highest chemical shift non-equivalence of all 
chiral mono-acids examined for both methyl and methine protons (Table 9). 
a-Bromophenyl -acet ic acid 8 1 2:1 complex (Spectrum 15) had a chemical 
shift non-equivalence of 0.339 ppm in the methine protons at 5.2 ppm which 
was the largest observed for all the chiral carboxylic acids tested. 
The introduction of the a-halogen atom substantially increases A5H compared 
to the corresponding a-aryl acids. The increased acidity of the chiral acid 
methine proton could be involved in 2° interactions which increase non-
equivalence in the conformation responsible for A5H . This could be 
considered similar to the effect of the acidic proton in Pirkle's reagent 
1 -(9-anthryl)-2,2,2-tr i f luoroethanol 48 
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3.2 The measurement ol chemical shil t non-equivalence with chira l carboxylic acids 
A more typical example of this class of substrate is provided by 
2-chloropropionic acid with A6H = 0.269 ppm observed between the 
diastereomeric methine protons at 3.8 ppm in dg-chloroform (Spectrum 16). 
3.2.1 Compar ison of DPDAE with g-Methv lbenzvlamine 
The conformation which the 1,2-diamine adopts with the chiral acid at 2:1 
stoichiometry could be affected by the neighbouring phenyl and amine 
substi tute. In an attempt to resolve this point the known CSA 
a-methyibenzylamine, with an essentially similar structure to a mono amine 
subunit of the diamine was tested against a l imited range of chiral acids (at 1:1 
stoichiometry) Table 10. The majority of diastereoisomeric complexes gave 
signif icantly lower chemical shift non-equivalence indicating that the 
p-substi tuents of 1,2-diphenyl-1,2-diaminoethane do indeed influence the 
structure and relative population of the preferred low-energy conformation. 
Whether this was sterically induced or due to the interactions between the two 
possible complex ing acids was not clear. Further investigations were thought 
necessary. The anomaly of entry 3 in Table 10, where A5H is larger for the di-
acid trans-cyclohexane-1,2-dicarboxyl ic acid Z£ with the mono-amine when 
compared to the diamine is notable. 
TABLE 10 
The measurement of A6 with 2-methylbenzylamine for selected chiral carboxyl ic ac ids^ . 
E n t r y s u b s t r a t e o b s e r v e d 
r e s o n a n c e 
s o l v e n t A5H 
1 2 0 CH3 6 6 0 . 0 4 5 
2 1 9 2 - H 
2 - O A c 
6 6 0 . 1 5 7 
0 . 0 1 6 
3 7 £ 2 - H 6 6 0 . 0 8 6 
4 7 1 2-CH3 6 6 0 . 0 4 1 
5 a2 2-CH3 6 6 0 . 0 1 4 
a) Chemical shift non-equivalence was measured at one molar equivalent of acid to amine 
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3.3 Parameters Determining Chemical Shift Non-equivalence 
In an attempt to discover the origins of anisochronicity and to examine how the 
magni tude of chemical shift non-equivalence varies with experimental 
condit ions, several NMR experiments were carried out. These involved 
observing how the magnitude of the chemical shift non-equivalence varied 
with changes in a) amine: acid stoichiometry, b) concentrat ions, c) substrate 
enant iomeric purity and d) temperature. 
In addit ion the nature of the 1,2-diamine structure was investigated. The X-ray 
structure of the mono-hydrobromide salt was used as a basis for considering 
the possible conformation in the related 2:1 complexes with 2 carboxylate 
anions. Meso-1,2-diphenyl-1,2-diamino ethane was synthesised and a series 
of racemic acids were tested. This al lowed an assessment of the possible 
contr ibution of 'self recognit ion' in the observed shift non-equivalence. In the 
case of 2:1 complexes of chiral acids with an achiral amine substrate, two sets 
of enant iomeric complexes may form (which are isochronous) and one meso 
complex may form (RS = SR). The relative ratio of these diastereoisomeric 
complexes (RR/SS versus meso) allows enantiomeric purity to be determined 
in principle (see section 1.2.1.3). 
The extent of the contribution of the phenyl group of the 1,2-diamine to induce 
non-equivalence was assessed by comparing shift non-equivalence values 
with 2:1 complexes of enantiopure trans-1,2-cyclohexyldiamine (using parallel 
chiral acid complexes of the diamine). The extent to which the primary amine 
structure in DPDAE determines non-equivalence was studied by comparing its 
behaviour with its NHR analogue. As discussed previously, higher A5H values 
have been noted using 2° amines compared to 1° amines in such CSA 
exper iments. 
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3.3.1 The Effect of Stoichiometrv on Observed A8H 
Standard solut ions of both acid and diamine (0.1 M) were prepared in a 
suitable deuterated solvent. The solutions were mixed to give the required 
stoichiometric ratio. Care was taken to maintain the concentrat ion of the 
combined acid and amine solution at 0.1 mmol .ml - i . 
Variable stoichiometry data for 2-chloropropionic ^ acid and (1R,2R)-1,2-
d iphenyl -1,2-d iaminoethane in CDCI3 is given in Table 11. The shift non-
equivalence values are recorded in the range of 10:1 to 2:5 ratio of acid to 
1,2-diamine. A plot of the fractional ratio of diamine against the observed shift 
non-equivalence for the a-methyl resonance of the acid displays some 
interesting features of the data (Graph 1). Maximum shift non-equivalence 
was observed at 2:1 stoichiometry of the acid:amine. The rapid rate of change 
in non-equivalence with increasing acid ratio in the range 10:1 to 2:1 
acid:amine could be attributed to several factors. The concentrat ion of 
uncomplexed acid al though enhancing 2:1 acid:amine complexat ion through 
t ime averaged exchange does not contr ibute to the observed non-equivalence 
(See section 1.2.3). Secondly acid-amine complexation competes with acid 
dimerisat ion in the non-polar solvent used. Although less effective, 
dimerisat ion will tend to increase the amount of uncomplexed acid. The 
increase in the CSA relative to the acid substrate between 2:1 and 1:1 
stoichiometry also decreased chemical shift non-equivalence. This could be 
due to competi t ive formation of the 1:1 diastereomeric salt complexes with 
lower intrinsic A5H values. The increase in 1,2-diamine stoichiometry beyond 
1:1 ratio does not significantly perturb shift non-equivalence. A threshold 
value is reached which is probably a good measure of the inthnsic value of 
A5H for the 1:1 complex. It is particularly striking that this is smaller compared 
to the related 2:1 complex (0.28 ppm 2 : 1 , 0.07 ppm 1:1 for 2-chloropropionic 
acid) . 
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G r a p h 1 
The plot of non-equivalence against stoichiometry for 1,2-DPDAE and 2-
chloropropionic acid Q2 
0.25 H 
0.20 H 
Ad p p m 0.15 
0.1 OH 
0.05-
• • I • I • • ' ' • I ' • ' ' ' I ' ' ' ' ' I • I • • • I 
.0 0.5 1.0 1.5 2.0 2.5 
S t o i c h i o m e t r y ( D P D A E : 2 C P A ) 
3.0 
TABLE 11 
T h e m e a s u r e m e n t of A 5 H aga ins t s to i ch iome t r y for 
2 - c h l o r o p r o p i o n i c ac id 8 2 
F r a c t i o n a l 
r a t i o 
DPEDA 
o b s e r v e d a - m e 
r e s o n a n c e (p 
t h i n e 
om) 
o b s e r v e d a - m 
resonance (p 
3 t h y l 
Dm) 
Hf L f A5H Hf L f A5H 
0 . 0 9 9 4 . 3 8 9 4 . 3 8 0 0 . 0 0 9 1 .678 1 .661 0 . 0 1 6 
0 . 2 5 5 4 . 1 9 4 4 . 1 2 7 0 . 0 6 7 1 .587 1 . 4 8 5 0 . 1 0 2 
0 . 2 5 8 4 . 1 9 4 4 . 1 2 7 0 . 0 6 7 1 .587 1 . 4 8 4 0 . 1 0 3 
0 . 0 3 4 4 . 0 3 2 3 . 8 9 8 0 . 1 3 4 1 .529 1 . 3 3 8 0 . 1 9 1 
0 . 3 7 4 4 . 0 2 5 3 . 8 8 5 0 . 1 4 0 1 .523 1 . 3 3 4 0 . 1 8 9 
0 . 4 0 3 3 . 8 6 9 3 . 6 4 2 0 . 2 2 7 1 .467 1 . 1 9 4 0 . 2 7 3 
0 . 4 3 4 3 . 9 0 1 3 . 6 9 4 0 . 2 0 7 1 .482 1 .221 
1 . 1 7 6 
0 . 2 6 1 
0 . 2 8 0 0 . 4 6 1 3 . 8 4 6 3 . 6 0 1 0 . 2 4 5 1 .456 
0 . 5 9 0 
0 . 6 0 8 
0 . 6 1 5 
3 . 8 7 5 
3 . 8 9 3 
3 . 9 3 0 
3 . 6 4 3 0 . 2 3 2 1 .442 1 . 2 0 8 0 . 2 3 4 
0 . 2 2 0 ^ 
0 . 1 9 1 
3 . 6 7 0 0 . 2 2 3 1 .447 1 . 2 2 7 
3 . 7 3 1 0 . 1 9 9 1 .455 1 . 2 6 4 
0 . 8 3 3 3 . 9 6 9 3 . 7 8 7 0 . 1 8 2 1.461 1 . 2 9 7 
1 . 3 2 7 
0 . 1 6 4 
0 . 1 3 9 0 . 9 0 7 4 . 0 0 4 3 . 8 4 5 0 . 1 5 9 1 .466 
1 .628 4 . 0 6 9 3 . 9 4 5 0 . 1 2 4 1 .485 1 .381 0 . 1 0 4 
1 . 2 8 2 4 . 1 2 0 4 . 0 2 9 0 . 0 9 1 1 .504 1 . 4 2 6 0 . 0 7 8 
2 . 5 0 0 1 .530 1 . 4 6 2 0 . 0 6 8 
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3.3 Parameters determining chemical shilt non-equivalence 
The variation of A5H VS stoichiometry was also studied for 2-bromopropionic 
acid (figure 11). The diastereotopic a-methyl doublets in each complex 
are shifted to lower frequency, when approaching the optimal 2:1 
stoichiometry. The R-2-bromopropionic acid ( IR,2R)-1,2-DPDAE 
diastereomeric salt complex shows the larger change in shift difference with 
varying stoichiometry. This implies that the diastereotopic methyl groups in 
the R-RR complex are closer, on average to the neighbouring anisotropic 
phenyl group in the preferred conformation. A different behaviour is observed 
simultaneously for the diastereotopic methine quartets, in this case, maximal 
A5 is observed at 1:1 stoichiometry. 
3.3.2 The Effect of Concentration on Observed ASH 
A concentrated solution of the salt complex in a suitable NMR solvent was 
di luted incremental ly; at each stage the NMR Spectrum was recorded. The 
concentrat ion dependence of the shift non-equivalence for 2-phenylpropionic 
acid ZQ and (IR,2R)-1,2-DPDAE was measured in the range of 0.005 M to 0.5 
M CSA. The results are listed in Table 12. The variation of concentration 
with A6H (Graph 2) for the a-methyl protons of 2-phenylpropionic acid show a 
rapid increase in shift non-equivalence with concentrat ion to approximately 
0.1 M. Thereafter there is a less steep dependence. A reduction in A5H due to 
ion-pair aggregat ion was not noted in the concentrat ion range studied, but 
was apparent at > 0.5 M for the equivalent complex in CqDq. Examination of 
the spin coupled methine peaks yielded analogous results. Both 
diastereomeric methine protons of 2-phenyl-propionic acid are shifted to lower 
f requency with increasing concentrat ion. The diastereomeric complex of S-2-
phenyl-propionic acid (1 R,2R)-1,2-DPDAE (lower frequency doublet) 
d isplayed the larger sensitivity of shift difference with change in concentration. 
Increasing the concentrat ion of salt favours the formation of the diastereomeric 
complexes. This would be expected due to the nature of the rapid equilibrium 
8 1 
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between the free and complexed acids and the differential sensitivity of the 
observed chemical shift for the methyl doublet in the diastereoisomeric 
complexes must relate to the fact that their association constants are non-
equivalent . 
G r a p h 2 
A plot of chemical shift non-equivalence against 1,2-DPDAE, and 
2-phenylpropionic acid 70 concentrat ion 
Ad p p m 
A Ad - Meth ine 
A a 9 -methy l 
0.0 0.6 
C o n c e n t r a t i o n (Mo l / I ) 
TABLE 12 
T h e concen t ra t i on d e p e n d a n c e of a 5 H for 
2 - p h e n y l p r o p i o n i c ac id 7 0 
c o n c e n t r a t i o 
n 
w . r . t . 
DPEDA 
o b s e r v e d a - m e t h i n e 
r e s o n a n c e (ppm) 
o b s e r v e d a - m e t h y l 
r esonance (ppm) 
H f L f A5H Hf L f A5H 
0 . 5 6 0 3 . 3 8 4 3 . 2 2 7 0 . 1 5 7 1 .297 1 .246 0 . 0 5 1 
0 . 4 5 0 
0 . 3 4 0 
3 . 4 0 4 3 . 2 6 2 0 . 1 4 2 1 .305 1 .260 0 . 0 4 5 
3 . 4 2 3 3 . 2 9 3 0 . 1 3 0 1 .314 1 . 2 7 4 
1 . 2 9 2 
0 . 0 4 0 
0 . 0 3 1 0 . 2 2 0 3 . 4 4 9 3 . 3 3 6 0 . 1 1 3 1 .324 
0 . 1 1 0 3 . 5 0 1 3 . 4 1 8 0 . 0 8 3 1 .356 1 .330 0 . 0 2 6 
0 . 0 1 3 
0" '015" 
0 . 0 5 6 1 .400 
1 .395 
1 .387 
1 .380 " 0 . 0 4 5 3 . 5 6 5 3 . 5 1 4 0 . 0 5 1 
0 . 0 3 4 3 . 5 7 7 3 . 5 3 2 0 . 0 4 5 1 .404 1 .390 0 . 0 1 4 
0 . 0 2 2 3 . 6 0 3 3 . 5 7 3 0 . 0 3 0 1 .408 1 .400 0 . 0 0 8 
0 . 0 1 1 3 . 6 5 3 3 . 6 3 7 0 . 0 1 5 
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3.3.3 The Effect of Enantiomeric Composit ion on A5H 
Standard solutions of 0-acety lmandel ic acids, [ 0AM] , (0.1 mmol ml-"") at 
var ious enant iomeric composit ions were prepared. The solutions were mixed 
with 0.5 molar equivalents of 1S,2S-(+)-1,2-diphenyl-1,2-diaminoethane. The 
data is col lated in Tab le 13 and displayed graphical ly (Graph 3) for the 
variation of the 0 A M a-methine proton against increasing enantiomeric 
composit ion of R-OAM. An approximately linear or a weakly sigmoidal 
relationship between these two parameters may be considered. This has 
previously been observed with other systems^^'*'''^°'''^3'^^'''^^^ and is a 
consequence of the non-equivalence of the associated constants for 
diastereoisomeric salt formation K r and Kg. 
Graph 3 
A plot of enant iomeric purity versus chemical shift non-equivalence for the 1,2-
DPDAE salt complexes of 0-acety lmandel ic acid. 
0.20 
0.15H 
Ad ppmo . i o - j 
0.05 H 
0.00 
o Ad - O A c 
• Ad - Meth ine 
• 1 00 - 50 0 50 1 00 
Enantiomeric purity of 0 A M 
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TABLE 13 
The m e a s u r e m e n t of A 5 H aga ins t enan t i omer i c pur i ty of 
0 - a c e t y l m a n d e l i c ac id I S 
Enantiomeric 
E x c e s s 
R - O A M 
o b s e r v e d a - m e 
r e s o n a n c e (p 
t h i n e 
pm) 
obse rved 0/ 
r esonance (p pm) 
H f L f A5H Hf L f A 5 H 
0 . 6 5 6 5 . 7 3 8 5 . 5 7 4 0 . 1 6 4 2 . 1 1 4 2 . 0 2 8 0 . 0 8 6 
0 . 4 3 9 
0 . 2 0 7 
0 . 0 1 1 
5 . 5 7 2 5 . 7 3 1 0 . 1 5 9 2 . 1 0 5 2 . 0 2 6 
2 . 0 2 5 
2 . 0 2 3 " 
0 . 0 7 9 
0 . 0 7 0 " 
0 . 0 6 5 " 
5 . 5 7 4 
^ 5 . 5 7 9 
5 . 7 2 5 
5 . 7 2 7 
0 . 1 5 J _ 
0 . 1 4 8 
2 - 0 9 5 _ 
~ 2 . 0 8 8 
- 0 . 1 7 8 5 . 5 7 9 5 . 7 1 8 0 . 1 3 9 2 . 0 8 0 2 . 0 2 2 
2 . 0 1 9 
0 . 0 5 8 
0 . 0 5 3 - 0 . 3 8 5 5 . 5 8 5 5 . 7 1 7 0 . 1 3 2 2 . 0 7 2 
- 0 . 5 9 2 5 . 7 1 7 5 . 5 9 9 0 . 1 1 8 2 . 0 6 2 2 . 0 1 9 0 . 0 4 3 
The effect of increasing the enantiomeric purity of S-OAM with 1S,2S-DPDAE 
on both the diastereotopic methine and acetyl resonances is illustrated in 
figure 12. Both diastereotopic resonances are affected by the changes in 
enant iomehc composi t ion. For the methine resonance, as the enantiomeric 
purity of the R-OAM increases the chemical shift in the R-0AM:1 S,2S-DPDAE 
complex shifts to lower frequency. In the case of the 0-Acety l singlet, an 
increase in the percentage of R-OAM in the mixture results in a shift to higher 
frequency of the acetyl singlet in the R-0AM:S-DPDAE complex. In the case of 
the acetyl signals in particular, the observed variation of A5H with % ee of 0 A M 
is associated primarily with this differential shift which must reflect the fact that 
the acetyl methyl in the R-0AM:1S,2S-DPDAE complex is closer to the phenyl 
ring of the DPDAE, than it is in the corresponding S-OAM complex. 
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F i g u r e 12 
The variation in enantiomeric purity of O-Acetylmandelic acid 
(OAM) 12 in 1S,2S-DPDAE : O-Acetylmandelic acid complexes 
a) OAM methine resonance 
-A, 
1 R : 9 S 
2 R : 8 S 
i 3 R : 7 S 
5 R : 5 S 
i J 6 R : 4 S 
A 
1 7 R : 3 S 
J I 8 R : 2 S 
A 9 R : 1 S 
b) OAM methyl resonance 
1 R : 9 S 
2 R : 8 S 
3 R : 7 S 
4 R : 6 S 
5 R : 5 S 
-1 ^ 
; i 6 R : 4 S 
A 7 R : 3 S 
j\ 8 R : 2 S 
9 R : 1 S 
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3 . 3 . 4 The Effect of Temperature on A5u 
Ibuprofen and 1R,2R-diphenyl-1,2-diaminoethane were mixed in dg-toluene at 
2:1 acid-base stoichiometry at a concentrat ion of 0.1 mmol ml"'' w.r.t. racemic 
acid. Spectra were acquired at 10K intervals between 333-223K. 
The shift non-equivalence for Ibuprofen resonances between 303-243K is 
g iven in Table 14. A plot of the logari thm of the chemical shift non-
equivalence of the methine proton of Ibuprofen against reciprocal temperature 
is also given (Graph 4). The temperature dependence conforms only 
approximately to a simple Bol tzmann distribution for which a l inear plot is 
expected. A l inear variation would have implied preferential population of 
lower energy conformations of the diastereoisomeric salt complexes as the 
absolute temperature falls. As the temperature is lowered the obsen/ed 
increasing shift non-equivalence can be correlated to a preferred population 
of a part icular low energy conformat ion for one of the diastereoisomeric 
complexes in which the methyl protons spend more t ime, on average in the 
vicinity of the anisotropic phenyl group. The variation of shift non-equivalence 
with temperature for the methine quartet of Ibuprofen is given in figure 13. 
With decreasing temperature, the resonance due to the S-lbuprofen:1R,2R-
DPDAE complex shifts to lower frequency while that of the R-lbuprofen:1R,2R-
DPDAE is static. Again this implies that in the S-lbuprofen:1 R,2R-DPDAE 
complex, differential shielding occurs (via the DPDAE moiety). In addition low 
temperature spectra show differential line broadening between the two 
mult iplets. This might be a consequence of the difference in free energies of 
act ivat ion for exchange between free and bound acids in the two 
diastereoisomeric salt complexes, and at low temperatures, the slower rates of 
exchange on the NMR t imescale is apparent for the S-lbuprofen:1 R,2R-
DPDAE complex. Alternatively as the exchange rate slows at lower 
temperatures, selective broadening may arise due to the differing frequency 
8 6 
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difference (A-o) between the free and complexed acid. The extent of 
broadening is dependent on this frequency difference and is defined for a 
equally populated system with two sites by equation 8. 
T.-1 = T.-1 
n2 
(8) 
Large frequency differences, dv give increased broadening compared to the 
observed natural line width Tj"' ' . For Ibuprofen with the S-lbuprofen:1 R,2R-
DPDAE complex the frequency difference between the shifts of free and 
bound acid is indeed larger (74.2 Hz) compared to the value for the R-RR 
complex (70.4 Hz). 
Graph 4 
A plot of In chemical shift non-equivalence against temperature for the 1,2-
DPDAE, ibuprofen diastereoisomeric complex. 
In Ad 
0.0 n 
-1.0H 
-2.0 H 
-3.0 
-4.0 H 
-5.0 4 
-6.0-
3.0 
• In a9 - Methine 
» In Aa • Methyl 
I 11 I I I I I I I I I I I I ' ' ' ' I I ' ' I ' I ' I ' I I I 
3.2 3.4 3.6 3.8 4.0 4.2 
1/Tx 1000 
87 
3.3 Parameters determining chemicai shitt non-equivaience 
DS CD 
E 
Q. 
a 
ai 
in 
C D 
m 
C D 
C D 
O) 
88 
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T A B L E 14 
The measurement of A 5 H against temperature for 
ibuprofen TJ. 
Temperature 
K 
observed a-me 
resonance (p 
th ine 
Dm) 
observed a-m 
resonance (p 
ethyl 
om) 
Hf L f A 5 H Hf Lf A 5 H 
3 1 3 3.671 3.651 0.020 
3 0 3 
2 9 3 
2 8 3 
3 .674 3 .622 0.052 1.495 1.490 0.005 
3 .659 
3 .654 
3 .574 0.095 1.476 1.463 0.013 
0.026 3 .492 0.162 1.482 1.456 
2 7 3 3 .647 3.390 0.257 1.494 1.447 0.047 
2 6 3 3 .642 3.283 0.359 1.515 1.441 0.074 
0.110 2 5 3 1.538 1.428 
2 4 3 1.573 1.428 0.145 
3.3.5 The Examination of the Structural Features of 1.2-Diphenvl-1.2-
diaminoethane which induce Chemical Shift Non-eouivalence 
Given that the effectiveness of a chiral solvating agent depends on how it 
interacts with the solvate in solution, attempts were made to obtain structural 
information on intramolecular through space contacts via NOE experiments. 
In most of the 2:1 complexes no conclusive or misleading results were 
obtained. This could be due to the low molecular weight of the complex or to 
the rapid conformational changes of the solvated ion-pair, impairing the 
acquisition of reliable NOE data. Suitable crystals of (1R,2R)-1,2-diphenyl-
1,2-diaminoethane mono-hydrobromide were grown for X-ray analysis to 
determine the conformation of the protonated CSA. Figure 14 shows the X-
ray structure, the absolute configuration agrees with that determined by 
polarimetry. The molecule has approximate Cg-symmetry around the C(1)-
C(2) bond and around the central C-C bond fully staggered hydrogens. 
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This could be considered to represent the conformation in solution, but it must 
be remembered that additional interactions between neighbouring groups in 
the crystal structure which effect conformation will not be present in solution. 
The achiral diamine meso-1,2-diphenyl-1,2-diaminoethane M (Figure 15) 
was used to ascertain whether self recognition between the two chiral acids in 
the 2:1 acid:amine salt complex might have occured. The achiral diamine was 
mixed with Ibuprofen 71, Flurbiprofen 78 and Naproxen 79 at 0.1 mmol ml-"" 
w.r.t. chiral acid in both C D C I 3 and CqDq. The spectra displayed no 
measurable shift non-equivalence leading to the conclusion that the chiral 
acids undergo no self recognition in the diastereoisomeric salt complexes. 
The extent of shift non-equivalence in both acid methyl and methine protons 
has previously been shown to be linked to the anisotropic phenyl groups of 
the 1,2-diamine. Replacement with non-anisotropic groups should 
dramatically decrease the observed A6n value (confirmation of this premise 
was sought by the analysis of various chiral carboxylic acids with 1 R,2R-trans-
1,2-diamino-cyclohexane S5)- The extent of non-equivalence for both types of 
proton is listed (Table 15). The observed A 5 H values for the majority of 
examples are significantly smaller than for the equivalent 1,2-DPDAE 
complexes, and in the case of a-halo acids, no A 5 H was seen at all. Although 
entry 3, Naproxen displayed zero shift non-equivalence in CqDq at 2:1 
stoichiometry, the chemical shift non-equivalence for the methyl doublets in 
C D C I 3 was 0.099 ppm (spectrum 17). This is almost 3 times the value for 
the 1,2-DPDAE salt (A5H = 0.034, C D C I 3 ) . The relative disposition of the bulky 
napthyl substituent in the diastereoisomeric complexes probably is 
responsible for inducing such large non-equivalence. 
9 1 
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P h ^ N H a P h ^ N H R 
NH2 
8 4 85 86 
Figure 15 
a) R = CH2Ph 
b) R = CH2CH3 
The observation in section 2.3 that secondary mono amines CSA gave higher 
non-equivalence than their primary and tertiary analogues led to the synthesis 
of two N-substituted 1,2-DPDAE derivatives which were examined as potential 
CSA's. (1 S,2S)-N,N'-dibenzyl-1,2-diphenyl-1,2-diaminoethane 86a and 
(1S,2S)-N,N'-Diethyl-1,2-diphenyl-1,2-diaminoethane 86b were mixed with 
Ibuprofen and 2-chloropropionic acid in CDCI3, or C6D5. Results are 
summarised in Table 16. Mono substitution greatly reduces A 5 H . The 
largest A S was observed with 86a and 2-chioropropionic acid 82 
(Spectrum 18, for 2-CH3 protons in CDCI3). The introduction of 
substituents on the 1° amine of the CSA must inhibit the selective association 
and is suggestive of a simple two-point hydrogen bonding interaction in the 
salt complexes. 
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T A B L E 15 
The measurement of AS^ with (1 R,2R)-Diaminocyclohexane with selected 
chiral carboxylic acids. 
Entry subs t ra te^ observed so l ven t a5H 
resonance ppm 
1 7 1 2 -H C D C I 3 0.018 
CeDe 0.024 
2-CH3 CDCI3 0.014 
2 7 8 2-CH3 CDCI3 0.019 
CeDe 0.007 
2 -H C D C I 3 0.018 
CeDe 0.019 
3 79 2-CH3 CDCI3 0.099 
4 7 2 2-CH3 CDCI3 0.002 
CeDe 0.002 
2 -H CeDe 0.009 
5 1 9 2-OAc C D C I 3 0.010 
CeDe 0.014 
a) 2-Chloropropionic acid 82 and 2-Bromopropinoic acid 80 were tested but gave no 
Cheniical shift non-equivalence. 
T A B L E 16 
The measurement of Ad^ for chiral solvating agents 8£a, S6b with selected 
chrial carboxylic acids. 
Ent ry substrate 86a 86b 
Observed 
resonance 
So lvent A5^^ ppm Observed 
resonance 
So lvent A 5 ^ ppm 
i a 7 1 2-CH3 CDCI3 
CeDe 
0.010 
0.008 
2-CH3 CDCI3 
CeDe 
0.019 
2 2-CH3 CDCI3 
CeDe 
0.032 
0.037 
2-H CDCI3 
CeDe 
0 . 0 2 " 
0.027 
a) 0.025 mmol amine 86a 
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3.4 The Analysis of Enantiotopic Methylene Protons 
Internally enantiotopic methylene hydrogens are rendered internally 
diastereotopic by derivatisation with a chiral substrate (Figure 16). Chemical 
shift non-equivalence may result if the preferred conformation places Hp, and 
Hg in different magnetic environments for the majority of time in the rapidly 
rotating system. If all conformations are equally populated then no A5 will 
result. 
The example of 1,2-diphenyl-1,2-diaminoethane acts as a CSA for 1° 
carboxylic acids RCH2CO2H presents an unusual case in which internal 
diastereotopicity is induced by an external non-covalently bonded chiral 
reagent. No other examples of this type have been reported for 1° carboxylic 
acids at this time. 
Several achiral carboxylic acids were studied (SZ-S2, figure 17) at both 2:1 
and 1:1 stoichiometry. Spectra were also acquired using samples at 
concentrations of 0.4 mmol mhi and 0.1 mmol"'' respectively. The higher 
concentration corresponds to the optimal conditions defined with other chiral 
2° acids in maximising A5h. The results are listed in Table 17. Maximum 
non-equivalence was observed with phenyl acetic acid SZ (Spectrum 19) 
and 4-bromo phenyl acetic acid (Spectrum 20) both of which are a-aryl 
carboxylic acids. This corresponds to previous observations with chiral 
carboxylic acids. Unbranched alkyi acids and 3-phenylpropionic acid gave 
limited amounts of non-equivalence over the range of conditions. None of the 
substrates examined failed to give non-equivalence. 
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R2 Ri 
R2 Ri* 
Figure 16 
Rc Ri 
H H 
CH2CO2H 
Phenylacetic acid 
8 7 
CH3CH2CO2H 
Propionic acid 
8 8 
Br \ / -CH2CO2H 
4-Bronnophenyiacetic acid 
8 9 
CH3CH2CH2CO2H 
n-Butyric acid 
9 0 
(CH3)2CHCH2CH2C02H 
4-Methylpentanoic acid 
9 1 
CH2CH2CO2H 
3-Phenylpropionic acid 
9 2 
Figure 17 
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T A B L E 17 
The measurement of A S ^ Hg/HR for the achiral acids SZ-H£ with chiral solvating 
agent 1,2-DPDAE. 
A5H ppma 
Entry substrate Solvent 1:1 stoichiometry 2:1 stoichiometry 
0.4 M 0.1 M 0.4 M 0.1 M 
1 87 CDCI3 0.051 0.048 0.136 0.056 
CeDe 
CeDgCDg ~0.o l2 
0.031 0.016 
0.017 
2 M CDCI3 
CeDe 
0.035 0.042 
3 89 CDCI3 
CeDe 
0.060 0.063 0.130 0.082 
C D C I 3 
CeDe 
"~^ToT5""" 
5 91 CDCI3 
CeDe 
0.035 
6 £2 CDCI3 
CeDe 
0.024 
0.033 0.030 
a) Spectra were recorded at 2:1 or 1 
acid concentration at 298K 
:1 acid to amine stoichiometry at 0.4 or 0.1 mmol/ml. 
Spectra for the 2:1 complex of phenyl acetic acid with 1 R,2R-DPDAE were 
recorded at various temperatures (Table 18) and the methylene resonances 
are shown in Figure 18. Both diastereotopic methylene resonances are 
shifted to lower frequency as the temperature falls, the low frequency doublet 
to a greater extent. This is in agreement with previous observations made for 
chiral carboxylic acids and corresponds to the pro S (or pro R) hydrogen being 
closer on average to the anisotopic phenyl group in the preferred 
conformation. Attempts to assign the prochirality of the methylene resonances 
(pro R and pro S) failed due to the lack of a suitable amount of chiral 
a deuteriated substrates. Determination of the enantiomeric purity of 
a deutero carboxylic acids by either or NMR is quite feasible due to the 
high degree of anischronicity induced in methylene protons by 1,2-DPDAE. 
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TABLE 18 
The measurement of HS/HR for Phenylacetic acid with (1R,2R)-DPDAE at 
different temperatures^. 
Entry Temperature 
K 
observed resonance A6H 
ppm H H' 
1 2 9 3 3.288 3.222 0.056 
2 2 8 3 3.227 3.110 0.117 
3 2 7 3 3.183 3.012 0.171 
4 2 6 3 3.162 2.943 0.219 
a) Spectra were recorded at 0.1 mmol/ml acid concentration at 2:1 stoichiometry acid to 
amine. 
3.5 Applications of 1.2-Diphenvl-1.2-diaminoethane 
The primary function of such a chiral solvating agent is in the non-destructive 
analysis of the enantiomeric composition of chiral acids. The reagent can be 
used to determine absolute configuration within certain limitations. If the sense 
of non-equivalence has been assigned previously with samples of known 
enantiomeric composition. The determination of substrate configuration in 
closely related carboxylic acids is prone to error. The conformation 
responsible for shift non-equivalence could alter between related acids in their 
rapidly reversible salt complexes. This could effect the sense as well as the 
value of A5. 
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3.5.1 Enantiomeric Excfiss Dfitfirminations 
To obtain accurate and reliable integrals for enantiomeric purity analysis the 
spectrum must be fully relaxed before acquisition. A typical relaxation delay of 
5 X T, of the signal under observation is usually required. A high signal to 
noise ratio is also desirable which can be obtained at high field and with 
longer acquisition times. High sensitivity and full relaxation is essential when 
utilising ^^C satellite peaks in calibrating enantiomeric purity determinations. 
The sample must also remain in solution during acquisition. Degassing and 
filtration before acquisition is desirable to increase resolution. 
Several commercially available enantiopure carboxylic acids were analysed 
with 1,2-DPDAE in order to determine their enantiomeric purity. The results, 
are listed in Table 19 for both the R and S enantiomers in most cases. 
T A B L E 19 
The measurement of AS^ for chiral solvating agents S£a, Q3h with selected 
chiral carboxylic acids. 
Ent ry Substrate Solvent Observed 
resonance^ 
Enantiomeric 
composition 
Enantiomeric 
excess 
% %R % S 
1 71 CeDe 2-Hb 99.6 
1.0 
0.4 
99.0 
99.2 
98.0 
2 7 8 CeDe 2-Hb 99.4 
3.7 
0.6 
96.2 
98.8 
92.6 
98.8 3 Z9 C D C I 3 2 - C H 3 0.6 99.4 
4 ZQ C D C I 3 2 - C H 3 99.0 
0.1 
1.0 
99.9 
98.0 
99.8 
" " " 9 9 . 6 
99.6 
5 £2 C D C I 3 2 - C H 3 99.8 
0.2 
0.2 
99.8 
a) Enantiomeric composition derived by compairing the carbon-13 satellites of the major 
diastereoisomer with the resonance of the minor. 
b) Enantiomeric compostion derived by comparing the major and minor diasiereomeric 
resonances 
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Figure 19 
The variation of enantiomeric purity for naproxen methyl 
resonances in 1R,2R-DPDAE : 2 x RS-Naproxen complexes 
Ph- ^NH2 
58 
2 X HO2C 
7 9 
OMe 
R:S 
1R:4S 
i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i | i i i i [ i i i i | i i i i | i i i i | i i i i | i i i i | m i | i i i i | i i i i | i M i | i ' i i 
1.52 1.50 1.48 1.46 1.44 1.42 1.40 1.38 1.36 ppm 
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The position of the resonance due to the minor enantiomer has to be 
established before enantiomeric purity determinations are carried out. This 
avoids the danger of assigning spinning side bands or impurities to the minor 
enantiomer. This was usually achieved by comparing the chemical shifts of 
resonances due to the racemate with the enantiopure acid, although it is 
possible, as illustrated by Figure 19 (a stacked plot of the methyl resonance 
of Naproxen at different enantiomeric purities) that the absolute peak position 
changes slightly with enantiomeric purity. 
In the majority of cases enantiomeric excess was derived by comparing the 
integral of the resonance due to the minor enantiomer with the ^^C satellites of 
the resonance due to the major enantiomer, as shown in Spectrum 21 and 
the related Figure 20 for S-2-phenylpropionic acid and S,S-(-)-DPDAE. Both 
^^C satellites and the resonance due to the minor enantiomer are shown on 
the same scale permitting an initial assessment of enantiomer composition. 
Excess determination requires a conversion factor for the ^^C satellite (0.54% 
intensity of the major enantiomer). 
The values quoted in Table 19 above 99% e.e. are approaching the limits of 
detection and will incur large errors due to base line noise. In practice these 
compounds can be considered to be essentially enantiomerically pure. 
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3.5 Applications ol l ,2 -Dlphenyl - l ,2 -d iamlnoethane 
3.5 .2 Determination of Absolute Configuration in 2-Methvlbutvric Acid 
A small (0 .1 mmol) sample of chemically impure enzymatically derived 
2-methylbutyrjc acid 7 4 was supplied for analysis by Dr D O'Hagan. 
Alternative methods of analysis are difficult due to the small amount of material 
available and the marginal difference in alkyi substituents around the 
asymmetric carbon. R and S-2-methylbutyric acid are both readily available, 
and a stacked plot varying the enantiomeric composition of the 2-methylbutyric 
acid in the presence of 1R,2R-(- ) -1,2-DPDAE in C D C I 3 was produced to 
establish the absolute configuration of the diastereomeric resonances (figure 
21). The sense of the shift non-equivalence was observed with the 2 - and 3-
methyl groups of the acid at 1 . 1 2 ppm (doublet), 0.92 ppm (triplet) respectively. 
The two groups had opposing sense in the diastereomehc complexes. 
The 2-methyl butyric acid enzymatic sample was mixed with 1 R,2R-DPDAE in 
C D C I 3 , which had been shown to give maximum attainable A 5 h . Initially one 
resonance was observed with the methyl group indicating a sample with high 
enantiomeric purity. Examination of the chemical shift of this resonance 
seemed to indicate that the absolute configuration was R, but due to the small 
non-equivalence this was not totally certain. Two small amounts of racemic 
2-methylbutyric acid was added to the unknown solution. In each spectrum, 
the resonance due to the 2 - C H 3 proton (doublet) displayed both the expected 
major R peaks plus a minor S-resonance associated with racemate addition. 
To dispel the possibility that the minor enantiomer could be attributed to a 
chemical impurity, the 2 - C H 3 resonances were decoupled from the 2-methine 
proton. Figure 22 displays the decoupled resonances which are compared 
to racemic 2-methylbutyric acid. The lower frequency shoulders on both 
samples corresponds to the S-enantiomer in the racemate. This confirms that 
the absolute configuration is R-2-methylbutyric acid for the unknown sample. 
108 
3.5 Applications ol l ,2 -Dlphenyl - l ,2 -d iaminoethane 
< 
Q 
CL 
ci: o o 
-< •4-
CO ra 
E o o 
•g 
u 
O 
CM 
X o 
u 3 
OJ) 
0) 
E 
X 
oc 
in 
Q. 
Q. 
in 
CD 
o 
CJl 
C/5 
t r 
CO 
CO 
en 
in 
CD 
0) 
CO 
o o 
in o 
in 
109 
3.5 Applications ot 1,2-Uiphenyl-1,2-dianiinoethane 
OJ) CO S 
- S 
:- Q . — a. 
:i- o 
o 
in 
Z- o 
- 1^  
•:- o 
- cn t. o 
B 
CL 
Q 
o 
I-
•r in o 
:^  o 
r- cn 
P o 
110 
3.6 Conclusions 
3.6 Conclusions 
1,2-Diphenyl-1,2-diaminoethane induces remarkably high chemical shift non-
equivalence in a wide range of a-aryl and a-halo carboxylic acids under a 
variety of conditions. It may be prepared via a simple synthetic procedure 
(1,2-DPDAE is now commercially available from Fluka). In most cases the 
diastereoisomeric salts of 1,2-DPDAE show high solubility in both deutero-aryl 
and deutero-chlorinated solvents. Although selective precipitation of one 
diastereoisomeric complex was observed occasionally, selective precipitation 
of the major enantiomer in enantiomeric excess determinations was avoided 
by using the complementary enantiomer of the CSA. With almost all observed 
complexes, optimal non-equivalence was observed at 2:1 stoichiometry and 
0.4 mmol ml-i concentration at room temperature. 
The effectiveness of 1,2-DPDAE was demonstrated by the ability to render 
internally enantiotopic methylene hydrogens diastereotopic for aryl and alkyI -
1° carboxylic acids. This observation has no precedent for 1° carboxylic acids. 
The large observed chemical shift non-equivalence with its consistency in 
inducing non-equivalence in a wide variety of acids makes 1,2-DPDAE 
suitable for the analysis of enantiomeric excess as illustrated in Section 3.5. 
To effectively develop derivatives of 1,2-DPDAE with the goal of improving 
non-equivalence or to make predictions of the absolute configuration for a-aryl 
carboxylic acid a model for the preferred conformation of complexation needs 
to be devised. 
The following assumptions can be used to construct a model for recognition. 
The protonated amino groups in the 2:1 complex will probably prefer an 
antiperiplanar conformation to reduce columbic interactions. Both the amino 
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groups probably undergo hydrogen bond interactions with the carbonyl group 
of chiral acids. Given that the 2:1 complex displays higher non-equivalence 
than the 1:1 complex, this could infer that the position of both aryl rings in 
relation to the 2-chiral carboxylic acids is important. Furthermore, no self 
induced recognition was observed between the two chiral acids with the 
analogous achiral meso-diamine. This reaffirms the need for trans-
antiperiplaner arrangement of the amino groups in the diamine. Small values 
of A 5 h observed with acids in the presence of a-methylbenzylamine, which is 
effectively a subunit of 1,2-DPDAE, supports the importance of the second aryl 
group in the involvement of inducing non-equivalence. 
The failure to observe any measurable NOE's between the acid and the 
diamine could suggest the absence of intermolecular interactions between the 
acid and diamine, so the conformation adopted is one in which the groups are 
not in close proximity. 
Differential shifts obtained by altering several experimental parameters with 
the carboxylic acid substrates suggested that frequency shifts in the NMR 
spectra were due to the proximity of the observed a-groups ( C H 3 or H usually) 
to an aryl group on the CSA. This was highlighted by the fact that differential 
shifts were observed with temperature for the pro-S and pro-R protons of 1 ° 
carboxylic acids. In addition the selective shift of the a-methyl group occurred 
in one of the diastereoisomeric salt complexes (it moved substantially to lower 
frequency). This suggest that one of the substitutuents a to the C O 2 H group is 
in proximity to the aryl group in the preferred conformation. 
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The crystal structure for 1R,2R-diphenyl-1,2-diaminoethane mono-
hydrobromide suggests a conformation in which both amino and phenyl 
groups are gauche. This may be represented by the Newman projection 
Figure 23ai. This conformation would minimise steric repulsions between 
the functional groups, bringing in close proximity the ammonium and amine 
groups which can undergo dipolar interactions reducing the energy of this 
conformation. 
Models for 1:1 and 2:1 complexation can be devised encompassing all the 
above points (Figure 23). In the case of 1:1 complexation the proposed 
model resembles the crystal structure (Figure 23ai) where complexation 
could be considered to occur by a chelating interaction between the 1,2-
diamine and the carboxylic functionality Figure 23b. The low obsen/ed 
non-equivalence is in agreement with the model in which the anisotropic 
phenyl groups of the diamine are relatively remote from the chiral carboxylic 
acid. The 1:1 model agrees with the crystal structure, but suffers from a lack of 
sufficient experimental observations. 
A more rigorous investigation of 2:1 complexation should yield a better 
description of the solvation complex. The low energy conformation 
Figure 23ai proposed as the principle conformer involved in 1:1 
compiexation could play a similar role in 2:1 complexation, although the 
behaviour of the protonated amine functionalities must be taken into account. 
The increase in steric repulsion between the amines due to protonation or 
hydrogen bonding in the 2:1 complex would tend to disfavour a conformation 
placing the amine groups in close proximity. Also, the 2:1 complex would 
prefer a conformation which reduced the columbic interactions between the 
charged groups. The conformer depicted by Figure 23aii places the amine 
groups antiperiplanar and is the only conformer which satisfies the above 
points. A proposed model based on this conformation is illustrated by 
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Figure23c It is assumed that the aryl group of the acid effectively plays no 
part in the molecular interactions within the complex. The 1,2-DPDAE 
complex has C2 symmetry, the methine protons of the amine are also pointing 
away from the complex and are effectively isolated. Diastereomeric 
interactions arise between the 2° aryl group of 1,2-DPDAE and the a-
substituents as depicted in Figure 23. The anisotropy of the phenyl ring 
leads to a larger shift in the position of the a-substituent resonance and a 
lesser effect is seen with the other a-substituent, which is more remote with 
respect to the phenyl ring. 
NH3+ 
NH2 
Ph 
NH2 
i i 
a 
Figure 23 
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H or Me directed towards 
the phenyl 7c-cloud according 
to the configuration of the 
acid (R or S) 
Ar 
Only one interaction between 
the amino group of DPDAE and 
the Chiral acid is shown for 
c l a r i t y 
O 
Aryl group points 
away form DPDAE 
phenyl ring 
Figure 23 
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Oganometallic Chiral Derivatising Agents 
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4.1 The Chiral Derivatising Agent n^-Ethene Platinum-DlOP 
The zero valent platinum complex 25 and the palladium analogue 23 have 
been shown to be effective chiral derivatising agents for electron poor and 
strained ri^-donors The versatility of DIOP-Pt°-ethene (Spectrum 22) 
as a chiral derivatising agent is shown in this chapter by the breath of 
enantiomeric purity determinations that may be made on chiral alkynes, 
enones, and norbornene derivatives. 
The derivatisation may be carried out in an aprotic solvent or in situ under 
argon in the NMR tube. The reaction proceeds by displacement of the bound 
ethene by the substrate. Binding of the chiral ri^-donor may occur via the Re 
or Si face (Figure 24). In the constitutional isomers formed, loss of C2 
symmetry leads to chemically non-equivalent phosphorus atoms. With 
racemic olefins two diastereoismers may be formed in equal amounts for each 
constitutional isomer. The resulting pair of diasteroisomers can be analysed 
by proton-decoupled ^^P NMR spectroscopy. Platinum(195) with a nuclear 
spin of ^ and 30% natural abundance will couple to the phosphorus atoms to 
give additional high and low frequency satellites. 
35 
p t -
/ 
Bound by 
Si - face 
Bound by 
Re - face 
Figure 24 
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4.1 The Chlral Derivatlsing Agent Ti^-Ethene PlaUnum-DIOP 
35 
p ^7: 
93 
Pd-
\ 
P t -/ 
PhoP 
94 
95 
p t -
98 
COoMe 
77 
N H 
96 
CO2H 99 
97 
100 
This gives a possible total of 12 pairs of resonances in the ^^P NMR spectrum 
of complexes of racemic olefins. The phosphorus-phosphorus coupling 
constant is sensitive to chemical environment, with typical values of 60 Hz. 
The values can be used to distinguish diastereoisomers and constitutional 
isomers. In the alkene complexes with remote chiral centres, pairs of 
constitutional isomers will have similar phosphorus couplings. 
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The assignment of diastereoisomeric resonances is aided by analysing both 
enantiopure and enantiomerically enriched samples. This also establishes 
whether derivatisation is stereoselective (i.e. whether kinetic resolution may 
be occurring.) or facially selective. Enantiomeric purity is obtained by 
comparing two sets of unperturbed resonances in the ^^P NMR spectrum. 
The CDA 35 was used to determine the enantiomeric purity of selected chiral 
cyclohexene and norbornene derivative, and results are summarised in 
Table 20. The bicyclic lactam S6. 2-aza-bicyclo[2.2.1]hept-5-en-3-one was 
selectively bound to the platinum by the more open exo face. This is 
illustrated in the ^^P NMR spectrum in which two diastereoisomeric second 
order doublets may be distinguished corresponding to the bound (+) and (-) 
enantiomers (Figure 25a). The different appearance of the high and low 
frequency satellites (Figure 25b) is due to the non-equivalence (anisogamy) 
of platinum-phosphorus coupling constants. The minor diastereoisomeric 
resonance due to the (+)-lactam is present in both the main and the satellite 
peaks of supposedly enantiopure (-)-bicyclic lactam. Integration of these 
resonances gave an enantiomeric purity of 98% (±0.2%). 
Pulegone S2 and the norbornene derivative 2Z also undergo face selective 
complexation. In the case of ZZ. diastereomeric resonances due to the 
racemate display no chemical shift non-equivalence in the ^^P NMR spectrum, 
so that enantiomeric excess could not be determined. 
The enone Damascene 28 whose S-enantiomer is a powerful fragrance 
undergoes non-selective complexation with the platinum complex to yield Si 
and Re bound constitutional isomers for each enantiomer, (Figure 26). For 
each sample of R and S damascene complexes no resonance due to the 
opposite enantiomer of damascene was seen. The enantiomeric purity is 
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4.1 The Chiral Derivatlsing Agent Ti^-Ethene Platlnum-DIOP 
Figure 26 
The ^^P NMR spectra of damascone derivatives 
of ( - ) -DIOP-Pt-ethene 
( - ) -D IOP-Pt -R(+) -Damascone 
' t • ' ^ ^ - T ' ' ' ' 1 ' ' I ' ^ '—I ' ' I • • • • I • 
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Table 20 
3^P NMR data and enantiomeric excess for chiral alkene derivatives of 
Ti2 - ethene Platinuim DlOP 
Ent ry Substrate Spb Jpa-Pb Jpt-Pa Jpt-Pb % e.e. 
ppm ppm Hz Hz Hz 
1 14 .77 12.73 5 5 3 3 0 1 3 3 1 3 98.6 
±0.2 % 
13.80 13.51 5 5 3 5 9 5 3 0 9 4 a 
2 R-97 14.36 11 .14 6 0 3 3 8 1 3 4 1 9 > 98 
3 R-98C 14.17 11.68 6 5 3 5 2 3 3 5 7 1 > 99.7 
12.55 10.55 6 0 3 8 1 5 3 8 3 5 
S-98^ 12 .82 12.30 63 3 6 6 8 3 8 5 4 > 99.7 
12.79 10.44 6 2 3 4 9 3 3 7 2 8 
4 7 7 15 .06 13.58 71 3 4 7 2 2 4 4 3 b 
5 13 .77 9.88 6 5 3 4 0 9 3 8 8 1 96 
12.50 10.75 6 5 3 5 3 7 3 9 3 8 
6 10.73 1.27 3 8 3 4 9 4 3 4 4 9 b 
S-100e 10.68 1.24 3 9 3481 3 4 8 1 b 
a) Data from racemate. 
b) Unable to determine enantiomeric excess due to absence of observable A5. 
c) Constitutionally isomeric species related by binding of the Si or Re face. 
d) '^F NMR spectrum displayed non-equivalence Ad = 0.737, high frequency singlet 
ee = 85.6 % 
e) '^F NMR spectrum displayed non-equivalence A5 = 0.739, low frequency singlet 
ee = 69.8 % 
therefore at least 99.7%, in agreement with values deduced from optical 
rotation measurements 
The chiral alkyne 100 bound non-selectively to the platinum-DlOP moiety to 
produce one pair of diastereoisomeric resonances for each enantiomer. For 
each diastereomeric complex, the minor enantiomeric complex could not be 
distinguished from the major enantiomer in the ^ ^P NMR spectrum. The 
diastereomeric complexes did display chemical shift non-equivalence in their 
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4.1 The Chlral Derivatising Agent ii^-Ethene Platinum-DIOP 
^^F NMR spectra. The ^^F resonance for both the R and S complex is shown 
in Figure 27. The observed chemical shift non-equivalence was large 
(A5 = 0.739 ppm, CqDq, 293K) and both of the samples analysed possessed 
moderate enantiomeric purity. 
Crystals of ri^-ethene platinum DlOP Suitable for X-ray crystallography were 
obtained from a dimethylsulphoxide solution. A representation of the 
molecular structure deduced from the X-ray crystallographic data is shown in 
Figure 28, and Table 21 highlights some of the significant geometric 
parameters. 
The structure is similar to that of the analogous palladium complex The 
ethene carbon-carbon bond length may be related to the Tt-donor ability of the 
d^° metal. The greater the electron donation from the metal the longer the C-C 
bond length will be. The ethene bond lengths for the platinum complex 25, the 
Palladium complex and in free ethene are 1.402(9), 1.366(11) and 
1.337(2) A respectively. This compares to 1.434(13) and 1.45(2) A for the 
bis(triphenylphosphine) 93. and the seven-ring chelating biphosphine 
^ 184, 185 
These values may therefore be related to the degree of 7i-donation from the 
metal to the LUMO of the ethene. n-donor ability correlates to the relative 
order of energy promotion, from the (n -1 )d^° state to the (n - 1 )d^ np state of 
the metal species, this increases from nickel, platinum and palladium by 1.72, 
3.28 and 4.23 eV . Metals with greater electron availability would be 
expected to from stronger metal-olefin bonds, hence more stable alkene 
complexes. Platinum coordination geometry is trigonal and approximately 
planar with a dihedral angle of 4.9(4)° between PPtP and CPtC planes, similar 
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Figure 28 
The crystal structure for (-)-DIOP-Pt-ethene 
Ph 
3 5 
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to that found in structures 23, M, 25- The PPtP chelate bite angle is 
105.25(4)°, similar to that of the palladium complex 22. and in the seven-ring 
chelate complex 25. Attempts were made to synthesise the analogous 
Ti^-ethene nickel-DlOP, but this proved to be unsuccessful. The synthesis was 
attempted in a similar manner to the formation of the platinum complex, but the 
final step, the reductive addition of ethene to zero valent nickel failed to yield 
the expected product. NMR Analysis of the reaction mixture was further 
complicated by the presents of the paramagnetic nickel(ll) ion, indicative of 
incomplete reduction. 
Table 21. 
Select geometric data for Pt complex 25 
Bond distances 
A 
Bond angles 
Degrees 
P t - P ( 1 ) 2 .261(4) P ( 1 ) - P t - P ( 2 ) 105.25(4) 
P t - P ( 2 ) 2 .254(1) C (1 ) -P t -C (2 ) 38.9(3) 
P t -C (1 ) 2 .109(5) P (1 ) -P t -C (2 ) 108.8(2) 
P t -C (2 ) 2 .100(5) P.(2)-Pt-C(1) 107.1(2) 
C(1) -C(2) 1.402(9) P.Pt.P-C.Pt.Ca 4.9(4) 
a) Dihedral angle. 
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4.2 The Analysis of Rhodiumfn Acetylacetone Diethene 
Derivatives as Reagents to Induce Self Recognition 
With previous observations with the achiral reagent PCI3 and related 
compounds (see Section 1.2.1.3), we would expect, in principle that two 
chiral alkenes bound to an achiral metal centre would also produce two sets of 
diastereomeric complexes (two meso forms and a pair of enantiomers). 
The square planar d^ rhodium(l) acetylacetonate diethylene complex 101a. 
has previously been used in conformational studies of its alkene 
derivatives The achiral di-ethene complex and it's fluorinated analogue 
101b .were reacted with 2 equivalents of a chiral ri^-donor then the ^^F and 
spectra recorded in order to observe the presence of self recognition. The 
rhodium complex was dissolved in dry, degassed THF under Argon. Two 
equivalences of the unsaturated chiral substrate was introduced to the 
solution which displaced the bound ethene. The solvent was removed under 
reduced pressure and the residue dissolved in a suitable NMR solvent, 
usually C D 2 C I 2 . For the the derivatives tested 102a-d. non - equivalence was 
not observed in the or ^^F spectra, and in the majority of cases, the reaction 
did not proceed as expected. 
RoC 
r 
a) R = H 
b) R = F 
R3C 
101 
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The possible cause of the incomplete or failed reactions may be related to the 
high steric demand in the alkene substituents examined. Also the analysis of 
the spectra is complicated by the possibility of Si or Re binding for each 
diastereomer and of slow interconversion (on the NMR time scale) of the 
rotameric isomers resulting from relatively free rotation about the metal-carbon 
bond. 
Although the reagent did not work with the reagents tested, it could still 
induced chemical shift non-equivalence with less bulky reagents, however in 
the free rotating system (about the M-C bond) the different conformations 
adopted by these complexes would complicate their spectra. 
a) r ' .R1 = H , F 
b) R^ . R ' = H , F 
F c) r ' "XXji^ ^ '^ 
d) R^ , [ = H , F 
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5.1 Instrumentation 
5.1.1 NMR Spectroscopv 
Proton NMR spectra were recorded on a Bruker AC 250 Spectrometer with 8K 
data points, a Varian VR 400S with 64K data points, and a Bruker AMX 500 
Spectrometer with 64K data points. All chemical shifts are quoted against 
TMS standard at 0 ppm. 
Phosphorus 31 NMR spectra were recorded on a Bruker AC 250 with 8K data 
points and a Varian with 128K data points. Manipulation of data and 
acquisition parameters was carried out where necessary. 
SQlvent? 
Chloroform-d, 99.8 atom % D Aldrich 22,578-9 
Benzene-dg, 100 atom % D Aldrich 17,587-0 
Benzene-dg, 100 atom % D Aldrich 23,697-7 
Benzene-de, 100 atom % D Aldrich 29,616-9 
Pyridine-d5, 99 atom %D Aldrich 15,232-3 
Deuterium oxide 99 atom % D 26,979-4 
Toluene-ds 99-1- atom % D 15,199-8 
Methyl Sulphoxide-de 99.9 atom % D Aldrich 23, 692-6 
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Limits of Detection 
Bruker AC 250 Spectrometer - single pulse (90°) 
S/N 50:1 (0 .1% ethylbenzene) 
Varian VR 400S Spectrometer - single pulse (90°) 
S/N 120:1 (0 .1% ethylbenzene) 
Bucker AMX 500 Spectrometer - single pulse (90°) 
S/N (0.1 % ethylbenzene) 
5.1.2 Mass Spectroscopv 
Mass spectra were recorded on a VG 7070E Spectrometer operating in 
chemical ionisation, electron impact or desorption chemical ionisation mode. 
5.1.3 X-rav Crvstalloaraphv 
Data collection and processing was carried out on a CAD4 diffractometer. 
Enraf Nonius CAD4 software was used for data collection and cell refinement 
utilising least squares analysis. Data processing parameters are given in the 
appendix. 
1 3 2 
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5.2.1 Chiral Solvatina Agents 
Unless othenwise stated, these compounds were used as received:-
R (-1-)- N,N-Dimethyl-1-Phenethylamine - Aldrich 24,207-1 
S (-)- N,N-Dimethyl-1-Phenlethylamine - Aldrich 24,206-3 
RS-N,N-Dimethyl-1-(Naphthyl) ethylamine (5.2.7) 
RS-N,N-Dimethyl-2-Phenyl Glycine Methyl ester (5.2.6) 
(IR,2S)-Ephedrine - Aldrich 13,491-0 
(IR,2R)-N-methyl ephedrine - Aldrich 28,777-6 
(IS,2S)-Pseudoephedrine - Aldrich 28,763-6 
(IS,2S)-Methyl Pseudoephedrine - Aldrich 29,004-1 
RS-Benzyl-Phenethylamine (5.2.8) 
RS-N-methyl-1 -Phenethylamine (5.2.9) 
S-2-(Anilinomethyl)-Pyrrolidine - Merck 818236 
S-Proline t-Butyl ester - Sigma P-7769 
S-Prolinamide - Sigma P-6675 
S-Proline p-nitroanilide from 
S-Proline p-Nitroanilide trifluoroacetic acid salt - Sigma P-5267 
S-Proline N-Methylamide (5.2.10) 
(1 R,2R)/(1 S,2S)-1,2-Diphenyl-1,2-Diaminoethane (5.2.11) 
(1R,2R)/1S,2S)-N,N'-Dibenzyl-1,2 Diphenyl-1,2 Diaminoethane (5.2.13) 
(1R,2R)/1S,2S)-N,N'-Diethyl-1,2-Diphenyl-1,2-Diaminoethane (5.2.14) 
(1 R,2S)-1,2-Diphenyl-1,2-Diaminoethane (5.2.15) 
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5.2.2 Solutes 
RS-Mandelic acid 99-h% - Aldrich 24,121-0 
(-)-Camphanic acid - Merck 364404 
(+)-Camphanic acid - Merck 52260 
3- Phenybutyric acid - Aldrich 11,680-7 
2-Phenylpropionic acid - Aldrich P3,170-1 
Ibuprofen - Sigma 1-4883 
Ketoprofen - Sigma F-8514 
RS-a-Methoxy-a-(trifluoromethyl) phenylacetic acid - Aldrich 15,655-8 
R-O-Acetylmandelic acid - Aldrich 25,303-0 
S-O-Acetylmandelic acid - Aldhch 25,302-2 
2-Bromopropionic acid - Fluka 18170 
2-Chloropropionic acid - Fluka 26158 
R-Hexahydromandelic acid - Fluka 52550 
S-Hexahydromandelic acid - Fluka 52545 
(-i-)-0,0-Dibenzoyl-L-Tartaric acid - Fluka 33610 
(-)-0,0-Dibenzoyl-L-Tartaric acid - Fluka 33620 
(±)-Cis-endo-bicyclo[2,2,1 ]-6/5-methoxycarbonyl-hepta-2-ene-5/6-oic acid 
Trans-Cyclohexane-1,2-dicarboxylic acid - Fluka 28975 
RS-Naproxen (5.2.3) 
Flurbiprofen -SigmaF-8714 
2- Fluorobutanoic acid (5.2.4) 
Phenylacetic acid - Aldrich PI,662-1 
Propionic acid - Aldrich 24,035-4 
4- Bromophenylacetic acid - Aldhch 13,867-3 
n-Butyric acid - Aldrich B10,350-0 
4-methylpentanoic acid - Aldrich 27,782-7 
RS-2-Methylbutyhc acid - Aldhch 19,307-0 
3- Phenylpropionic acid - Aldhch 13,523-2 
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5.2.3 RS-Naproxen (Racemisation Method) (79) 
(S)-Naproxen (5.47 g, 23.75 mmol) was dissolved in 2.5M NaOH solution 
(5.0 g in 50 ml EtOH), then heated under reflux for 3 days. The solvent was 
removed under reduced pressure. The residue was dissolved in water (20 ml) 
then acidified to pH 0 with 6M HCI, The free acid was extracted into 
chloroform, dried over magnesium sulphate, filtered, and the solvent removed 
under reduced pressure. The product was recrystallised from chloroform 
/hexane (1:4) to yield a white crystalline solid (3.20 g, 58.5%). 
Found %: C, 73.0 ; H, 6.1. calculated for C14H18O3; C, 73.0 ; H, 6.2 
5H (CDCI3) 7.64-7.03 (7H, M, Nap), 3.84 (1H, q , J = 7.1Hz, CH), 1.58 (3H, d, 
J = 7.1Hz, -CH3) 
[a]^° = 0° (c l .O, CDCI3) 
5.2.4 Fiuorobutanioc Acid (83) 
Methyl-2-Fluorobutanoate^ (0.27 g, 2.54 mmol) was dissolved in 6M HCI 
(20 ml), the solution was refluxed for 5 hours, cooled and the free acid 
extracted into dichloromethane ( 3 x 1 0 ml), dried over magnesium sulphate 
and the solvent removed under reduced pressure to give a colourless oil (0.18 
g, 70.1%). 
5H (CDCI3) 4.94 (1H, ddd, J = 7.8Hz, J = 6.4Hz, J = 48.9Hz, HCF), 2.06-1.93 
(2H, m, -CH2), 1.08 (3H, t, J = 7.5Hz, -CH3) 
a. Received July 1991, from Dr D. O'Hagan, Department of Chemistry, 
University of Durham. 
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5.2.5 The Formation of Diastereomeric Salts for NMR Analysis. 
The CSA (0.10 mmol, solid, liquid or solution of known molarity) was added to 
its complementary solute (0.10 mmol, 1:1 molar ratio) in a suitable deuterated 
solvent (1 ml; chloroform-d, benzene-dg, benzene-d6+ pyridine-ds, toluene-
da). The solution was filtered, degassed and the NMR spectrum recorded. 
In the case of 1,2-diphenyl-1,2-diaminoethane, maximum non-equivalence 
was observed with a 2:1 acid/amine molar ratio (0.05 mmol diamine, 
0.10 mmol complementary reagent). 
5.2.6 N.N'-Dimethyl-2-phenylglycine methvl ester (£1) 
(R) or (S)-Phenylglycine (13.61 g, 90 mmol) was dissolved in aqueous 
formaldehyde (14.6 ml, 180 mmol in 270 ml H2O). To the solution a catalytic 
amount of palladium on activated carbon (5%, 6.65 g) was added and the 
mixture was subjected to hydrogenation for 6 hours (H2, 35lbs per sq inch). 
The solution was filtered and the solvent was removed under reduced 
pressure. The product was recrystallised from acetone/ethanol (1:1) to yield a 
white crystalline solid (8.39 g, 52%). Mpt 255-256° C (lit. Mpt 257° C) 188 
Found % : C, 68.2 ; H, 7.9 ; O, 16.6 ; N, 7.3. calculated for C11H15NO2 : C, 
68 .4 ;H , 7 .9 ; N.7.3; 0,16.6 
5H {D2O) 7.52 (5H, s, Ph), 4.61 (1H, s, CH), 3.01, 2.54 (6H, d, N(CH3)2) 
m/e (NH3, CI) 203 (M+ + 10), 185 (M+ + 8), 181 (M+ + 12), 180 (M+ + 13) 
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(R) or (S)-N,N'-Dimethyl-2-phenylglycine (8 g, 45 mmol) was dissolved in 
methanol (500 ml) and cooled to 0° C. A solution of Diazomethane in 
ether/methanol (2.90 g, 68 mmol, 0° C) was added dropwise over 15 minutes. 
The solution was kept at 0° C for 30 minutes, and then the solvent and excess 
diazomethane was removed under reduced pressure. The ester was 
extracted into ether ( 3 x 1 0 cm^), the solvent removed under reduced 
pressure and the product purified by distillation (50-60° C, 0.02 mm Hg) to 
give a colourless oil (3.88 g, 45%). 
5H (CDCI3) 7.45-7.25 (5H,m,Ph), 3.87 (IH.s.CH), 3.70 (3H,s,OCH3), 2.25 
(6H,s,N(CH3)2) 
m/e (NH3,CI) 195 (M+ + 2), 194 (M+ -t- 1) 
5.2.7 N.N'-Dimethvl-1 -(1 -NaphthvDethvlamine (62) 
(R) or (S)-l-(l-Naphthyl) ethylamine (1 g, 5.84 mmol) was added to dilute 
acetic acid (5M, 80 ml) and formaldehyde (2 ml, 24.66 mmol). Palladium on 
activated carbon (5%, 2 g) was added to the solution prior to hydrogenation 
(H2, 34.9 lbs per sq inch, 6 h, 20°C). 
The solution was filtered, the pH raised to 12 (KOH solution) and the resultant 
free amine was extracted into chloroform ( 2 x 1 0 cm^). The combined organic 
extracts were dried over anhydrous potassium carbonate, the solution was 
filtered and the solvent removed under reduced pressure to yield a colourless 
oil (592 mg, 51%). 
m/e (SMI) C14H17N Found : 199.12448, (mmv 11.6). Calculated : 199.2950 
5H (CDCI3) 8.33-7.17 (7H, m, Ar), 3.92 (1H, q, J = 6.6 Hz NCH), 2.20 
(6H, s, N(CH3)2), 1.40 (3H, d, J=6.6 Hz, CH3) 
m/e (NH3, CI) 201 (M+ + 2), 200 (M+ + 1) 
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5.2.8 N-Benzvl-Phenethvlamine (63a) 
(R) or (S)-a-methylbenzylamine (1.92 ml, 1.81 g, 15 mmol) was mixed with dry 
ethanol (10 ml) under nitrogen. Benzaldehyde (4.57 ml, 4.77 g, 45 mmol) 
was slowly added to the solution which was then stirred for 30 minutes. 
The resultant imine was cooled to 0° C, a solution of sodium borohydride in 
ethanol (1.13 g, 30 mmol in 10 ml EtOH) was gradually introduced. The 
solution was allowed to reach room temperature and was then stirred for 15 
hours. An excess of ethanol (5 ml) was added to the solution which was 
stirred for a further 30 minutes. 
The solvent was removed under reduced pressure, the residue was dissolved 
in water, acidified to pH 2 (HCI solution) then washed with ether ( 3 x 1 0 ml). 
The pH of the aqueous solution was raised to 12 (KOH solution) and the free 
amine extracted into dichloromethane (3 x 20 ml). The solution was dried over 
magnesium sulphate, filtered and the solvent removed under reduced 
pressure to yield a colourless oil (2.49 g, 78.5%). 
5H (CDCI3) 7.59-7.41 (10H, m, 2Ph), 4.26 (1H, q, Jgx = 6.6 Hz, NCH), 
3.87, 3.80 (2H, q, Jaa' = 13.3 Hz), 1.84 (1H, s, NH), 1.57 (3H, d, Jgx = 6.6Hz, 
CH3) 
m/e (NH3, CI), 212 (M+ + 1), 213 (M+ + 2) 
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5.2.9 N-Methvl-1 -Phenethvlamine '^'^ (£2^) 
(R) or (S) -a-methylbenzylamine (1.93 ml, 1.83 g, 16 mmol) was mixed with 
dry toluene (84 ml) and pyridine (11 ml) then cooled to 0° C. 
Isobutylchloroformate (5.84 ml, 6.12 g, 45 mmol) was dissolved in dry toluene 
(14 ml). This was slowly added to the amine solution over 20 minutes. The 
solution was allowed to reach room temperature then was stirred for 2 hours. 
2M sodium hydroxide (75 ml) solution was added to the solution. The two 
immiscable layers were stirred vigorously together for 3 hours. The aqueous 
layer was removed then washed with toluene ( 3 x 1 5 ml). The organic 
solution and washings were combined and dried over magnesium sulphate 
and the solvent was removed by reduced pressure. The produce was 
recrystallised from hexane (1.94 g, 55.2%). 
Found % : C, 71.1 ; H, 8.9 ; N, 6.0. calculated for C13H19NO2 : C, 71.0 ; H, 8.7 
; N.6.3. 
5H (CDCI3) 7.33-7.27 (5H,m,Ph), 4.93 (1H,s,NH), 4.84 (1H,s,NCH), 3.84, 3.83, 
3.81, 3.80 (2H, dd, J^g. = 2.2 Hz, 4 , 6.59 Hz, CHgO), 1.89, 1.87, 1.84. (1H, 
J = 5.0 Hz, J = 6.6 Hz, CHMe2), 1.49, 1.46 (3H, d, J = 6.6 Hz, CH3), 0.90. 0.88 
(6H,d, J = 5 . 1 Hz, C(CH3)2) 
m/e (NH3, CI) 222 (M+ + 1), 301 (M+ +18). 
(R) or (S)-N-lsobutyl-l-phenethylamine (1.01 g, 4.6 mmol) was dissolved in 
dry, degassed tetrahydrofuran (7 ml). Lithium aluminium hydride (0.54 g, 14.2 
mmol) was dissolved in dry, degassed THF under nitrogen and cooled to 0° C, 
the amine solution was slowly added over a 30 minute period. The solution 
was allowed to warm to room temperature then refluxed for 3 hours. 
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The solution was cooled and excess LiAIH4 removed by the addition of water 
(0.5 ml) then 2M NaOH (0.5 ml). The solution was filtered and the solvent 
removed by reduced pressure, the residue was dissolved in water, acidified 
and washed with ether ( 3 x 5 ml). After the pH of the solution was raised to 12 
(KOH solution), the free amine was extracted into chloroform ( 3 x 1 0 ml). The 
solution was dried over magnesium sulphate, filtered, and the solvent 
removed under reduced pressure to yield a colourless oil (80° C, 12 mmHg, 
0.36 g, 59.4%). 
m/e (SMI) C9H13N Found : 135.08740, (mmv 17.4). Calculated : 135.2084 
5H 7.17 (5H,s,Ph), 3.38 (1H, q, = 6.5 Hz, NCH), 2.10 (3H,s,NCH3), 1.17 (3H, 
d, Jax = 6.5 Hz, CH3), 0.91 (1H, b, NH). 
m/e (NH3, CI) (M+ -h 1) 136, (M+ -16) 120 
5.2.10 L-Proline-N-Methvlamide (66d) 
L-Proline methylester hydrochloride (1.05 g, 6.4 mmol) was dissolved in 
methanol (10 ml). The solution was cooled to -78° C. Methylamine was 
condensed into the proline solution. The mixture was stirred for 5 hours. The 
solution was left to warm to room temperature, and the solvent removed under 
reduced pressure. The residue was dissolved in ether, filtered, and the 
solvent removed under reduced pressure to give a colourless solution. The 
solution was distilled under reduced pressure (80° C, 0.1 mmHg, 0.55 g, 
67.4%). 
5H (CDCI3) 3.84 (1H, dd, J^a = 9.3 Hz, Jae 5.5 Hz, CHCO), 3.55 (1 H,s,NHMe), 
3.12 (1H, b, NH), 3.11-2.92 (2H, m, CHg), 2.88, 2.86 (3H, s,s', NHCHg), 2.19 
(1H, dt, J = 7.5 Hz, JHH' = 19.7 Hz, CHJ, 1.95 (1H, dt, J = 6.5 Hz, JHH' = 19.3 Hz, 
CHe), 1.75 (2H, quin, J = 6.9 Hz, CHg) 
m/e (NH3, CI) 129 (M+ + 1), 70 (M+ - 58) 
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5.2.11 (RSV1-1.2-Diphenvl-1.2-diaminoethane (£8) 
Benzil (78.22 g, 0.37 mmol) was mixed with cyclohexanone (39.3 ml, 37.2 g, 
0.38 mmol), ammonium acetate (296.5 g, 3.84 mmol) and acetic acid (741 ml). 
The solution was refluxed for one hour, then allowed to cool slightly before it 
was poured into water (11). The solution was stirred for 2 hours then left for 15 
hours. The resulting crystals were removed by filtration, washed with water (3 
x 200 ml). The product was recrystallised from methanol/water (4:1) to yield a 
yellow solid (86.8 g, 81%). 
Found % : C 83.8 ; H 7.0 ; N 9.1 ; calculated for C20H20N2 : C 83.8 ; H 7.0 ; 
N 9.7 
5H (CDCI3) 7.52-7.32 (5H, m, Ph), 1.97-1.92 (IH.m.CHgC), 1.84-1.68 (2H, m, 
CH2CH2) 
5-Spirocyclohexyl-2,3-diphenylisoimidazole (40 g, 138,7 mmol) was dissolved 
in THF (200 ml) and cooled to -78° C. Ammonia was condensed into the 
solution (250 ml) then lithium (4 g, 576.4 mmol) was added in small amounts. 
The solution was stirred under a nitrogen atmosphere for 2 hours. Ammonium 
chloride (40 g,747.8 mmol) was added to the solution before being allowed to 
reach room temperature. Water (200 ml) was stirred with the organic layer for 
30 minutes, the aqueous phase was separated then washed with ether (3 x 
50 ml). The combined washing and organic layer was washed with sodium 
chloride solution (3 x 30 ml) then dried over anhydrous magnesium sulphate, 
filtered then the solvent volume reduced to 150 ml. 
2M HCI (200 ml) was added to the solution, the phases were stirred vigorously 
for 2 hours. The organic layer was removed then washed with water (3 x 
30 ml). The combined aqueous solution and washings was basified with 
NaOH (pH 14). The free amine was extracted into dichloromethane (3 x 
60 ml) 
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dried, filtered, and the solvent removed under reduced pressure to yield a 
colourless solid (24.18 g, 81.4%). Mpt 82-83° C (lit. Mpt 83° C) 
5H (CDCI3) 7.30 (5H, s, Ph), 4.10 (1H, s, CH), 1.60 (2H, s, NH2) 
5.2.12 Resolution of Racemic-1.2-Diphenvl-1.2-diaminoethane ( ^ ) 
(RS)-1,2-diphenyl-1,2-diaminoethane (4.30 g, 20.0 mmol) was dissolved in 
35 ml of dry ethanol upon heating. S-mandelic acid (6.10 g, 40.1 mmol) was 
dissolved in the hot solution which was left to cool forming crystals of the salt. 
The precipitate was removed by filtration and recrystallised twice from ethanol 
(50 ml, 30 ml) then dried (3.49 g, 67.3%) Mpt 156-157° C (lit 164-165° C) [a]o 
= + 122.0° (lit 126.9°, c 1.51, MeOH) The washings were combined and 
saved. 
The (1S,2S) DPDAE (S)MA salt (3.49 g, 6.73 mmol) was dissolved in water 
(40 ml) basified with NaOH (pH14). The free amine was extracted into ether 
( 3 x 1 0 ml), the solution was dried, filtered then the solvent removed under 
reduced pressure to yield a white precipitate. The product was recrystallised 
from ether/hexane (1:1) (0.94 g, 65.4%) Mpt 79.5-80.5° C (lit 80° C) [a]D° = 
104.1° (lit 106.5°, c 1.0, MeOH) 195 
The saved washing's ((1R,2R) DPDAE (S)MA) solvent was removed under 
reduced pressure. The free amine was obtained as above. The impure 
(1R,2R)DPDAE (1.8 g, 8.43 mmol) was dissolved in ethanol (50 ml) upon 
heating. R-Mandelic acid (2.57 g, 16.9 mmol) was dissolved in the hot 
solution then the solution was left for crystal formation. The crystals were 
filtered and dried (3.55 g, 81.3%). 
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mpt 158-159° C (lit 164-165° C) [a]o = 15.70° (lit 126.9°, c 1.4, MeOH) 
The free (1 R,2R) DPDAE was obtained from (1 R,2R) DPDAE (R)MA as 
described above. 
(1.20 g, 66.7%) mpt 80-80.5° C (lit 80° C) [afo = 95.7° (lit 106-5°, c 1.0, 
92 
MeOH) 195 
The enantiomeric purity of the resolved amine was checked by ^H NMR using 
R-O-acetylmandelic acid as a Chiral solvating agent (CgDg, A6 = 0.077 ppm). 
No minor resonance was seen for the complementry enantiomer. The 
resolved amines are essentially pure with an enantiomeric execess > 99.7% 
' (limit of detection). 
5.2.13 N.N'-Dibenzovl-1.2-diphenvl-1.2-diaminoethane (86a) 
(R) or (S)-1,2-diphenyl-1,2-diaminoethane (0.28 g, 1.29 mmol) was dissolved 
in dry chloroform (30 ml) with triethylamine (0.45 ml, 0.32 g, 3.24 mmol). The 
solution was cooled to 0° C and benzoyl chloride (0.5 ml, 0.54 g, 3.84 mmol) 
added dropwise over 10 minutes. The solution was allowed to reach room 
temperature, the precipitate was removed by filtration, and washed with 1M 
HCI ( 3 x 1 0 ml) then washed with water (3 x 20 ml). The white solid was dried 
under reduced pressure (0.37 g, 67.3%). Sublimes 168-170° C. 
Found % : C, 79.9 ; H, 5.8 ; N, 6.4 calculated for C28H24N2O2 : C, 79.9 ; H 5.8 ; 
N, ;6.6 
m/e (NH3, CI) 421 (M+ -i- 1), 212 (M+ - 208), 106 (M+ - 314) 
(R) or (S)-N,N'-Dibenzoyl-1,2-diphenyl-1,2-diaminoethane (0.37 g, 0.87 mmol) 
was mixed with tetrahydrofuran (20 ml) and lithium aluminium hydride (0.36 g, 
9.49 mmol) at 0° C under nitrogen. The solution was allowed to reach room 
temperature then heated to reflux for 4 days. The solution was cooled and 
excess LiAIH4 removed by the addition of water and 4M NaOH.(0.36 ml 
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H2O, 1.2 ml 4M NaOH, 2 x 1 ml H2O). The solvent was removed under 
reduced pressure and the residue was mixed with HCI solution (pH 1, 20 ml) 
The solution was filtered and the pH was raised to 12 (KOH solution). The free 
amine was extracted into dichloromethane ( 3 x 1 0 ml), dried over potassium 
carbonate, filtered, and the solvent removed under reduced pressure to yield a 
colourless oil (0.18 g, 51.2%). 
The product was purified by column chromatography (AI2O3, 2% Hexane in 
dichloromethane) R, = 0.37. 
5H (CDCI3) 7.30-7.03 (10H, m, 2Ph), 3.71 (1H, s. CH), 3.68, 3.65, 3.50, 3.47 
(2H, dd, = 13.4 Hz, CH2), 2.21 (1H, b, NH). 
5.2.14 N.N'-Diethvl-1.2-diphenvl-1.2-diaminoethane (86b) 
(R) or (S)-1,2-Diphenyl-1,2-diaminoethane (0.44 g, 2.06 mmol) was dissolved 
in dry dichloromethane (20 ml) with triethylamine (1.84 ml, 1.32 g, 13.2 mmol). 
The solution was cooled to 0° C under Nitrogen and acetyl chloride (1 ml, 14.1 
mmol) was added dropwise over 15 minutes, the reaction was left to warm to 
room temperature then stirred for 2 hours. 1M HCI (10 ml) was added to the 
solution which was stirred for a further 30 minutes. The organic and aqueous 
layers were separated, and the aqueous layer washed with dichloromethane. 
The organic layer and combined washing were dried over potassium 
carbonate, filtered and the solvent removed under reduced pressure to yield a 
white solid (0.53 g, 86.3%). Recrystallisation from methanol/water (1:1 v.v) 
gave a colourless solid (0.44 g, 72.0%) Mpt 130-133°C. 
Found % : N, 8.3 ; C, 67.4 ; H, 6.8 Cal. for C18H20N2O2: C, 73.0 ; N, 9.5 ; H, 6.8 
m/e (NH3, CI) 297 (M+ + 1), 269 (M+ - 28), 105 (M+ -191). 
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(R) or (S)-N,N'-Acetyl-1,2-diphenyl-1,2diaminoethane (0.44 g, 72.0%) was 
mixed with THF (20 ml) and LiAIH4 (0.35 g, 9.18 mmol) at 0° C under Nitrogen. 
The solution was allowed to reach room temperature then refluxed for 2 days. 
The solution was cooled and water, 4M NaOH (0.6 ml H2O, 2.4 ml 4M NaOH, 
2 X 1 ml H2O) was added. The solvent was removed under reduced pressure. 
To the residue 1M HCI solution (30 ml) was added. The solution was filtered 
and the pH raised to 12 (KOH solution). The free amine was extracted into 
dichloromethane ( 3 x 1 0 ml), dried over magnesium sulphate, filtered and the 
solvent removed under reduced pressure to yield a white solid (0.25 g, 
62.8%). 
5H (CDCI3) 7.31-7.00 (5H, m, Ph). 3.96 (1H, s, CH), 2.69-2.36 (2H, m, CH2), 
1.19(3H,t, J = 7.1 Hz. CH3). 
m/e (NH3, CI) 269 (M+ + 1), 134 (M+ - 134), 106 (M+ - 162). 
5.2.15 meso-1.2-Diphenvl-1.2-Diaminoethane (84) 
Benzaldehyde (100 ml, 104.7 g, 986.6 mmol) was mixed with ammonium 
acetate (66.9 g, 86.1 mmol) and the solution was heated under reflux for 3 
hours, then allowed to cool to room temperature. The precipitate was 
collected by filtration, washed with ethanol (3 x 20 ml) and dried under 
reduced pressure to yield N-benzoyl-N'-benzylidine-Meso-l ,2-Diphenyl-1,2-
Diaminoethane as a white solid (47.3 g, 47.4%) Mpt 257-258° C, 
(lit 259° C) 
5H (DMS0-d6) 8.81 (1H, d, J = 9.2 Hz. NCPh), 7.14 (1H. s. NHCO). 6.76-6.28 
(22H. m, 4Ph), 4.76 (1H, t, J = 9.40, HCNHCO), 3.94 (1H. d, J = 9.6 Hz, HCNC) 
m/e (NH3, CI) 405 (M+ + 1), 210 (M+ - 194), 106 (M+ - 298) 
Found % : N, 6.8 ; C, 83.8 ; H, 6.0 Cal. for C28H24N2O : N, 6.9 ; C, 83.1 ; H, 6.0 
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N-benzoyl-N'-benzylidine-Meso-1,2-Diphenyl-1,2-Diaminoethane (10.0 g, 
24.7 mmol) was dissolved in 6M sulphuric acid (100 cm^). The solution was 
steam distilled for 7 hours on (until the distillate was no longer acidic). The 
solution was cooled, filtered and neutralised with ammonia solution (33% w/v). 
The free amine was extracted into ether (3 x 20 ml), dried over magnesium 
sulphate, filtered and the solvent removed under reduced pressure. The 
diamine was recrystallised from Hexane to yield a white crystalline solid (2.3 
g, 44%) Mpt 118-119° C, (lit 120° C) 
5H (CDCI3) 7.41-7.30 (5H, m, Ph), 4.03 (1H, s, CH), 1.41 (2H, s, NHg) 
m/e (NH3, CI) 213 (M+ -H1), 196 (M+ - 16), 106 (M+ - 106) 
Found % : N, 13.0 ; C, 79.0 ; H, 7.6 Cal. for C14H16N2: N, 13.2 ; C, 79.2 ; H, 7.6 
5.2.16 The Formation of (1R. 2R)-1.2-Diphenvl-1.2-Diaminoethane 
Monohvdrobromide Crvstals for X-rav Analvsis. 
(1R, 2R)-1,2-DPEDA (30.8 mg, 0.145 mmol) was dissolved in iso-
propylalcohol (1 ml) containing 2-Bromopropionic acid (21.4 mg, 0.140 mmol). 
Iso-propylether vapour was allowed to diffuse into the solution over 3 days 
during which time crystals suitable for X-ray analysis formed. 
(See appendix for desposition data) 
6H (CDCI3) 7.18-7.17 (3H, m, o,p-Ph), 6.98-6.97 (2H, m, m-Ph), 
4.41 (1H, s, CH). 
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5.2.17 The Attempted crystallisation of 1.2 diohenvl-l .2-diaminoethane salts 
for X-rav analvsis. 
Several unsuccessful attempts were made to grow crystals of 1,2-DPDAE 
carboxylate salts suitable for X-ray analysis. A summary of the reagents and 
methods used follows. 
Vapour diffusion 
1 Equivalent of the acid (0.1 mmol) was added to 0.5 equivalents of 1R,2R-
DPDAE (0.5 mmol). The dicarboxylate salt was dissolved in a minimum 
volume of the polar solvent (0.5 ml), filtered and placed in a vapour diffusion 
chamber containing isopropyl ether as the vapour diffusing agent. The 
chamber was left until crystal formed or an equilibrium was reached. 
Polar solvent - Isopropyl alcohol 
Reagents 
a-Bromopropionic acid 
S-Naproxen 
R(+)/S(-)-2-Chloropropionic acid 
R(-)/S(-i-)-2-Phenylpropionic acid 
R/S-Mandelic acid 
Crystals formed 
No crystals 
No Crystals 
No Crystals 
No Crystals 
Polar solvent - Acetronitrile 
Reagents 
S-Naproxen 
R(+)/S(-)-2-Chloropropionic acid 
Crystals Formed 
No Crystals 
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Crystallisation from constant volume 
1 Equivalent of the acid was added to 0.5 equivalents of 1 R,2R-DPDAE. The 
dicarboxylate salt was dissolved in a minimum of the polar solvent (1.0 ml), 
filtered and placed in a sealed container. 
Polar solvent - Dichloromethane 
Reagents 
R(+)/S(-)-2-Chloropropionic acid (0.1 mmol) 
a-Bromophenylacetic acid (0.1, 0.2, 0.3 mmol) 
4-Bromophenylacetic acid (0.1 mmol) 
(0.4 mmol) 
2-Bromopropionic acid (0.1, 0.4, 0.5 mmol) 
Crystals (fine needles) 
No Crystals 
No Crystals 
Crystals formed 
Crystals formed 
Polar solvent - Benzene 
Reagents 
a-Bromophenylacetic acid (0.1 mmol) 
4-Bromophenylacetic acid (0.1, 0.3, 0.5 mmol) 
2-Bromopropionic acid (0.1, 0.3, 0.5 mmol) 
No Crystals 
Crystals formed 
Crystals formed 
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5.3.1 The Formation of Diastereomeric Complexes for NMR Analvsis. 
(R,R)-DIOP-Pt--C2H4 (15 mg. 0.02 mmol) was dissolved in dry. degassed 
tetrahydrofuran (1.5 ml). The solid ri^-donor (0.02mmol) was dissolved in dry, 
degassed THF (1.5 ml). 
The ri^-donor solution or liquid was added by syringe to the platinum complex. 
The solution was stirred for 10 minutes with concomitant evolution of ethene. 
The THF was removed under reduced pressure, the residue dissolved in 
deutero-benzene (0.5 ml) and the NMR spectrum recorded. 
5.3.2 Ti^-donors 
(R,R)-DIOP-Pt2-(RS)-Damascone^ (98). 
R-Enantiomer- 5p {CQDQ) Pa 14.17 (Jpa-Pb 65 Hz, Jpg-R 3523 Hz), Pb 11.68 
(Jpb.Pa 65 Hz, Jpb-pt 3571 Hz), Pa' 12.55 (Jpa'-Pb' 60 Hz, Jpa.pt 3815 Hz), Pb' 
10.55 (Jpb'-Pa- 60 Hz, Jpb'.R 3835 Hz) 
S-Enantiomer- 8p {CQDQ) Pa 12.82 (Jpa-Pb 63 Hz, Jpa-R 3668 Hz), Pb 12.30 
(Jpb-Pa 63 Hz, Jpb-Pt 3854 Hz), Pa' 12.79 (Jpa'.pb' 62 Hz, Jpa-pt 3493 Hz), Pb' 
10.44 (Jpb'-Pa- 62 Hz, Jpb-.R 3728 Hz) 
(R,R)-DIOP-Pt2-(RS)-2-aza bicycle [2.2.1] hept-5-en-3-one'' (96). 
H-Enantiomer 5p {CQDQ) Pa 14.77 (Jpa-Pb 55 Hz, Jpg.R 3301 Hz) Pb 12.73 
(Jpb-Pa 55 Hz, Jpb-pt 3313 Hz) 
[+]-Enantiomer 5p {CQDQ) Pa 13.80 (Jpa-Pb 55 Hz, Jpa.R 3595 Hz) Pb 13.51 
(Jpb-Pa 55 Hz, Jpb-R 3094 Hz) 
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(R,R)-DIOP-Pt2-(R)-Pulegone<= (97) 
Palegone was added in large excess to a solution of DIOP-platinum ethane 
(15 mg, 0.02 mmol) in tetrahydrofuran (1.5 ml). Excess palegone was 
removed after 5 days at room temperature. 
R-Enantiomer- 5p {CQDQ) Pa 14.36 (Jpa-Pb 60 Hz, Jpa-R 3381 Hz), Pb 11.14 
(Jpb.Pa 60 Hz, Jpb.pt 3919 Hz) 
(R,R)-DIOP-Pt2-(±)-Cis-endo-bicyclo[2,2,1]-6/5-methoxycarbonyl-hepta-2-ene-
5/6-oic acid^ (77) 
Racemate- 5p (CQDQ) Pa 15.06 (Jpa-Pb 71 Hz, Jpg.pt 3472 Hz), Pb 13.58 
(Jpb-Pa 71 Hz, Jpb-pt 3443 Hz) 
(R,R)-DIOP-Pt^-(RS)- 1,1,1 -Trifluoro-2-acetoxy-2-phenylbut-3-yne (100). 
R-enantiomer- 6p {CQDQ) Pa 10.73 (Jpa-Pb 38 Hz, Jpg-R 3494 Hz), Pb 1.27 
(Jpb-Pa 39 Hz, Jpb-p, 3449 Hz) 
S-enantiomer- 5p {CQDQ) Pa 10.68 (Jpa-Pb 39 Hz, Jpa-R 3481 Hz), Pb 1.24 
(Jpb-Pa 39 Hz, Jpb-R 3481 Hz) 
5p {CQDQ) 74.88 (1H, s, (s)-CF3), 75.62 (1H, s, (R)-CF3), 78.32 (xH, s, free-CFg) 
a) . Received January 1989 from Fehr, C. 
Fehr, C; Galindo, J. J. Am. Chem. Soc, 1988, 110, 6909. 
b) . Received April 1990 from Roberts, S. M. Department of 
Chemistry, Exeter University. 
c) . Compound obtained from Fluka 82569 
d) . Received January 1990, from J. Gopal, J. Department of 
Chemistry, Durham University. 
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5.3.3 (R.m-2.3-0- lsopropyl idene-2.3-Dihvdroxv-1.4-Bis (Diphenvl phosphino) 
Butane Dichloro Platinum (W) aR.R)-DIOP-Pti iClo) 
Pt(*Bu CN)2Cl2^ (90 mg, 0.21 mmol) was dissolved in dry, degassed 
chloroform (3 cm3) under nitrogen, (R,R)-DIOP ^ (102 mg, 0.21 mmol) was 
dissolved in dry degassed chloroform then transferred by steel cannula to the 
plat inum complex. The solution was stirred for 20 minutes. The volume of 
d ichloromethane was reduced by a quarter, then methanol (0.5 cm^) was 
added. A precipitate formed which was collected by filtration, washed with 
methanol (3 x 0.5 ml) and dried under reduced pressure (106 mg, 67%). 
6p (CDCI3) 17.0 ppm (Jp.p, 3513 Hz) 
a - Bis (trimethylacetonitri le) dichloroplat inum(l l) . 
b - (R, R)-2,3-0-lsopropyl idene-2,3-dihydroxyl-1,4-
bis(diphenyl-phosphino)butane. 
5.3.4 (R.R)-2.3-Q-lsoprQpvl idene-2.3-Dihvdroxv-1.4-bis(diphenvlphosphino) 
butane Platinum m^-ethene fm.R)-DIOP-Pt° -CoH.) (35) 
(R,R)-DI0P-Pt"Cl2 (191 rng, 0.25 mmol) was dissolved in dry, degassed 
dichloromethane (4 ml) and dry, degassed ethanol (4 ml) was added. The 
solut ion was degassed with ethene and cooled to -78° C under nitrogen. 
Sod ium borohydride (22.7 mg, 0.60 mmol) was dissolved in dry ethanol (4 ml) 
and degassed with ethene then cooled to -78° C. The sodium borohydride 
solut ion was transferred by steel cannula to the platinum complex. Ethene 
was bubbled through the solut ion for 30 minutes. 
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The solution was al lowed to warm to room temperature, and at the first signs of 
darkening the complex was transferred to the dry degassed ethanol (15 ml). 
The solution was left for 15 minutes while the product precipitated. The 
product was f i l tered, washed with ethanol ( 3 x 5 ml) then dried under reduced 
pressure (144 mg, 80%) . 
5p {CQDQ) 14.39 ppm (Jp.pt3589 Hz) 
5.3.5 The Formation of (R.RVDIQP-Pt°-C2H^ Crystals for X-rav Analysis 
(R,R)-DIOP-Pt2-C2H4 (22.1 mg, 0.03 mmol) was dissolyed in 0.7 ml of DMSO 
and THF (2 ml). The THF was removed under reduced pressure, the solution 
fi l tered, degassed and left under nitrogen for 3 days for the crystals to form 
(See appendix for deposit ion data). 
5p {CQDQ) 14.53 ppm (Jp.pt3588 Hz) 
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Deposition Data 
1.1 (R.RVDI0P-Pt^-C9HA (35) 
Bond distances (A) 
P t - P ( l ) 2, 2 6 1 ( 1 ) C ( 1 2 ; - C ( 1 3 ) 1. 3 9 0 ( 8 ) 
P t - P ( 2 ) 2. 2 5 4 ( 1 ) 0 (13 ] - C ( 1 4 ) 1. 3 5 0 ( 1 1 ) 
P t - C ( l ) 2. 1 0 9 ( 5 ) C ( 1 4 ] - C ( 1 5 ) 1. 3 5 6 ( 1 0 ) 
P t - C ( 2 ) 2, 100 (5 ) C ( 1 5 ] - C ( 1 6 ) 1. 3 8 4 ( 8 ) 
P ( l ) - C ( 3 ) 1. 8 3 9 ( 4 ) C ( 2 1 ] - C ( 2 2 ) 1. 3 9 8 ( 7 ) 
P ( l ) - C ( l l ) 1. 8 2 7 ( 5 ) C ( 2 1 ) - C ( 2 6 ) 1. 3 7 4 ( 7 ) 
P ( l ) - C ( 2 1 ) 1. 823 (4) C ( 2 2 ) - C ( 2 3 ) 1. 4 0 4 ( 9 ) 
P ( 2 ) - C ( 6 ) 1. 8 4 3 ( 5 ) C ( 2 3 ) - C ( 2 4 ) 1. 364 (12) 
P ( 2 ) - C ( 3 1 ) 1. 8 3 1 ( 4 ) C ( 2 4 ) - C ( 2 5 ) 1. 3 4 7 ( 1 1 ) 
P ( 2 ) - C ( 4 1 ) 1. 8 3 4 ( 4 ) C ( 2 5 ) - C ( 2 6 ) 1. 3 8 6 ( 8 ) 
0 ( 1 ) - C ( 4 ) 1. 4 3 7 ( 5 ) C ( 3 1 ) - C ( 3 2 ) 1. 3 9 2 ( 6 ) 
0 ( 1 ) - C ( 7 ) 1. 4 3 7 ( 6 ) C ( 3 1 ) - C ( 3 6 ) 1. 3 9 5 ( 6 ) 
0 ( 2 ) - C ( 5 ) 1. 4 3 3 ( 5 ) C ( 3 2 ) - C ( 3 3 ) 1. 3 7 5 ( 9 ) 
0 ( 2 ) - C ( 7 ) 1. 4 0 1 ( 6 ) C ( 3 3 ) - C ( 3 4 ) 1. 3 7 2 ( 9 ) 
C ( l ) - C ( 2 ) 1. 4 0 2 ( 9 ) C ( 3 4 ) - C ( 3 5 ) 1. 3 7 3 ( 9 ) 
C ( 3 ) - C ( 4 ) 1. 5 2 5 ( 6 ) C ( 3 5 ) - C ( 3 6 ) 1. 3 8 8 ( 7 ) 
C ( 4 ) - C ( 5 ) 1. 5 2 1 ( 6 ) C ( 4 1 ) - C ( 4 2 ) 1. 3 8 4 ( 7 ) 
C ( 5 ) - C ( 6 ) 1. 5 2 1 ( 6 ) C ( 4 1 ) - C ( 4 6 ) 1. 3 7 1 ( 8 ) 
C ( 7 ) - C ( 8 ) 1- 4 9 4 ( 9 ) C ( 4 2 ) - C ( 4 3 ) 1. 3 7 3 ( 9 ) 
C ( 7 ) - C ( 9 ) 1. 5 3 0 ( 1 0 ) C ( 4 3 ) - C ( 4 4 ) 1. 3 7 6 ( 1 4 ) 
C ( l l ) - C ( 1 2 ) 1. 3 7 7 ( 7 ) C ( 4 4 ) - C ( 4 5 ) 1. 3 5 8 ( 1 3 ) 
C ( l l ) - C ( 1 6 ) 1. 3 9 6 ( 7 ) C ( 4 5 ) - C ( 4 6 ) 1. 3 9 9 ( 8 ) 
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Bond angles (°) 
P ( l ) - P t - P ( 2 ) 105 . 2 5 ( 4 ) 0 ( 2 ) - C ( 7 ) - 0 ( 9 ) 109 . 7 (5) 
P ( l ) - P t - C ( l ) 147 5 ( 2 ) C ( 8 ) - C ( 7 ) - 0 ( 9 ) 113 . 7 (6) 
P ( l ) - P t - C ( 2 ) 108 8 (2) P ( l ) - C ( l l ) - 0 ( 1 2 ) 125 . 0 (4) 
P ( 2 ) - P t - C ' ( l ) 107 1 ( 2 ) P ( l ) - C ( l l ) - C ( 1 6 ) 116 . 9 (4) 
P ( 2 ) - P t - C ( 2 ) 145. 9 ( 2 ) C ( 1 2 ) - C ( l l ) - C ( 1 6 ) 118 . 2 (5) 
C ( l ) - P t - C ( 2 ) 38 . 9 ( 3 ) C ( l l ) - C ( 1 2 ) - C ( 1 3 ) 120 . 3 (5) 
P t - P ( l ) - C ( 3 ) 118. 7 ( 1 ) C ( 1 2 ) - C ( 1 3 ) - C ( 1 4 ) 120 . 7 (6) 
P t - P ( l ) - C ( l l ) 111 . 8 ( 2 ) C ( 1 3 ) - C ( 1 4 ) - C ( 1 5 ) 120 . 1 (5) 
P t - P { l ) - C ( 2 1 ) 118 . 6 ( 2 ) C ( 1 4 ) - C ( 1 5 ) - C ( 1 6 ) 120. 6 (6) 
C ( 3 ) - P ( l ) - C ( l l ) 104 . 0 ( 2 ) C ( l l ) - C ( 1 6 ) - C ( 1 5 ) 120 . 1 (6) 
C ( 3 ) - P ( l ) - C ( 2 1 ) 100 . 2 (2) P ( l ) - C ( 2 1 ) - 0 ( 2 2 ) 121 . 2 (4) 
C ( l l ) - P ( l ) - C ( 2 1 ) 101 . 3 (2) P ( l ) - C ( 2 1 ) - 0 ( 2 6 ) 120 . 5 [4) 
P t - P ( 2 ) - C ( 6 ) 115 . 8 ( 2 ) C ( 2 2 ) - C ( 2 1 ) - C ( 2 6 ) 118 . 3 (5) 
P t - P ( 2 ) - C ( 3 1 ) 118 . 3 ( 1 ) C ( 2 1 ) - C ( 2 2 ) - C ( 2 3 ) 119. 5 (6) 
P t - P ( 2 ) - C ( 4 1 ) 115 . 6 ( 2 ) C ( 2 2 ) - C ( 2 3 ) - C ( 2 4 ) 120 . 4 [6) 
C ( 6 ) - P ( 2 ) - C ( 3 1 ) 100 . 5 ( 2 ) C ( 2 3 ) - C ( 2 4 ) - 0 ( 2 5 ) 120 . 1 (5) 
C ( 6 ) - P ( 2 ) - C ( 4 1 ) 102 . 5 ( 2 ) C(24 ) - C ( 2 5 ) - C ( 2 6 ) 120 . 8 (6) 
C ( 3 1 ) - P ( 2 ) - C ( 4 1 ) 101 . 7 ( 2 ) C ( 2 1 ) - C ( 2 6 ) - C ( 2 5 ) 120 . 9 [5) 
C ( 4 ) - 0 ( l ) - C ( 7 ) 109 . 5 ( 3 ) P ( 2 ) - - C ( 3 1 ) - 0 ( 3 2 ) 121 . 1 [4) 
C ( 5 ) - 0 ( 2 ) - C ( 7 ) 107 . 0 ( 3 ) P ( 2 ) - - C ( 3 1 ) - 0 ( 3 6 ) 120 . 1 [3) 
P t - C ( l ) - C ( 2 ) 7 0 . 2 ( 3 ) C ( 3 2 ) - C ( 3 1 ) - 0 ( 3 6 ) 118 . 7 [5) 
P t - C ( 2 ) - C ( l ) 7 0 . 9 ( 3 ) C ( 3 1 I - C ( 3 2 ) - 0 ( 3 3 ) 119 . 8 [7) 
P ( l ) - C ( 3 ) - C ( 4 ) 112 . 0 ( 3 ) C ( 3 2 ) - C ( 3 3 ) - C ( 3 4 ) 121 . 2 [6) 
0 ( 1 ) - C ( 4 ) - C ( 3 ) 107 . 5 ( 4 ) C ( 3 3 ) - C ( 3 4 ) - 0 ( 3 5 ) 120 . 0 [5) 
0 ( 1 ) - C ( 4 ) - C ( 5 ) 101 . 7 ( 3 ) C(34 - C ( 3 5 ) - C ( 3 6 ) 119. 6 [5) 
C ( 3 ) - C ( 4 ) - C ( 5 ) 117 . 5 ( 4 ) C ( 3 1 - C ( 3 6 ) - 0 ( 3 5 ) 120 . 7 [4) 
0 ( 2 ) - C ( 5 ) - C ( 4 ) 101 . 9 ( 3 ) P ( 2 ) - - C ( 4 1 ) - 0 ( 4 2 ) 117 . 3 [4) 
0 ( 2 ) - C ( 5 ) - C ( 6 ) 106- 0 ( 4 ) P ( 2 ) - - 0 ( 4 1 ) - 0 ( 4 6 ) 124 . 5 [4) 
C ( 4 ) - C ( 5 ) - C ( 6 ) 119 . 4 (4) C ( 4 2 , - 0 ( 4 1 ) - 0 ( 4 6 ) 118 . 2 [5) 
P ( 2 ) - C ( 6 ) - C ( 5 ) 114 . 2 ( 3 ) 0 ( 4 1 ] - 0 ( 4 2 ) - C ( 4 3 ) 121 . 21 [7) 
0 ( l ) - C ( 7 ) - 0 ( 2 ) 105 . 6 ( 4 ) 0 ( 4 2 ] - 0 ( 4 3 ) - 0 ( 4 4 ) 120 . 1 [7) 
0 ( 1 ) - C ( 7 ) - C ( 8 ) 110 . 0 ( 5 ) C ( 4 3 ] - 0 ( 4 4 ) - 0 ( 4 5 ) 119 . 8 [5) 
0 ( 1 ) - C ( 7 ) - C ( 9 ) 108 . 6 ( 6 ) C ( 4 4 ] - 0 ( 4 5 ( - 0 ( 4 6 ) 120 . 0 [7) 
0 ( 2 ) - C ( 7 ) - C ( 8 ) 109 . 0 ( 5 ) C ( 4 1 ] - 0 ( 4 6 ) - 0 ( 4 5 ) 120 . 7 [6) 
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Final atomic parameters (xlO'^, x lO^ for Pt, P1 and P2) and equivalent 
isotropic thermal parameters B|so (A^) 
ISO 
X y z 
Pt 11720(1) 25000 23296(1) 2 .950(8) 
P I . 15593(10) 7467(10) 32113(8) 3 . 0 5 ( 4 ) 
P2 -9080(11) 30380(10) 22221(9) 3 . 0 3 ( 4 ) 
01 -773(4) 98(4) 4880(3) 5 . 9 ( 2 ) 
02 -2073(3) 1759(3) 4530(3) 4 . 1 ( 1 ) 
C I 1856(6) 3792(5) 1503(5) 5 . 1 ( 3 ) 
02 2869(5) 2959(6) 1961(5) 5 . 3 ( 3 ) 
03 195(4) 53(4) 3550(4) 3 . 5 ( 2 ) 
04 -290(4) 864(4) 4242(3) 3 . 4 ( 2 ) 
05 -1497(4) 1651(4) 3733(4) 3 . 1 ( 2 ) 
06 -1297(5) 2931(4) 3422(4) 3 . 2 ( 2 ) 
07 -1920(5) 641(5) 5026(4) 4 . 5 ( 2 ) 
08 -1673(7) 841(8) 6143(5) 7 . 6 ( 4 ) 
09 -3132(10) -149(8) 4506(8) 9 . 1 ( 6 ) 
O i l 2090(5) -439(4) 2517(3) 3 . 7 ( 2 ) 
012 1338(5) -1425(5) 2070(5) 5 . 1 ( 3 ) 
013 1833(8) -2271(6) 1549(5) 6 . 7 ( 4 ) 
014 3042(7) -2124(6) 1451(4) 6 . 1 ( 3 ) 
015 3797(6) -1154(7) 1875(5) 6 . 1 ( 3 ) 
016 3336(6) -301(6 ) 2405(5) 5 . 1 ( 3 ) 
021 2880(4) 699(4) 4454(3) 3 . 4 ( 2 ) 
022 3186(6) -366(6 ) 5024(5) 5 . 1 ( 3 ) 
023 4168(6) -354(7 ) 5998(5) 6 . 5 ( 3 ) 
024 4838(6) 682(8) 6379(5) 6 . 3 ( 3 ) 
025 4558(7) 1703(6) 5821(5) 6 . 6 ( 3 ) 
026 3592(6) 1718(5) 4858(4) 5 . 1 ( 2 ) 
031 -2303(4) 2191(3) 1351(3) 3 . 2 ( 2 ) 
032 -3612(4) 2542(9) 1181(3) 4 . 4 ( 2 ) 
033 -4640(5) 1836(6) 590(5) 5 . 8 ( 3 ) 
034 -4403(6) 786(6) 156(5) 5 . 5 ( 3 ) 
035 -3121(6 ) 429(4) 302(4) 4 . 7 ( 3 ) 
036 -2070(5) 1132(4) 895(4) 3 . 8 ( 2 ) 
041 -1378(4) 4593(4) 1814(4) 3 . 7 ( 2 ) 
042 -1305(6) 4943(5) 872(5) 5 . 5 ( 3 ) 
043 -1577(7 ) 6105(7) 528(6) 7 . 1 ( 4 ) 
044 -1932(7) 6947(6) 1120(7) 7 . 5 ( 4 ) 
045 -2021(7) 6623(5) 2043(7) 7 . 1 ( 4 ) 
046 -1760(6) 5434(5) 2386(5) 5 . 4 ( 3 ) 
i s the mean o f the p r i n c i p a l axes o f the thermal 
e l l i p s o i d 
1 5 6 
Appendix 1 
Crystal data 
C^H.^PtO.R. >/ 721.68: monoclimc. a = 10.666(2). b = 11.105(3). c = 13.818(3) 
A. ^ = 109.45(2)°. K = 1543.3(6) k\ Z), = 1.553 gem"-'. Z = 2. ^(iMo-/CJ = 47.2 
cm" ' . F(OOO) = 715.85. Space group P2,. Crystal dimensions 0.49 x 0.36 x 0.33 
mm. 
Data collection and processing 
Intensity data were collected with a CAD4 diffractometer by the cj/2^-scan 
method with to = 0.6 + 0.35 tan ^. to a maximum 2^ = 53.8°. Cell data were 
determined by a least squares analysis of the settmg angles of 25 reflections with 
20 < 27 < 38°. The range of indices was h - 13 to 12. k - 1 4 to 14. / - 17 to 17. 
6492 Unique reflections were collected. Data were corrected for absorption Lorentz 
and polarisation effects and during refinement for secondary extinction. The 5901 
reflections with / > 3CT(/) were used in structure solution and refinement. 
Structure analysis and refinement 
The structure was solved by the heavy-atom method and refined by full-matrix, 
least-squares calculations. All non-hydrogen atoms were allowed anisotropic mo-
tion, with hydrogen atoms positioned geometrically ( C - H 0.95 A) and included (as 
riding atoms) in the structure factor calculations with an overall B-^^ of 5 A". The 
final cycle of refinement included 343 variable parameters and converged to 
R = 0.021. = 0.026. The absolute configuration was established unequivocally by 
refinement of a Sf" multiplier. Al l calculations were performed on a PC 386 system 
with the N R C V A X suite of programs 
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Electrostatic potentials for the planar ethene l igand. 
1 5 8 
Appendix 1 
1.2 1 R.2R-1 •2-Diphenvl-1 •2-diaminoethane Monohvdrobromide 
z y Z 
Br 037639 (3) 0.00000 0.994824(15) 
N(l) 0.1306(3) 0J485 (3) 0.03900(13) 
N(2) 0.1801 (5) 0.6511 (3) 0.12321 (18) 
C(l) 0.1918(4) 0J495 (3) 0.14472(18) 
C( l l ) 0.0964(3) 0.20056 (24) 0.19176(16) 
C(12) 0.2225(4) 0.1178(3) 0.26511 (17) 
C(13) 0.1358(5) -0.0166(5) 031114(17) 
C(14) -0.0736(5) -0.0690(4) 0.28361 (19) 
C(15) -0.1995(4) 0.0112(6) 0.21076(17) 
C(16) -0.1146(4) 0.1471 (3) 0.16541(18) 
G(2) 0.1209(3) 0J154(4) 0.18564(13) 
C(21) 0^86(4) 033170(25) 0.29143 (15) 
C(22) 0.4186(5) 0.5824(4) 031980(21) 
C(23) 0.4930(7) 0.6004 (5) 0.4159(3) 
C(24) 0 J557 (7) 0.5679 (7) 0.48433 (22) 
C(25) 0.1472(6) 0.5179 (9) 0.45749 (20) 
C(26) 0.0730(4) 0.4976 (7) 036117(16) 
Fract ional atomic coordinates and equivalent isotropic 
thermal parameters (A^) 
Geometr ic parameters (A, °) 
N ( l ) - C ( l ) 
N(2)-C(2) 
C ( l ) - C ( l l ) 
C( l ) -C(2) 
C(ll)—C(12) 
C( l l ) -C(16) 
C(l2)-Ca3) 
C(13)—C(14) 
C(14>-C(15) 
N(1)-C(1)_C(11) 
N(1)_C(1)-C(2) 
C ( l l ) - C ( l ) - C ( 2 ) 
C(l)—C(ll)—C(12) 
C(l>—C(ll)-C(16) 
C2—CI—Cll—C12 
C2—€1—€11—<:i6 
Nl—CI—C2—N2 
C l l -
0.04367(12) 
0.0333 (8) 
0.0409 (13) 
0.0320(10) 
0.0333 (9) 
0.0445(11) 
0.0522(14) 
0.0526(13) 
0.0501 (13) 
0.0419(11) 
0.0342 (9) 
0.0382(11) 
0.0566(15) 
0.0771 (20) 
0.091 (3) 
0.088 (3) 
0.0602(14) 
1.489(3) C(15)-C(16) 1395(4) 
1.469(4) C(2)—C(21) 1328(3) 
1.517(3) C(21)—C(22) 1377(4) 
1.535(4) C(21)—ca6) 1380P) 
1391 (3) C(22)—C(23) 1383(4) 
1384(3) C(23}—Ca4) 1370(6) 
1395(4) C(24}—C(25) 1363(7) 
1376(4) C(25)-C(26) 1388(4) 
1376(4) 
110.97(21) N(2)-C(2)-ai ) 109.00(19) 
108.89(20) N(2)—C(2)—Cai) 11535(23) 
112.71 (20) C(2)-C(21)—C(22) 122.10(21) 
119.11(21) C(2)—C(21)-C(26) 11932(21) 
121.84 (21) C(l)—C(2)—021) 11034(21) 
98.0 (2) CI—C2—C21—C22 81.4(2) 
803 (2) CI—C2—C21—C26 -99.7(3) 
443 (2) HI—CI—C2—H2 -173 a ) 
643 (2) 
Br—N(l)* 
Br—N(l)" 
3346(2) 
3279 (2) 
B r - N ( l ) ^ 
Br-N(2)'" 
3359 (2) 
3360(3) 
Symmetry codes: {\)-x,y-\A- z; (ii) x, y, 1 +r, (iii) 1 -x , y - ^, I - z. 
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Crystal data 
C14H17N2.Br-
Mr = 293.20 
Monocimic 
^21 
a = 6.1749 (4) A 
b = 8.0494 (4) A 
c = 14.0057 (5) A 
3 = 96.078 (4)° 
V = 692.23 (6) A^ 
Z = 2 
D, = 1.407 Mg m" 
Mo Ka radiation 
A = 0.70930 A 
Cell parameters from 25 
refiecDons 
9 = 15.00-20.00° 
^ = 2.92 mm"'' 
7 = 293 K 
Place 
0.12 X 0.25 X 0.55 mm 
Colourless 
Data collection 
Enraf-Nonius CAD-4 
diffrac to meter 
Lu/29 scans 
Absorption correction: 
empirical 
rn„n = 0.3107. T^ = 
0.5302 
2997 measured reflections 
2866 independent reflections 
2578 observed reflections 
> 3.0^(7^,)] 
y?ini = 0.008 
= 26.9 r 
A = 0 — 7 
k = - 1 0 — 10 
/ = _17 _ 17 
3 standard reflections 
frequency: 120 min 
intensirv' variation: 2.5% 
Refinement 
Refinement on F 
Final R = 0.021 
yvR = 0.026 
S = 1.09 
2578 reflections 
222 parameters 
All H-atom parameters re-
fined 
w = l/[<r^(F)+0.0004f^] 
( A / ^ t W = 0.003 
A p n ^ = 0.42 e A"^ 
Apnin = -0.30 e A - ^ 
Extinction correction: Larson 
(1970) 
Extinction coefficient; 3075 
(389) 
Atomic scattering factors 
from International Tables 
for X-ray Crystallogra-
phy (1974, Vol. IV, Table 
2.2B) 
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1.3 Oxonium (RVO-Acetvlman(jelate 
Crystal structure 
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Fractional atomic coordinates and equivalent isotropic 
thermal parameters (A^) 
0(1) 
0(2) 
0(3) 
0(4) 
0(W) 
C(l) 
C(2) 
CP) 
C(4) 
C(l l ) 
C(12) 
C(13) 
C(14) 
C(15) 
C(16) 
HOH'(l) 
HOVV(2) 
H0W(3) 
H0H'(4) 
X 
0.72312(18) 
0.48918(24) 
0.86806(20) 
0.8980(3) 
0.84868 (23) 
0.82823 (25) 
0J5529 (3) 
0.4592(4) 
0.8652(3) 
1.0032(3) 
1.0803 (3) 
1.2419(3) 
13269(3) 
12507 (3) 
1.0890(3) 
0.728 
0.964 
0.847 
0.854 
y 
0.24910 
0.0515(5) 
0.0492 (4) 
-0.2502(4) 
-0.5338(4) 
0.0561 (4) 
0.2254(5) 
0.4352 (6) 
-0.0576(4) 
0.1224(4) 
0.3199(4) 
03736(5) 
0.2329 (6) 
0.0351 (6) 
-0.0198(5) 
-0.506 
-0.512 
-0.678 
-0.420 
0.73775(12) 
0.65104(17) 
0^8554(12) 
0.68155(16) 
0.51118(15) 
0.76964(16) 
0.67886(20) 
0.6535 (3) 
0.66919(18) 
0.84925(16) 
0.84185(19) 
0.91500(24) 
0.99679 (22) 
1.00337(21) 
0.93026(19) 
0.449 
0.480 
0550 
0.580 
0.0457 (7) 
0.0764(12) 
0.0470 (8) 
0.07S7 (14) 
0.0603(10) 
0.0389(10) 
0.0531 (13) 
0.0777(18) 
0.0426(11) 
0.0378(10) 
0.0477(11) 
0.0614(15) 
0.0617(14) 
0.0632(14) 
0.0496(12) 
0.0707 
0.0707 
0.0707 
0.0707 
Bond lengths (A), bond angles (°) and contact distances (A) 
0(1)-C(1) 
0(1)-C(2) 
0(2)—C(2) 
0(3)-C(4) 
C ( l ) _ 0 ( l ) - C ( 2 ) 
0(1)—C(l)—C(4) 
0(1)_C(1)-C(11) 
C ( 4 ) - C ( l ) - C ( l l ) 
0(1)—C(2)-0(2) 
0(1)—C(2)-C(3) 
C2—OI—CI—C4 
C2—Ol—CI—Cll 
CI—Ol—C2—02 
C I — O l — C 2 — a 
Ol_Cl—C4—03 
Ol—CI—C4—04 
OIV—0(2)' 
IIOH'(l)—0(2)' 
0W—0{3y 
IlOlV(2)-0(3)' 
0I_C1—C4—04 
OIV—0(2)* 
H0H'(l)-0(2)' 
OW—0(3)' 
n0W'(2)-0(3)' 
1.451 (3) 
1.326 (3) 
1.211 (4) 
1.246(3) 
117.09(17) 
111.70(17) 
106.85 (20) 
110.27(16) 
122.1 (3) 
111.9 (3) 
67.7 (2) 
-171.6 (2) 
-1.0(1) 
1787 (2) 
26.4(1) 
-156.7 (3) 
2.902 (3) 
1.85 
2.794 (2) 
1.74 
-156.7(3) 
2.902(3) 
1.85 
2.794 (2) 
1.74 
Symmetry codes 
0(4)—C(4) 
C( l ) -C(4) 
C ( l ) - C ( l l ) 
cay-co) 
0(2)-C(2)-C(3) 
0(3)-C(4)-O(4) 
0(3 ) -C(4) -a i ) 
0(4) -C(4) -C( l ) 
C(ll)—C(16>-C(15) 
C l l - C l — C 4 — 0 3 
0 1 — C I - C I I — C 1 2 
01—CI—Cll—CI6 
C 4 — C I — C l l - C I 2 
C4—CI—Cll—CI 6 
OW—0(3) 
U0W(2)—O0) 
OIV—0(4) 
H01V(4)—0(4) 
C4-C1—Cn—C16 
OVV-OP) 
II0»V(3)—0(3) 
()IV_0(4) 
nOW(4)—0(4) 
(i) -x,{+y,-z. 
1.234(4) 
1^31(3) 
l i l 0 ( 3 ) 
1.496(5) 
126.01 (23) 
125.69(23) 
118.94(23) 
115.29(21) 
120.1 P) 
-923 (2) 
84.6(2) 
-31.1(1) 
149.8(2) 
905 (2) 
-88.6(2) 
2.763 p) 
1.76 
2.722 P) 
1.62 
-88.6(2) 
2.763 P) 
1.76 
2.722 P) 
1.62 
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Crystal daia 
HsO'.CioHgOr Mo Ka radiation 
Mr = 212.20 A = 0.70930 A 
Monoclinic Cell parameters from 25 
reflections 
a = 7.6772 (6) A 0 = 10.00-20.00° 
b = 6.2628 (5) A = 0.09 mm"' 
c = 12.4889 (8) A T = 293 K 
P = 104.879 (6)° Block 
V = 580.34 (7) A^ 0.60 X 0.30 X 0.10 mm 
Z = 2 Colourless 
Dx = 1.214 Mg m"' 
Data colleciion 
Nonius CAD-4 diffraciomc-
ter 
one scan . 
Absorption coireciion: 
none 
2511 measured reflections 
2426 independent reflections 
1893 observed refieciions 
> 3.0<7(/r.O] 
Refinemeni 
Refinement on F 
Final R = 0.039 
wR = 0.055 
S = 1.24 
1893 rcfleci:ons 
135 parameters 
w = I/[a^(r)^0.0G12f^] 
(A/(7)„ux = <0.001 
/?in, = 0.005 
/^rruu = 26.91° 
A = _9 _ 9 
k = {) — 1 
/ = 0 — 15 
3 standard reflections 
frequency: 120 min 
intensity variation: none 
Apnux = 0.12 e A"^ 
A/9,nin = -0.18 e A~^ 
Atomic scattering factors 
from Inlernaiional Tables 
for X-ray Crystallogra-
phy (1974, Vol. IV, Table 
2.2B) 
163 
Appendix 2 
Appendix 2 
List of spectra and figures 
2.1 List of Spectra 
1. R-N,N-Dimethyl-2-phenylglycine methyl ester (61) 
(±)-Camphanic acid (20) NMR, 400 MHz, CDCI3 
2. R-N,N-1-(1-Naphthyl)ethylamine (62) 
(±)-Camphanic acid (20) ' H NMR, 400 MHz, C D C I 3 
3. S-N-Methyl-l-Phenylethylamine (63b) 
RS-Mandelic acid (68) ' H NMR, 250 MHz, CDCI3 
4. (lS,2R)-(-t-)-Ephedrine (64a) 
RS-3-Phenylbutyric acid (69) ^H NMR, 400 MHz, CQDQ 
5. (lS,2R)-(+)-N-Methylephedrine (64b) 
RS-Phenylpropionic acid (70) ^H NMR, 400 MHz, CQDQ 
6. (lS,2S)-(+)-Pseudoephedrine (65a) 
RS-3-Phenylbutyric acid (69) ^H NMR, 400 MHz, CQDQ 
7. (lS,2S)-(-i-)-N-Methyl pseudoephedrine (65b) 
RS-3-Phenylbutyric acid (69) NMR, 400 MHz, CgDg 
8. S-2-(Anilinomethyl)-pyrrolidine (67) 
Ketoprofen (72) ' H NMR, 250 MHz, CDCI3 
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9. L-Proline p-Nitroanilide (66c) 
MTPA (11) NMR, 250 MHz, CgDg 
10. l,2-Diphenyl-l,2-diaminoethane (58) NMR, 250 MHz, CDCI3 
11. (lS,2S)-l,2-Diphenyl-l,2-diaminoethane (58) 
RS-O-Acetylmandelic acid (19) ^H NMR, 400 MHz 
12. (lR,2R)-l,2-Diphenyl-l,2-diaminoethane (58) 
RS-Hexahydromandelic acid (73) ^H NMR, 250 MHz, CDCI3 
13. (lR,2R)-l,2-Diphenyl-l,2-diaminoethane (58) 
(±)-Trans-cyclohexane-l,2-dicarboxylic acid (76) 
iH NMR, 500 MHz, CgDg 
14. (lR,2R)-l,2-Diphenyl-l,2-diaminoethane (58) 
RS-Ibuprofen (71) NMR, 400 MHz, CDCI3 
15. (lR,2R)-l,2-Diphenyl-l,2-diaminoethane (58) 
RS-a-Bromophenylacetic acid (81) ^H NMR, 400 MHz, CgDg 
16. (lS,2S)-l,2-Diphenyl-l,2-diaminoethane (58) 
RS-Chloropropionic acid (82) NMR, 250 MHz, CDCI3 
17. (lR,2R)-Diaminocyclohexane (85) 
RS-Naproxen (79) ^H NMR, 500 MHz, CDCI3 
18. (lS,2S)-N,N-Dibenzyl-l,2-diphenyl-l,2-diaminoethane (86a) 
RS-2-Chloropropionic acid (82) NMR, 500 MHz, CQDQ 
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19. (lR,2R)-l,2-Diphenyl-l,2-diaminoethane (58) 
Phenylacetic acid (87) ^H NMR, 400 MHz, CDCI3 
20. (1R,2R)-1,2-Diphenyl-1,2-diaminoethane (58) 
4-Bromophenylacetic acid (89) ^H NMR, 500 MHz, CDCI3 
21. (lS,2S)-l,2-Diphenyl-l,2-diaminoethane (58) 
S(-^)-2-Phenylpropionic acid (70) ^H NMR, 400 MHz, CDCI3 
22. (-)-DIOP-Pt-ethene (35) 3 i p NMR, 101 MHz, CQDQ 
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2.2 List of Figures 
1. Esters derived from mandelic acid 
2. Mosher's model and the sign of A5 for S-MTPA-R-MPTA correlated to 
absolute configuration 
3. The formation of an enantiomeric pair and a pair of non-equivalent 
meso diastereoisomers from an achiral alcohol and phosphorus(III) 
chloride. 
4. The formation of four diastereomeric complexes from Re, Si bound 
chiral allylic ethers and chiral trisubstituted allenes 
5. Commonly used chiral lanthanide shift reagents 
6. Conformations of L-proline 
7. Suggested conformation for the (S)-2-(Anilinomethyl)-pyrrohdine 
diastereomeric complexes with chiral acids 
8. Racemic mono- and di-carboxylic acids, cyclic alkane and branched 
alkyl substrates 
9. Anti-inflammatory agents and a-halo acids 
10. The methine resonances for 1R,2R-DPDAE (58) : RS-Flurbiprofen (78) 
complexes at both 2:1 and 1:1 ratio of amine to acid in CDCI3 and C5D5 
NMR, 400 MHz 
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11. A stacked plot of the variation of Chemical shift non-equivalence 
against stoichiometry for 1R,2R-DPDAE : RS-Bromopropionic acid 
NMR, 400 MHz, CDCI3 
12. A stacked plot of the variation of shift non-equivalence against the 
variation in enantiomeric purity of 0-Acetylmandelic acid (19) in 
1S,2S-DPDAE : 0-Acetylmandelic acid complexes 
m NMR, 400 MHz, CDCI3 
13. A stacked plot of the variation in shift non-equivalence with 
temperature for the 1R,2R-DPDAE : Ibuprofen complex 
^H NMR, 400 MHz, CeDgCDg 
14. The crystal structure for lR,2R-Diphenyldiaminoethane mono-
hydrobromide 
15. Diphenyldiaminoethane analogues 
16. Enantiotopic groups rendered diastereotopic by the introduction of a 
chiral centre 
17. Achiral carboxylic acids with enantiotopic methylene protons 
18. The variation of HR/HS with temperature for phenylacetic acid 87 
m NMR, 400 MHz, CDCI3 
19. A stacked plot of the methyl resonances of naproxen 79 at different 
enantiomeric purities for DPDAE : naproxen complexes 
m NMR, 400 MHz, CDCI3 
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20. A spectrum of S(-i-)-2-phenylpropionic acid 70 : DPDAE complex with 
expanded R(-)-2-phenylpropionic acid and S(-i-)-2-phenylpropionic 
acid ^^ C satellite resonances 
m NMR, 400 MHz, CDCI3 
21. A stacked plot for the varying enantiorrieric composition of 
2-methylbutyric acid 74 in 1R,2R-DPDAE : 2-methylbutyric acid 
complexes 
iH NMR, 400 MHz, CDCI3 
22. A stacked plot for the a-methyl resonances of racemic 
2-methylbutyric acid against enz3TTiatically derived 2-methylbutyric 
acid in their 1R,2R-DPDAE complexes 
^H NMR, 400 MHz, CDCI3 
23. a) Newman projections for lR,2R-l,2-diphenyl-l,2-diaminoethane 
b) A model for 1:1 complexation of l,2-diphenyl-l,2-diaminoethane 
c) A model for 2:1 complexation of l,2-diphenyl-l,2-diaminoethane 
24. The binding of chiral ri2-donors to DIOP-Pt°-ethene 
25. The Decoupled ^^ P spectra of 2-aza-bicyclo[2.2. l]-5-en-3-one 96 
derivatives with (-)-DIOP-Pt°-ethene 
'^^ P NMR, 202 MHz, CQDQ 
26. The Decoupled ^^ P spectra of damascone derivatives of 
(-)-DIOP-Pt°-ethene 
3ip NMR, 101 MHz, CfiDg 
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27. The NMR spectra of the R and S chiral alkyne l,l,l-trifluoro-2-
acetoxy-2-phenylbut-3-yne 100 
i^ F NMR, 376 MHz, CeDg 
28. The crystal structure for (-)-DIOP-Pt°-ethene 
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UNIVERSITY OF DURHAM 
Board of Studies in Chemistry 
COLLOQUIA, LECTURES AND SEMINARS GIVEN BY INVITED 
SPEAKERS 
1st October 1989 to 31st July 1990 
(* indicates lectures attended by the author) 
Palmer, Dr. F. (University of Nottingham) 17.10.89 
Thunder and Lightning 
Floriani, Prof. C. (University of Lausanne) 25.10.89 
Molecular Aggregates - A Bridge Between 
Homogeneous and Heterogeneous Systems 
Badyal, Dr. J. P. S. (University of Durham) 01.11.89 
Breakthroughs in Heterogeneous Catalysis 
Greenwood, Prof N. N. (University of Leeds) 09.11.89 
Novel Cluster Geometries in Metalloborane 
Chemistry 
Bercaw, Prof. J. E. (California Institute of Technology) 10.11.89 
Synthetic and Mechanistic Approaches to * 
Ziegler - Natta Polymerization of Olefins 
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Becher, Dr. J. (University of Odense) 13.11.89 
Synthesis of New Macrocyclic Systems Using 
Heterocyclic Building Blocks 
Parker, Dr. D. (University of Durham) 16.11.89 
Macrocycles, Drugs and Rock 'n' Roll * 
Cole-Hamilton, Prof D. J. (University of St. Andrews) 29.11.89 
New Polymers from Homogeneous Catalysis 
Hughes, Dr. M. N. (King's College, London) 30.11.89 
A Bug's Eye View of the Periodic Table 
Graham, Dr. D. (B. P. Research Centre) 04.12.89 
How Proteins Adsorb to Interfaces 
PoweU, Dr. R. L. (ICI) 06.12.89 
The Development of C.F.C. Replacements * 
Butler, Dr. A. (University of St. Andrews) 07.12.89 
The Discovery of Penicillin : Facts and Fancies * 
KUnowski, Dr. J. (University of Cambridge) 13.12.89 
Solid-state NMR Studies of Zeolite Catalysts 
Huisgen, Prof R. (Universitat Miinchen) 15.12.89 
Recent Mechanistic Studies of [2 + 2] Additions * 
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Perutz, Dr. R. N. (University of York) 24.01.90 
Plotting the Course of C-H Activations with 
Organometallics 
Dyer, Dr. U. (Glaxo) 31.01.90 
Synthesis and Conformation of C-Glycosides 
HoUoway, Prof J. H. (University of Leicester) 01.02.90 
Noble Gas Chemistry 
Thompson, Dr. D. P. (University of Newcastle upon Tyne) 07.02.90 
The Role of Nitrogen in Extending Silicate 
Crystal Chemistry 
Lancaster, Rev. R. (Kimbolton Fireworks) 08.02.90 
Fireworks - Principles and Practice * 
Lunazzi, Prof. L. (University of Bologna) 12.02.90 
Application of Dynamic NMR to the Study of * 
Conformational Enantiomerism 
Sutton, Prof. D. (Simon Fraser University, Vancouver) 14.02.90 
Synthesis and Applications of Dinitrogen and Diazo 
Compounds of Rhenium and Iridium 
Crombie, Prof. L. (University of Nottingham) 15.02.90 
The Chemistry of Cannabis and Khat * 
Bleasdale, Dr. C. (University of Newcastle upon Tyne) 21.02.90 
The Mode of Action of some Anti - Tumour Agents 
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Clark, Prof D.T. (ICI Wilton) 22.02.90 
Spatially Resolved Chemistry (using Nature's 
Paradigm in the Advanced Materials Arena) 
Thomas, Dr. R. K. (University of Oxford) 28.02.90 
Neutron Reflectometry from Surfaces 
Stoddart, Dr. J. F. (University of Sheffield) 01.03.90 
Molecular Lego * 
Cheetham, Dr. A. K. (University of Oxford) 08.03.90 
Chemistry of Zeolite Cages 
Fowls, Dr. I . (University of Nottingham) 21.03.90 
Spinning Off in a Huff: Photodissociation of 
Methyl Iodide 
Bowman, Prof J. M. (Emory University) 23.03.90 
Fitting Experiment with Theory in Ar-OH 
German, Prof L. S. (Soviet Academy of Sciences) 09.07.90 
New Syntheses in Fluoroaliphatic Chemistry : 
Recent Advances in the Chemistry of Fluorinated Oxiranes 
Platanov, Prof V.E. (Soviet Academy of Sciences, Novosibirsk 09.07.90 
Polyfluoroindanes : Synthesis and Transformation 
Rozhkov, Prof I . N. (Soviet Academy of Sciences, Moscow) 09.07.90 
Reactivity of Perfluoroalkyl Bromides 
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UNIVERSITY OF DURHAM 
Board of Studies in Chemistry 
COLLOQUIA, LECTURES AND SEMINARS GIVEN BY INVITED 
SPEAKERS 
1st August 1990 to 31st July 1991 
Macdonald, Dr. W.A. (ICI Wilton) 11.10.90 
Materials for the Space Age 
Bochmann, Dr. M. (University of East Anglia) 24.10.90 
Synthesis, Reactions and Catalytic Activity of 
Cationic Titanium Alkyls 
Soulen, Prof R. (South Western University, Texas) 26.10.90 
Preparation and Reactions of Bicycloalkenes 
Jackson, Dr. R.F.W. (University of Newcastle upon Tyne) 31.10.90 
New Synthetic Methods : a-Amino Acids and Small Rings * 
Logan, Dr. N. (University of Nottingham) 0L11.90 
Rocket Propellants 
Kocovsky, Dr. P. (University of Uppsala) 06.11.90 
Stereo-Controlled Reactions Mediated by Transition * 
and Non-Transition Metals 
Gerrard, Dr. D. (British Petroleum) 07.11.90 
Raman Spectroscopy for Industrial Analysis 
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Scott, Dr. S.K. (University of Leeds) 08.11.90 
Clocks, Oscillations and Chaos * 
Bell, Prof T. (SUNY, Stoney Brook, USA) 14.11.90 
Functional Molecular Architecture and Molecular * 
Recognition 
Pritchard, Prof J. (Queen Mary & Westfield College) 21.11.90 
Copper Surfaces and Catalysts 
Whitaker, Dr. B.J. (University of Leeds) 28.11.90 
Two-Dimensional Velocity Imaging of State-Selected 
Reaction Products 
Crout, Prof D. (University of Warwick) 29.11.90 
Enzymes in Organic Synthesis 
Pringle, Dr. P.O. (University of Bristol) 05.12.90 
Metal Complexes with Functionalised Phosphines 
Cowley, Prof A.H. (University of Texas) 13.12.90 
New Organometallic Routes to Electronic Materials 
Alder, Dr. B.J. (Lawrence Livermore Labs., California) 15.01.91 
Hydrogen in all its Glory 
Sarre, Dr. P. (University of Nottingham) 17.01.91 
Comet Chemistry * 
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Sadler, Dr. P.J. (Birkbeck College London) 
Design of Inorganic Drugs : Precious Metals, 
Hypertension & HIV 
24.01.91 
Sinn, Prof. E. (University of Hull) 
Coupling of Little Electrons in Big Molecules : 
Implications for the Active Sites of Metalloproteins 
and other Macromolecules 
30.01.91 
Lacey, Dr. D. (University of Hull) 
Liquid Crystals 
31.01.91 
Bushby, Dr. R. (University of Leeds) 
Biradicals and Organic Magnets 
06.02.91 
Petty, Dr. M.C. (Durham University) 
Molecular Electronics 
14.02.91 
Shaw, Prof. B.L. (University of Leeds) 20.02.91 
Syntheses with Coordinated, Unsaturated Phosphine 
Ligands 
Brown, Dr. J. (University of Oxford) 28.02.91 
Can Chemistry Provide Catalysts Superior to Enzymes? 
Dobson, Dr. CM. (University of Oxford) 
NMR Studies of Dynamics in Molecular Crystals 
06.03.91 
Markam, Dr. J. (ICI Pharmaceuticals) 
DNA Fingerprinting 
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Schrock, Prof R.R. (M.I.T.) 24.04.91 
Metal-Ligand Multiple Bonds and Metathesis Initiators 
Hudlicky, Prof T. (Virginia Polytechnic Institute) 25.04.91 
Biocatalysis and Symmetry Based Approaches to the 
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